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Introduction 
 
The Australian Corneal Graft Registry (ACGR) opened in May 1985 and 
has now been operating for 33 years. Over the years, we have collected 
information on more than 33,000 corneal grafts. 
At registration, we seek information on the donor, eye bank practices, 
the recipient, the surgeon, the graft type and the operative procedure. 
Follow-up then occurs at approximately yearly intervals for an indefinite 
period, and ceases upon graft failure, or the death or loss-to-follow-up 
of the patient. At each round of follow-up, we request information on the 
survival of the graft, the visual outcomes, and any relevant post-
operative events and treatments. 
The data are entered into an Access database and checked for 
consistency. Descriptive, univariate and multivariate analyses are 
subsequently performed using SPSS and Stata software, and the report 
is eventually collated. As has been the case in the past, a pdf of the 
final report is placed in a permanent, open-access institutional 
repository, so that it can be accessed freely. This report can be 
accessed at: http://hdl.handle.net/2328/37917. 
We have analysed all grafts performed up to 30-04-2017 and registered 
with the Australian Corneal Graft Registry up to a census date of 31-
07-2017. Penetrating keratoplasties (PKs), traditional lamellar 
keratoplasties (TLKs), deep anterior lamellar keratoplasties (DALKs), 
and the various forms of endothelial cell keratoplasty (DSEKs/DSAEKs 
and DMEKs) have been examined separately.  
We thank our many contributors for their tireless efforts on our behalf. 
We hope this report is useful and relevant to your clinical practice. 
  
How to read our Kaplan-Meier Plots of 
Graft Survival  
1. The vertical axis shows the probability of graft survival. "Perfect" 
survival (no failures) equates to a probability of 1.0. It may help to think 
of this as 100% survival. 
2. The horizontal axis shows time elapsed from the date of graft. This 
is shown as years post-graft, although the analysis is performed on 
daily graft survival. 
3. The p-values shown have been calculated by log-rank analysis 
and reflect a comparison of the behaviour of the curves as a whole 
(taking all available data into consideration), rather than at any one 
time-point. 
4. The numbers of recipients being followed at given times after graft 
are shown below the curves in the “Number at risk” table. At time zero, 
all followed patients in the given cohort are at risk. At the furthermost 
point on the right hand side of any curve, the patient(s) who have been 
followed for the longest time are at risk. 
We suggest that you interpret the survival curves with this in mind. A 
sudden "dip" in survival at the far right of a given curve may merely 
mean, for example, that one of only two grafts that have been followed 
for this length of time has failed. When the survival curve drops to zero, 
this means that all grafts that have reached this length of follow-up have 
failed. It does not mean that all grafts in this stratum have failed, or will 
fail.  
For example, a single graft may have been followed for 2 years, at 
which point it failed, while 20 grafts may have been followed for 1 year 
and 364 days and are all surviving at last follow-up. No other grafts have 
been followed for as long as the one that has failed, so the survival 
curve will drop to zero at this point. However, had the graft failed at 1 
year and 364 days, the curve would not meet the horizontal axis, as 
there would be 20 other surviving grafts followed for the same amount 
of time.  
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1 Overview of the Australian Corneal Graft 
Registry 
 
1.1 The database 
 
At the time of census (31-07-2017), 33,920 grafts had been registered, of which 26,297 
(77.5%) had been followed at least once. Table 1.1 shows the number of each type of 
graft that had been registered, had follow-up information provided and remained “active” 
(the graft had not failed and the recipient is not known to have died, or been lost to 
follow-up by the surgeon). Table 1.2 shows the status of these grafts, in more detail.  
 
Table 1.1 Registered, followed and active grafts, 1985 onwards 
    
 Registered Followed* Active 
    
PK 24,827 (73.2%) 20,336 (77.3%) 5,567 (50.3%) 
DALK 1,531 (4.5%) 921 (3.5%) 1,054 (9.5%) 
DS(A)EK 4,736 (14.0%) 3,263 (12.4%) 3,189 (28.8%) 
DMEK 1,250 (3.7%) 600 (2.3%) 932 (8.4%) 
TLK 1,495 (4.4%) 1,114 (4.2%) 317 (2.9%) 
Limbal 81 (0.2%) 63 (0.2%) 12 (0.1%) 
Total 33,920 (100.0%) 26,297 (100.0%) 11,071 (100.0%) 
    
 
Note: PK = penetrating keratoplasty. DALK = deep anterior lamellar keratoplasty. DS(A)EK = Descemet’s stripping 
endothelial keratoplasty, Decemet’s stripping automated endothelial keratoplasty, ultra-thin Decemet’s stripping 
automated endothelial keratoplasty, or unspecified endothelial grafts. DMEK = Decemet’s membrane endothelial 
keratoplasty. TLK = traditional lamellar keratoplasty, including peripheral and scleral patch grafts. 







Table 1.2 Synopsis of the database, including registered, followed, surviving and active grafts 
        
 PK DALK DS(A)EK DMEK TLK Limbal Total 
Registered 24827 (100%) 1531 (100%) 4736 (100%) 1250 (100%) 1495 (100%) 81 (100%) 33920 (100%) 
         
Followed*  20336 (82%) 921 (60%) 3263 (69%) 600 (48%) 1114 (75%) 63 (78%) 26297 (78%) 
Failed 5686 (23%) 113 (7%) 791 (17%) 251 (20%) 296 (20%) 30 (37%) 7167 (21%) 
  Recipient still alive 3784 (15%) 112 (7%) 744 (16%) 248 (20%) 201 (13%) 25 (31%) 5114 (15%) 
  Recipient subsequently died 1902 (8%) 1 (<1%) 47 (<1%) 3 (<1%) 95 (6%) 5 (6%) 2053 (6%) 
Recipient died with surviving graft 4005 (16%) 14 (<1%) 140 (3%) 6 (<1%) 212 (14%) 9 (11%) 4386 (13%) 
Lost post follow-up 6648 (27%) 234 (15%) 448 (9%) 37 (3%) 423 (28%) 18 (22%) 7808 (23%) 
Followed, surviving and active 3997 (16%) 560 (37%) 1884 (40%) 306 (24%) 183 (12%) 6 (7%) 6936 (20%) 
        
Number of grafts not followed 4491 (18%) 610 (40%) 1473 (31%) 650 (52%) 381 (25%) 18 (22%) 7623 (22%) 
Recipient died pre follow-up 1033 (4%) 7 (<1%) 63 (1%) 9 (<1%) 106 (7%) 3 (4%) 1221 (4%) 
Lost prior to follow-up 1888 (8%) 109 (7%) 105 (2%) 15 (1%) 141 (9%) 9 (11%) 2267 (7%) 
Not yet followed but active 1570 (6%) 494 (32%) 1305 (28%) 626 (50%) 134 (9%) 6 (7%) 4135 (12%) 
         
Graft surviving when last seen 19141 (77%) 1418 (93%) 3945 (83%) 999 (80%) 1199 (80%) 51 (63%) 26753 (79%) 
Graft lost when surviving 8536 (34%) 343 (22%) 553 (12%) 52 (4%) 564 (38%) 27 (33%) 10075 (30%) 
  Lost prior to follow-up 1888 (8%) 109 (7%) 105 (2%) 15 (1%) 141 (9%) 9 (11%) 2267 (7%) 
  Lost post follow-up 6648 (27%) 234 (15%) 448 (9%) 37 (3%) 423 (28%) 18 (22%) 7808 (23%) 
Recipient died with surviving graft 5038 (20%) 21 (1%) 203 (4%) 15 (1%) 318 (21%) 12 (15%) 5607 (17%) 
  Recipient died pre follow-up 1033 (4%) 7 (<1%) 63 (1%) 9 (<1%) 106 (7%) 3 (4%) 1221 (4%) 
  Recipient died post follow-up 4005 (16%) 14 (<1%) 140 (3%) 6 (<1%) 212 (14%) 9 (11%) 4386 (13%) 
        
Currently active grafts  5567 (22%) 1054 (69%) 3189 (67%) 932 (75%) 317 (21%) 12 (15%) 11071 (33%) 
Not yet followed but active 1570 (6%) 494 (32%) 1305 (28%) 626 (50%) 134 (9%) 6 (7%) 4135 (12%) 
Followed, surviving and active 3997 (16%) 560 (37%) 1884 (40%) 306 (24%) 183 (12%) 6 (7%) 6936 (20%) 
        
*Excludes grafts where the recipient is known to have died but no further information has been provided regarding the survival of the graft.  
 
Overview 
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1.1.1 Changing practice: annual increase in corneal graft registrations 
 
The number of grafts registered with the Australian Corneal Graft Registry each year 
remained stable during the ten years to 2006, with an average of 933 grafts being 
registered annually. An increase was seen from this point, which coincided with the 
introduction of the newer endothelial transplantation techniques - DSEK and DSAEK, 
closely followed by DMEK. The number of grafts being registered continued to increase 
steadily from 2009 to 2012. There has been a further increase during the last two full 
years for which data is available, as shown in Figure 1.1.1.  
Figure 1.1.1 Number of grafts registered with the ACGR per year, 1997 onwards 
 
Note: Data relating to all registrations of grafts performed up to and including 30th April 
2017, for which forms had been received by the ACGR prior to 1st August 2017, were 
included. Some grafts performed prior to this date may still be registered in the future.  
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1.1.2 Changing practice: the introduction of partial-thickness keratoplasties 
 
Figure 1.1.2 shows registrations stratified by graft type over the last 20 years, for which 
data were available for the full year. Data from 2017 were excluded due to the low number 
of grafts registered at the census date. 
Figure 1.1.2 Graft type by year of registration, 1997 onwards 
 
 
The introduction of new types of partial-thickness corneal grafts has led to a marked shift 
away from full-thickness penetrating keratoplasty, so that ten years after their 
introduction, endothelial grafts (DS(A)EK and DMEK) account for more than half of all 
registered grafts.  
After a gradual increase from 2000 to 2008, the proportion of deep anterior lamellar 
keratoplasties (DALKs) remained stable for several years but has reduced recently, so 
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1.1.3 Comparison of desired outcome for different types of keratoplasty 
 
Surgeons indicated whether a graft was performed for: “improved visual acuity”, “pain 
relief”, “cosmesis”, “tectonic/structural repair”, or a combination of these reasons. Data 
were provided for 29,338 grafts (86%). Reason for graft was less likely to have been 
specified for TLK (80%), PK (84%) and limbal grafts (84%), compared with DALK (95%), 
DS(A)EK (96%), or DMEK (96%). Improved visual acuity was a desired outcome in 91% 
of these grafts, pain relief in 17%, structural repair in 9%, and cosmesis in 2%. 
Desired outcome varied depending on graft type. The desired outcome most often 
selected for PK, DALK, DS(A)EK, and DMEK, was improvement in visual acuity. This was 
an aim in 92%, 98%, 98% and 99% of grafts being performed in each group (either as an 
individual aim or in conjunction with other desired outcomes), respectively. Traditional 
lamellar keratoplasty was most often performed to provide structural repair (71%). Figure 
1.1.3 shows the desired outcomes indicated by surgeons, for each type of graft.  
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1.2 Overall survival probability 
 
Figure 1.2.1 shows the survival curves for each type of graft. Grafts for which follow-up 
has not yet been provided are modelled as surviving at 1 day. The initial number at risk 
(including these modelled grafts) are given in the graph for each graft type. The number 
of grafts at risk, and the survival probability, are provided at various time points for each 
graft type. These time points vary depending on the maximum length of follow-up 
available for each graft type, and cease when fewer than 15 grafts had been followed. 
Primary graft failure was reported in 181 penetrating keratoplasty (0.8%), 15 traditional 
lamellar keratoplasties (1.2%), 14 deep anterior lamellar keratoplasties (1.5%), 221 
Descemet’s stripping (automated) endothelial keratoplasties (6.6%), 158 Descemet’s 
membrane endothelial keratoplasties (25.9%), and 1 limbal graft (1.5%). Primary graft 
failure was reported for eight pairs of cornea (i.e. both corneas from the same donor). 
When conducting survival analysis, comparisons across groups containing very small 
numbers, or very small proportions of the study population, are not considered reliable or 
informative. With this in mind, we have only analysed comparisons amongst categories 
for which data on more than 20 followed grafts were available for DALK, DS(A)EK, DMEK 
and TLK, and data on more than 50 followed grafts were available for PK (20 in 
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Figure 1.2.1 Survival of corneal grafts for a) penetrating keratoplasty, b) deep 
anterior lamellar keratoplasty, c) Descemet's stripping (automated) endothelial 
keratoplasty, d) Descemet's membrane endothelial keratoplasty, e) traditional 
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2 Penetrating Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 24,827 
penetrating keratoplasties registered with the ACGR. Kaplan-Meier survival analyses 
were conducted using IBM SPSS for Windows (Version 22.0), to compare the graft 
survival across groups for a range of variables relating to the corneal donor, graft 
recipient, surgical procedure, surgeon, and follow-up care. 
2.1 Donor and Eye Banking Factors 
 
Table 2.1 shows the number of grafts within each of the variable sub-groups, for the donor 
and eye banking factors found to be significant in univariate analyses. The sum for each 
variable equals the total number of grafts (24,827 registered and 20,336 with follow-up 
provided) and the percentages, summed vertically for each variable, total 100. 
Table 2.1 Donor and eye banking factors, significant in univariate analyses 
 
Penetrating Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank M 8667 (35%) 6750 (33%) 
  Eye bank K 4795 (19%) 3988 (20%) 
  Eye bank V 4407 (18%) 3576 (18%) 
  Eye bank J 2436 (10%) 1762 (9%) 
  Eye bank N 2812 (11%) 2604 (13%) 
  Not advised 1710 (7%) 1656 (8%) 
   
Death-to-enucleation time   
  Up to 3 hours 4872 (20%) 4317 (21%) 
  4 to 6 hours 5831 (23%) 4907 (24%) 
  7 to 9 hours 5390 (22%) 4423 (22%) 
  10 to 12 hours 4380 (18%) 3563 (18%) 
  13 to 15 hours 1762 (7%) 1323 (7%) 
  16 to 18 hours 1117 (4%) 752 (4%) 
  More than 18 hours 1145 (5%) 766 (4%) 
  Not advised 330 (1%) 285 (1%) 
   
Storage medium   
  Optisol 12535 (50%) 9832 (48%) 
  Organ culture 2825 (11%) 1844 (9%) 
  Moist pot 335 (1%) 316 (2%) 
  Superseded hypothermic 8974 (36%) 8202 (40%) 
  Other 6 (<1%) 6 (<1%) 
  Not advised 152 (<1%) 136 (<1%) 
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 Registered (%) Followed (%) 
   
Storage-to-graft time – hypothermic   
  Within 5 days 13974 (56%) 11978 (59%) 
  6 or 7 days 2615 (11%) 2036 (10%) 
  More than a week 607 (2%) 481 (2%) 
  Not advised 4313 (17%) 3539 (17%) 
  Not applicable 3318 (13%) 2302 (11%) 
   
Sex of donor   
  Female 8884 (36%) 7291 (26%) 
  Male 15317 (62%) 12484 (61%) 
  Not advised 626 (3%) 561 (3%) 
   
Age group   
  Under 20 years 948 (4%) 775 (4%) 
  20 to 29 years 1260 (5%) 999 (5%) 
  30 to 39 years 1258 (5%) 1006 (5%) 
  40 to 49 years 2548 (10%) 2085 (10%) 
  50 to 59 years 4286 (17%) 3452 (17%) 
  60 to 69 years 6167 (25%) 5015 (25%) 
  70 to 79 years 5979 (24%) 5007 (25%) 
  80 years and older 2078 (8%) 1727 (8%) 
  Not advised 303 (1%) 270 (1%) 
   
Cause of death   
  Cardiac event 7410 (30%) 6123 (30%) 
  Malignancy 5838 (24%) 4685 (23%) 
  Trauma 2749 (11%) 2170 (11%) 
  Respiratory event 2302 (9%) 1935 (10%) 
  Intracranial/cerebral haemorrhage 4234 (17%) 3441 (17%) 
  Other specified 1179 (5%) 990 (5%) 
  Live donor 31 (<1%) 25 (<1%) 
  Not advised* 1084 (4%) 967 (5%) 
   
Multi-organ donor status   
  No 22684 (91%) 18654 (92%) 
  Yes 2143 (9%) 1682 (8%) 
   
Central corneal endothelial cell density  
  <2500 cells/mm² 452 (2%) 322 (2%) 
  2500 to 2749 cells/mm² 807 (3%) 554 (3%) 
  2750 to 2999 cells/mm² 1041 (4%) 736 (4%) 
  3000 to 3249 cells/mm² 1450 (6%) 956 (5%) 
  3250 to 3499 cells/mm² 771 (3%) 518 (3%) 
  ≥ 3500 cells/mm² 510 (2%) 351 (2%) 
  Not advised 19796 (80%) 16899 (83%) 
   
Total 24827 (100%) 20336 (100%) 
   
 
*ACGR advised that cause of death was not yet determined but there were no medical contraindications and the eye 
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Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Likelihood of follow-up was significantly more likely (p<0.05) in some groups that others. 
Higher rates of follow-up were received for grafts where donor tissue was stored in 
hypothermic solution for five days or less. Rates were lower for grafts performed using 
donor tissue that had been stored in organ culture, for donor tissue from multi organ 
donors, and those that had died from trauma. Significant differences in follow-up were 
also found across groups for eye bank, death-to-enucleation times and donor age.  
Table 2.2 shows the number of grafts within each of the variable sub-groups, for the donor 
and eye banking factors found to be non-significant in univariate analyses. The sum for 
each variable equals the total number of grafts (24,827 registered and 20,336 with follow-
up provided) and the percentages, summed vertically for each variable, total 100. The 
result of the Kaplan-Meier survival analysis is also provided for each variable.  
Table 2.2 Donor and eye banking factors, not significant in univariate analyses 
 
Penetrating Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Enucleation-to-storage time   
  Up to 3 hours 14764 (59%) 12307 (61%) 
  4 to 6 hours 2331 (9%) 1817 (9%) 
  7 to 12 hours 1135 (5%) 908 (5%) 
  13 hours or more 963 (4%) 769 (4%) 
  Not advised 5634 (23%) 4535 (22%) 
Chi²=4.00, df=3, p=0.262   
   
Storage to graft time - Organ culture  
   Up to 2 weeks 608 (2%) 399 (2%) 
   2 to 3 weeks 968 (4%) 600 (3%) 
   More than 3 weeks 288 (1%) 187 (<1%) 
   Not advised 961 (4%) 658 (3%) 
   Not applicable 22002 (89%) 18492 (91%) 
Chi²=2.34, df=2, p=0.311   
   
 24827 (100%) 20336 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not 
advised or not applicable.  
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2.1.1 Penetrating graft survival: influence of Australian eye bank 
 
Donor corneas are retrieved, processed, stored and distributed by five eye banks around 
Australia. Figure 2.1.1 shows the comparison of graft survival for corneas provided by 
each of these eye banks. A significant difference was found across eye banks (Log Rank 
Statistic=16.94; df=4; p=0.002), with grafts performed in State V having poorer survival 
than those performed in State M (p=0.001) and State J (p<0.001). Data on this variable 
were not provided in 7% of cases, primarily registered with the ACGR in the 1980s. A 
further category was thus created called “not advised”. A significant difference was still 
found across groups when this category was included (Log Rank Statistic=41.87; df=5; 
p<0.001). This variable was not retained in the multivariate analysis (see section 2.7) 
suggesting that this is not an independent factor significantly affecting graft survival. 
Figure 2.1.1 Australian eye bank 
 
Number at risk (years post-graft) 
 1 4 8 12 16 20 24 
Eye Bank M 5597 2578 1116 534 294 142 32 
Eye Bank K 3434 1503 614 269 110 30 3 
Eye Bank V 2860 1042 338 113 33 10 NA 
Eye Bank J 1434 740 363 207 96 48 18 
Eye Bank N 2160 1115 529 299 164 94 49 
Note: NA = not applicable, as no grafts followed at this time point 
Probability of graft survival (years post-graft) 
 1 4 8 12 16 20 24 
Eye Bank M 0.93 0.78 0.64 0.51 0.42 0.31 0.15 
Eye Bank K 0.94 0.76 0.63 0.51 0.42 0.27 NA 
Eye Bank V 0.93 0.75 0.59 0.45 0.33 NA NA 
Eye Bank J 0.92 0.79 0.68 0.57 0.43 0.32 NA 
Eye Bank N 0.91 0.76 0.65 0.56 0.48 0.38 0.32 
Note: NA = not applicable, as fewer than 20 grafts followed at this time point  
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2.1.2 Penetrating graft survival: influence of death-to-enucleation times 
 
Donor corneas are retrieved as soon as possible following donor death. Retrieval is 
recommended within the first 18 hours and 95% of donor eyes were enucleated within 
this time-frame. Times are rounded to the nearest hour and the median time from donor 
death to enucleation was 7 hours (range 0-43 hours).  
Figure 2.1.2 shows a comparison of graft survival depending on time from donor death to 
enucleation, stratified into three-hourly groups. A significant difference was found across 
time groups (Log Rank Statistic=20.58; df=6; p=0.002). Data on this variable were not 
provided in 1% of cases. A further category was thus created called “not advised”. A 
significant difference was still found across groups when this category was included (Log 
Rank Statistic=21.60; df=7; p=0.003). Grafts performed using donor tissue collected 
within 3 hours of death showed better outcomes than those for which the tissue was 
collected 4 to 6 hours or 7 to 9 hours after death (both p<0.001). When this group (up to 
3 hours) was excluded from the analysis, the difference across the remaining 6 groups 
was not significant (p=0.767). This variable was not retained in the final model (see 


















Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 
Up to 3 hours 3610 1851 941 534 288 147 60 
4 to 6 hours 4028 1950 882 449 242 120 45 
7 to 9 hours 3664 1667 749 368 168 74 30 
10 to 12 hours 2981 1336 536 234 100 50 10 
13 to 15 hours 1107 458 165 67 26 11 1 
16 to 18 hours 619 193 64 27 13 7 2 
More than 18 hours 630 182 40 12 5 3 1 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 
Up to 3 hours 0.93 0.79 0.68 0.58 0.48 0.35 0.25 
4 to 6 hours 0.92 0.76 0.66 0.55 0.45 0.31 0.19 
7 to 9 hours 0.93 0.76 0.62 0.51 0.42 0.31 0.20 
10 to 12 hours 0.93 0.77 0.61 0.49 0.37 0.29 NA 
13 to 15 hours 0.92 0.76 0.62 0.50 0.45 NA NA 
16 to 18 hours 0.92 0.75 0.63 0.52 NA NA NA 
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2.1.3 Penetrating graft survival: influence of type of corneal storage media 
 
In Australia, two storage methods are currently commonly used to preserve donor 
corneas prior to transplantation. In hypothermic storage, donor tissue is preserved and 
refrigerated below 4 degrees Celsius until required. The current storage media utilised for 
hypothermic preservation is Optisol GS, however a number of media have been used 
previously (e.g. K-Sol, Dextran, M-K medium). The alternative storage method, Organ 
Culture, involves warm storage, and was introduced to Australia in recent years. Data 
were not analysed for 335 grafts where the donor eye was stored in a moist pot, the 
cornea was preserved using another alternative specified method (n=6), or the eye bank 
did not specify which medium was used (n=152). Figure 2.1.3 shows the comparison of 
graft survival for corneas stored using hypothermic techniques compared to organ culture 
medium. A significant difference in outcomes was found between media (Log Rank 
Statistic=9.10; df=1; p=0.003). This variable was not retained in the final model (see 
section 2.7), suggesting that it is not an independent factor significantly affecting graft 
survival. 
Figure 2.1.3 Corneal storage media (modern media only) 
 
Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 28 
Organ culture 1574 394 42 11 NA NA NA NA 
Hypothermic 14937 7188 3298 1649 814 392 136 22 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 28 
Organ culture 0.93 0.73 0.51 0.45 NA NA NA NA 
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2.1.4 Penetrating graft survival: influence of storage time – hypothermic medium 
 
Corneas stored in hypothermic medium are most often used within 5 days of storage and 
are rarely stored for longer than 7 days. Figure 2.1.4 shows the comparison of graft 
survival across storage time for those corneas stored in hypothermic medium. A 
significant difference was found across groups (Log Rank Statistic=14.01; df=2; p=0.001). 
Data on this variable were not provided in 30% of cases (13% of tissue was stored using 
a different technique, and the other 17% had no data provided). Two further categories 
were thus created called “not applicable” and “not advised”. A significant difference was 
still found across groups when these categories were included (Log Rank Statistic=19.49; 
df=4; p=0.001). 
Grafts using donor tissue stored for up to 5 days exhibited better survival than those 
stored for 6 to 7 days (p=0.001) or more than a week (p=0.013). The difference in survival 
between the two groups of tissue stored for more than 5 days was not significant 
(p=0.359). This variable was not retained in the final model (see section 2.7), suggesting 
that it is not an independent factor significantly affecting graft survival. 
Figure 2.1.4 Time from storage to graft, Optisol medium storage  
 
Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 
Within 5 days 9941 4855 2305 1213 629 301 107 
6 to 7 days 1681 709 289 114 41 19 6 
More than 1 week 399 164 69 29 11 6 1 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 
Within 5 days 0.93 0.78 0.66 0.55 0.46 0.33 0.21 
6 to 7 days 0.93 0.75 0.62 0.47 0.34 NA NA 
More than 1 week 0.93 0.73 0.61 0.45 NA NA NA 
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2.1.5 Penetrating graft survival: influence of donor sex  
 
Almost two-thirds of corneal donors were male. Figure 2.1.5 shows the comparison of 
graft survival depending on donor sex. A significant difference was found between groups 
(Log Rank Statistic=7.88; df=1; p=0.005). Data on this variable were not provided in 3% 
of cases. A further category was thus created called “not advised”. A significant difference 
was still found across groups when this category was included (Log Rank Statistic=9.12; 
df=2; p=0.010). This variable was not included in the multivariate model (see section 2.7), 
as it is collinear with the variable analysing donor/recipient sex match/mismatch (see 
section 2.2.2), which was included. 




Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 
Female 6037 2768 1154 623 321 148 58 
Male 10395 4777 2123 1032 495 248 89 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 
Female 0.93 0.78 0.65 0.55 0.46 0.32 0.23 
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2.1.6 Penetrating graft survival: influence of donor age (years) 
 
Figure 2.1.6 shows the comparison of graft survival depending on donor age, stratified by 
10 year age groups. Donors aged under 10 years or over 90 years are rare, and so these 
data were combined with the adjacent age groups. A significant difference was found 
across groups (Log Rank Statistic=256.53; df=7; p<0.001).  
Grafts performed using tissue from donors aged under 20 years, 20 to 29 years, 30 to 39 
years and 40 to 49 years, had significantly better survival than those performed using 
tissue from donors aged 50 to 59 years, 60 to 69 years, 70 to 79 years and 80 years and 
older (all comparisons p<0.001). The differences in survival between grafts performed 
with tissue from donors aged 50 to 59 years and each of the three older age groups were 
also significantly different (all p<0.001), as was the comparison between grafts performed 
with tissue from donors aged 60 to 69 years and those aged 80 years or older (p<0.001). 
In all cases the younger donor tissue was associated with better survival. Donor age 
groups under 50 years were thus categorised together for multivariate analysis.  
Data on this variable were not provided in 1% of cases. A further category was thus 
created called “not advised”. A significant difference was still found across groups when 
this category was included (Log Rank Statistic=251.63; df=5; p<0.001). This variable was 
retained in multivariate analysis (see section 2.7) suggesting that this is an independent 
factor significantly affecting graft survival.  
 











Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 
Under 20 years 677 350 170 96 48 29 7 
20 to 29 years 845 439 228 126 57 27 14 
30 to 39 years 866 411 199 111 53 29 12 
40 to 49 years 1771 855 380 203 107 48 16 
50 to 59 years 2897 1394 619 310 145 76 27 
60 to 69 years 4163 1831 780 361 183 94 31 
70 to 79 years 4048 1788 784 374 190 88 34 
80 years and older 1387 584 219 109 58 22 9 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 
Under 20 years 0.95 0.87 0.79 0.73 0.62 0.49 NA 
20 to 29 years 0.94 0.86 0.78 0.70 0.59 0.43 NA 
30 to 39 years 0.94 0.82 0.76 0.66 0.57 0.46 NA 
40 to 49 years 0.94 0.83 0.72 0.63 0.56 0.40 NA 
50 to 59 years 0.93 0.79 0.67 0.56 0.44 0.35 0.22 
60 to 69 years 0.92 0.75 0.62 0.48 0.40 0.59 0.17 
70 to 79 years 0.92 0.73 0.58 0.47 0.37 0.25 0.15 
80 years and older 0.91 0.71 0.52 0.41 0.33 0.21 NA 
 
Donor age group is significantly correlated with central corneal endothelial cell count 
(ECC) (see section 2.1.9). Donors over the age of 60 had higher rates of ECC under 2500 
cells/mm² than those in the younger age groups (Chi²=126.78, df=7, p<0.001). Data on 
ECC were unavailable for 80% of grafts and thus this variable was excluded from 
multivariate analysis. It is possible that the retention of donor age group in the multivariate 
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2.1.6.1 Penetrating graft survival: influence of donor age (years) on grafts 
performed for keratoconus 
 
Figure 2.1.7 shows the comparison of graft survival depending on donor age, stratified by 
10 year age groups, for grafts performed for keratoconus. Donors aged under 10 years 
or over 90 years are rare, and so these data were combined with the adjacent age groups. 
No significant difference was found across groups (Log Rank Statistic=1.30; df=7; 
p=0.989).  
This finding is in contrast to that found for the entire cohort, suggesting that, despite this 
variable’s retention in the final multivariate model, other unknown factors may be 
confounding this result. 
 

















Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 
Under 20 years 389 206 106 61 32 20 6 
20 to 29 years 488 260 146 87 46 19 8 
30 to 39 years 424 211 105 61 33 18 10 
40 to 49 years 751 382 194 118 69 31 12 
50 to 59 years 1088 560 281 172 101 58 21 
60 to 69 years 1195 575 293 184 115 67 24 
70 to 79 years 938 502 287 181 111 64 27 
80 years and older 254 131 74 55 35 17 7 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 
Under 20 years 0.98 0.95 0.90 0.82 0.72 0.61 NA 
20 to 29 years 0.97 0.95 0.91 0.87 0.78 NA NA 
30 to 39 years 0.98 0.95 0.91 0.89 0.78 NA NA 
40 to 49 years 0.98 0.94 0.89 0.84 0.77 0.56 NA 
50 to 59 years 0.98 0.95 0.92 0.83 0.74 0.60 0.40 
60 to 69 years 0.97 0.95 0.92 0.84 0.78 0.61 0.40 
70 to 79 years 0.98 0.96 0.91 0.83 0.72 0.55 0.33 
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2.1.7 Penetrating graft survival: influence of cause of donor death 
 
Few causes of death exclude a person from becoming a corneal donor. Figure 2.1.8 
shows the comparison of graft survival depending on cause of donor death. 31 grafts 
were performed using donor tissue from live donors. These were excluded from the 
analysis. A significant difference was found across groups (Log Rank Statistic=55.24; 
df=5; p<0.001). Cause of death was unknown to the ACGR for 4% of grafts. A further 
category was thus created called “unknown”. A significant difference was still found 
across groups when this category was included (Log Rank Statistic=55.19; df=6; 
p<0.001). Grafts where the donor had died from trauma had significantly better survival 
than those where the donor had died from any of the other four major causes of death (all 
p<0.001). Grafts where the donor had died from an “other specified cause” also had 
superior survival to those where the donor had died from malignancy (p=0.002). This 
variable was not retained in the multivariate analysis (see section 2.7) suggesting that 
this is not an independent factor significantly affecting graft survival. 
 











Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 
Cardiac event 5081 2433 1127 576 295 144 54 
Malignancy 3898 1622 646 275 127 51 17 
Trauma 1860 926 438 235 106 55 18 
Respiratory event 1594 682 304 157 88 42 10 
Intracranial/cerebral haemorrhage 2866 1339 576 280 140 65 25 
Other specified cause 838 393 153 69 30 18 6 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 
Cardiac event 0.93 0.76 0.63 0.52 0.42 0.31 0.22 
Malignancy 0.92 0.75 0.62 0.49 0.41 0.27 NA 
Trauma 0.94 0.83 0.73 0.63 0.54 0.40 NA 
Respiratory event 0.93 0.75 0.62 0.53 0.44 0.32 NA 
Intracranial/cerebral haemorrhage 0.92 0.77 0.64 0.53 0.42 0.30 0.23 




“Other specified causes” included donors who died from diseases of the liver, kidney, 
pancreas, gastro-intestinal tract, encephalopathy, sepsis, and rare diseases. It also 
included 271 cases, where the donor was listed as dying from brain damage or brain 
death. In 46% of these cases, the donor was a multi-organ donor (compared to 9% of the 
overall cohort). It is possible that a large proportion of this latter group had undergone 
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2.1.8 Penetrating graft survival: influence of multi-organ donor status 
 
Figure 2.1.9 shows the comparison of graft survival depending on whether the donor 
cornea was obtained from a multi-organ donor. A significant difference was found 
between groups (Log Rank Statistic=22.54; df=1; p<0.001). This variable was not 
retained in the multivariate analysis (see section 2.7) suggesting that this is not an 
independent factor significantly affecting graft survival.  
Figure 2.1.9 Multi-organ donor status 
 
Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 28 
Eye only donor 15387 7115 3214 1629 831 414 153 28 
Multi organ donor 1490 661 240 107 37 10 NA NA 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 28 
Eye only donor 0.92 0.76 0.64 0.53 0.44 0.32 0.20 0.09 
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2.1.9 Penetrating graft survival: influence of donor central corneal endothelial cell 
density 
 
Information on donor central corneal endothelial cell count (ECC) has been requested by 
the Registry in recent years. ECC was reported for one-fifth (20%) of registered 
penetrating grafts. Reported ECC ranged from 1388 to 4951 cells/mm². Comparison of 
graft survival across donor ECC groups is shown in Figure 2.1.10. A significant difference 
was found across groups (Log Rank Statistic=24.77; df=3; p<0.001). Survival of grafts 
with less than 2500 cells/mm² had significantly poorer survival than those with 2750 to 
2999 cells/mm², 3000 to 3249 cells/mm², or 3500 and over cells/mm² (all p<0.001). This 
variable was not included in the multivariate analysis (see section 2.7), due to the very 
high levels (80%) of missing data. Endothelial cell count differed significantly across donor 
age groups, (Chi²=126.78, df=7, p<0.001), with older donors (over 60) more likely to have 
cell counts below 2500 cells/mm². 
Figure 2.1.10 Endothelial cell density 
 
Number at risk (at years post-graft) 
 1 2 4 6 8 
Less than 2500 cells/mm² 286 219 109 50 15 
2500 – 2749 cells/mm² 477 351 166 85 27 
2750 – 2999 cells/mm² 654 493 255 119 42 
3000 – 3249 cells/mm² 835 655 337 161 52 
3250 – 3499 cells/mm² 447 316 145 55 12 
3500 or more cells/mm² 314 234 123 53 14 
 
Probability of graft survival (at years post-graft) 
 1 2 4 6 8 
Less than 2500 cells/mm² 0.94 0.86 0.68 0.55 NA 
2500 – 2749 cells/mm² 0.92 0.85 0.76 0.67 0.57 
2750 – 2999 cells/mm² 0.95 0.90 0.78 0.67 0.56 
3000 – 3249 cells/mm² 0.93 0.89 0.80 0.71 0.60 
3250 – 3499 cells/mm² 0.94 0.87 0.73 0.63 NA 
3500 or more cells/mm² 0.96 0.92 0.81 0.73 NA 
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2.2 Recipient Factors 
 
Table 2.3 shows the number of grafts reported for each indication for graft, and also 
shows further sub-group breakdowns for each indication group. This breakdown is shown 
for all 24827 registered grafts as well as for the 20336 followed grafts. The total for each 
of the indication groups is the sum of the sub-categories shown below.  
Table 2.3 Indication for graft 
 
Penetrating Corneal Graft 
Indication for Graft 
 
 Registered (%) Followed (%) 
   
Keratoconus* 7621 (31%) 6262 (31%) 
  Uncomplicated 7185 (29%) 5928 (29%) 
  With hydrops 477 (2%) 362 (2%) 
   
Failed previous graft 6294 (25%) 4996 (25%) 
   
Bullous keratopathy 4628 (19%) 3932 (19%) 
  Pseudophakic 3626 (15%) 3076 (15%) 
  Aphakic 673 (3%) 570 (3%) 
  Phakic 329 (1%) 286 (1%) 
   
Corneal dystrophy** 2378 (10%) 2048 (10%) 
  Fuchs’ (endothelial) 2067 (8%) 1794 (9%) 
  Granular (epithelial/stromal) 138 (<1%) 113 (<1%) 
  Macular (stromal) 56 (<1%) 41 (<1%) 
  Lattice (epithelial/stromal) 54 (<1%) 45 (<1%) 
  Posterior polymorphous (endothelial) 27 (<1%) 25 (<1%) 
  Schnyder (stromal) 21 (<1%) 19 (<1%) 
  Reis-Bücklers (epithelial/stromal) 13 (<1%) 9 (<1%) 
  Meesmann (epithelial) 2 (<1%) 2 (<1%) 
   
Herpetic eye disease 1109 (4%) 918 (5%) 
  Inactive HSV, no perforation 680 (3%) 585 (3%) 
  Herpes zoster, no perforation 97 (<1%) 79 (<1%) 
  Active HSV, no perforation 82 (<1%) 67 (<1%) 
  HSV, or HZO, with perforation 250 (1%) 187 (<1%) 
   
Corneal scars and opacities 515 (2%) 407 (2%) 
  With cataract 74 (<1%) 63 (<1%) 
  From trachoma 43 (<1%) 34 (<1%) 
  Other 398 (2%) 310 (2%) 
   
Corneal ulcers/perforation 505 (2%) 379 (2%) 
  Perforated 415 (2%) 303 (1%) 
  No perforation 90 (<1%) 76 (<1%) 
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 Registered (%) Followed (%) 
   
Trauma 641 (3%) 507 (2%) 
  Burns 78 (<1%) 69 (<1%) 
  Beta radiation 11 (<1%) 11 (<1%) 
  With perforation 6 (<1%) 4 (<1%) 
  Unspecified 546 (2%) 423 (2%) 
   
Non-herpetic infections 445 (1%) 316 (2%) 
  Microbial keratitis/abscess 169 (<1%) 118 (<1%) 
  Mycotic/fungal ulcer 86 (<1%) 66 (<1%) 
  Pseudomonas infection 58 (<1%) 34 (<1%) 
  Acanthamoeba keratitis 36 (<1%) 30 (<1%) 
  Viral keratitis 13 (<1%) 11 (<1%) 
  Endophthalmitis 12 (<1%) 10 (<1%) 
  Unspecified 71 (<1%) 46 (<1%) 
   
Corneal degenerations 223 (<1%) 169 (<1%) 
   
Other*** 518 (2%) 434 (2%) 
   
Total 24827 (100%) 20336 (100%) 
   
 
*In April 2015, Gomes et al [see reference 1], published a paper in Cornea, outlining a 
process to develop global consensus regarding the diagnosis and treatment of 
keratoconus and other ectatic diseases. The Gomes et al (2015) paper states that 
“Keratoconus and keratoglobus are different clinical entities”. The data published in 
previous ACGR reports included keratoglobus with keratoconus. This report separates 
keratoglobus cases from keratoconus, and classifies them under “Other”. 
**In February 2015 Weiss et al [see reference 2] published a paper in Cornea, updating 
the International Classification of Corneal Dystrophies “incorporating new clinical, 
histopathologic, and genetic information”. This classification system has been used for 
the 2018 ACGR Report. 
***Other included: Interstitial keratitis (156), ICE syndrome (58), Peters’ anomaly (39), 
unknown (35), descemetocoele (20), lipid keratopathy (17), pterygium (16), band 
keratopathy (15), keratoglobus (15), congenital glaucoma (12), aniridia (9), autograft (8), 
corneal neovascularisation (8), congenital cataract (7), epithelial defects (7), blood 
staining (6), glaucoma (6), congenital corneal opacity (5), cystinosis (5), irregular 
astigmatism (5), mucopolysaccharidosis (5), superative keratitis (5), squamous cell 
carcinoma (4), congenital rubella (4), corneal staphyloma (4), dermoid (3), congenital 
corneal calcification (3), scleral necrosis (3), amyloidosis (2), congenital microphthalmia 
(2), congenital syphilis (2), epithelial downgrowth (2), ichthyosis (2), pemphigoid (2), 
porphyria (2), retinal detachment (2), Stevens-Johnson syndrome (2), aphakia (1), 
astigmatism (1), childhood fever (1), Crouzon’s syndrome (1), heterochromic cyclitis (1), 
hypopyon (1), keratoconjunctivitis (1), melanoma (1), monoclonal gammopathy (1), 
myopia (1), neuroparalytic keratitis (1), ocular surface dysplasia (1), osteogenesis 
imperfecta (1), phthisis (1), rosacea (1), Silver-Russell syndrome (1), synechia (1), 
vitamin A deficiency (1), wound dehiscence following IOL insertion (1).  
Chi² analysis indicated that follow-up was significantly more likely to have been received 
at least once for grafts performed for bullous keratopathy or corneal dystrophy, compared 
to other indications for graft (p<0.001).  
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Table 2.4 summarises the number of grafts within each of the variable sub-groups, for 
the recipient factors examined in this report that were found to be significant predictors of 
graft survival in univariate analyses. The sum for each variable equals the total number 
of grafts (24,827 registered and 20,336 followed) and the percentages, which should be 
summed vertically for each variable, total 100. The data are presented in the following 
sections. 
Table 2.4 Summary table of recipient factors, significant in univariate analyses 
 
Penetrating Corneal Graft 
Recipient Factors 
 
 Registered (%) Followed (%) 
Australian State where graft was performed  
  State M 8857 (36%) 6940 (34%) 
  State K 5388 (22%) 4574 (22%) 
  State V 4711 (19%) 3944 (19%) 
  State J 2851 (11%) 2053 (10%) 
  State N 2422 (10%) 2275 (11%) 
  State C 572 (2%) 536 (3%) 
  Other 26 (<1%) 14 (<1%) 
   
Interstate transportation   
  No 21812 (88%) 17600 (87%) 
  Yes 1295 (5%) 1080 (5%) 
  Not advised/not applicable 1720 (7%) 1656 (8%) 
   
Recipient age group   
  <20 years 1130 (5%) 937 (5%) 
  20 to 29 years 3293 (13%) 2671 (13%) 
  30 to 39 years 2862 (12%) 2375 (12%) 
  40 to 49 years 2679 (11%) 2179 (11%) 
  50 to 59 years 2701 (11%) 2222 (11%) 
  60 to 69 years 3645 (15%) 3012 (15%) 
  70 to 79 years 4993 (20%) 4125 (20%) 
  ≥ 80 years 3516 (14%) 2808 (14%) 
  Not advised 8 (<1%) 7 (<1%) 
   
Donor/recipient sex match   
  Female/female 4269 (17%) 3552 (17%) 
  Female/male 4615 (19%) 3739 (18%) 
  Male/female 7222 (29%) 5970 (29%) 
  Male/male 8095 (33%) 6514 (32%) 
  Not advised 626 (3%) 561 (3%) 
   
Change in lens status   
  Phakic/phakic 12220 (49%) 9959 (49%) 
  Phakic/pseudophakic 2422 (10%) 2076 (10%) 
  Other combination 10185 (41%) 8301 (41%) 
   
Pre-graft neovascularisation   
  None 16795 (68%) 13929 (69%) 
  One quadrant 2121 (9%) 1611 (8%) 
  Two quadrants 2652 (11%) 2100 (10%) 
  Three quadrants 1196 (5%) 995 (5%) 
  Four quadrants 2063 (8%) 1701 (8%) 
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 Registered (%) Followed (%) 
   
Pre-graft inflammation and/or steroid use   
  No 17568 (71%) 14480 (71%) 
  Yes 6984 (28%) 5652 (28%) 
  Not advised 275 (1%) 204 (1%) 
   
Presence of raised intraocular pressure   
  IOP never known to be raised 20934 (84%) 17135 (84%) 
  IOP raised in past and/or at graft 3893 (16%) 3201 (16%) 
   
Prior contralateral corneal graft/s   
  None 19557 (79%) 16036 (79%) 
  One 4290 (17%) 3526 (17%) 
  Two or more 980 (4%) 774 (4%) 
   
Total 24827 (100%) 20336 (100%) 
   
 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
for which a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Follow-up was significantly more likely (p<0.05) to have been received for grafts 
performed in female recipients, recipients with no history of inflammation and/or steroid 
use, grafts that had a no history of previous ipsilateral grafts, grafts that underwent a triple 
procedure (went from phakic to pseudophakic) and grafts performed with donor tissue 
that had been transported interstate. Follow-up was significantly lower for grafts 
performed in recipients from State M and State J, in recipients with mild pre-graft 
neovascularisation, and in recipients aged 80 or older. Forty-three percent of recipients 
known by the ACGR to have died prior to any follow-up having been received, were aged 
80 or older at the time of graft, which may account for this lower level of follow-up.  
Two-hundred and sixteen penetrating keratoplasties had been converted from a planned 
lamellar procedure: 195 DALK, seven DS(A)EK, three peripheral patch, two mushroom 
tuck-in, one DMEK, and eight unspecified. Thirty-seven had a concurrent graft (limbal or 
lamellar patch). Thirty-six eyes undergoing penetrating keratoplasty had a history of 
corneal cross-linking.  
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Table 2.5 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors found to be non-significant in univariate analyses. The sum for each 
variable equals the total number of grafts (24,827 registered and 20,336 with follow-up 
provided) and the percentages, summed vertically for each variable, total 100. The result 
of the Kaplan-Meier survival analysis is also provided for each variable. 
Table 2.5 Recipient factors, not significant in univariate analyses 
 
Penetrating Corneal Graft 
Recipient Factors 
 
 Registered (%) Followed (%) 
Recipient sex   
  Male 11798 (48%) 9800 (48%) 
  Female 13029 (52%) 10536 (52%) 
Chi²=0.17, df=1, p=0.677   
   
Eye grafted   
  Left 12345 (50%) 10120 (50%) 
  Right 12471 (50%) 10208 (50%) 
  Not advised 11 (<1%) 8 (<1%) 
Chi²=1.14, df=1, p=0.286   
   
Total 24827 (100%) 20336 (100%) 
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2.2.1 Penetrating graft survival: influence of indication for graft 
 
Figure 2.2.1 shows the comparison of graft survival depending on indication for graft. All 
repeat grafts were analysed together, regardless of original pathology. A significant 
difference was found across groups (Log Rank Statistic=2478.70; df=12; p<0.001).  
Grafts performed for keratoconus had better survival than those performed for any other 
indication, except corneal dystrophies other than Fuchs’ endothelial dystrophy. Grafts 
performed for Fuchs’ endothelial dystrophy, other corneal dystrophy, or herpetic eye 
disease had better survival than those for failed previous graft, pseudophakic bullous 
keratopathy, corneal ulcer, trauma, non-herpetic infection, or other bullous keratopathy. 
Grafts performed for corneal scar and/or opacity had better survival than those for failed 
previous graft, pseudophakic bullous keratopathy, corneal ulcer, non-herpetic infection, 
and other bullous keratopathy. In addition to the indications mentioned above, grafts 
performed for corneal ulcer had poorer survival than those for failed previous graft, 
pseudophakic bullous keratopathy, trauma, corneal degeneration, other bullous 
keratopathy and other (all p≤0.001).  
This variable was retained in multivariate analysis (see section 2.7) suggesting that this 
is an independent factor significantly affecting graft survival.  
 














Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
Failed previous graft 4018 1651 596 251 102 44 16 
Keratoconus 5597 2873 1519 944 559 302 117 
Pseudo bullous keratopathy 2385 840 259 74 21 6 NA 
Fuchs’ endothelial dystrophy 1620 965 472 165 47 10 4 
Corneal scar/opacity 304 133 48 25 9 6 1 
Ulcer/perforation 211 75 30 16 6 1 NA 
Herpetic eye disease 752 339 148 81 42 18 4 
Trauma 408 179 73 35 15 6 NA 
Non-herpetic infection 199 80 25 11 2 1 NA 
Corneal degeneration 143 44 18 8 3 2 NA 
Other bullous keratopathy 668 272 103 46 21 4 1 
Other dystrophy 220 134 67 33 21 15 7 
Other 352 187 96 47 20 9 3 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
Failed previous graft 0.88 0.63 0.45 0.31 0.22 0.15 NA 
Keratoconus 0.98 0.95 0.91 0.84 0.75 0.58 0.39 
Pseudo bullous keratopathy 0.91 0.63 0.43 0.30 0.19 NA NA 
Fuchs’ endothelial dystrophy 0.97 0.88 0.75 0.57 0.39 NA NA 
Corneal scar/opacity 0.95 0.84 0.67 0.62 NA NA NA 
Ulcer/perforation 0.72 0.51 0.41 NA NA NA NA 
Herpetic eye disease 0.91 0.76 0.65 0.54 0.47 NA NA 
Trauma 0.89 0.69 0.50 0.39 NA NA NA 
Non-herpetic infection 0.76 0.61 0.47 NA NA NA NA 
Corneal degeneration 0.92 0.79 NA NA NA NA NA 
Other bullous keratopathy 0.91 0.63 0.44 0.30 0.21 NA NA 
Other dystrophy 0.97 0.90 0.83 0.76 0.61 NA NA 
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2.2.2 Penetrating graft survival: subcategory analyses 
 
The analyses on pages 38 to 42 are of subcategories in individual indication for graft 
cohorts. The nature of the variables means that large percentages of the cohort do not 
have relevant data. These subgroup-analyses were therefore not included in multivariate 
analyses. The overarching variable “indication for graft” was included. 
2.2.2.1 Penetrating graft survival: influence of the number of previous ipsilateral 
grafts 
 
Survival was compared across groups based on the number of previous grafts in the 
same eye (range 1 to 12). Previous grafts may not have been penetrating keratoplasties. 
The ACGR has only specifically requested this information since 2016, consequently this 
is unknown in the majority (98%) of cases. Survival, shown in Figure 2.2.2, decreased 
(Log Rank Statistic=222.26, df=2, p<0.001) as the number of grafts increased. Survival 
of first grafts is included in the Kaplan-Meier plot for visual reference but these data were 
excluded from the log rank calculation. 
Figure 2.2.2 Number of previous ipsilateral grafts 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
One 2995 1264 482 205 85 36 12 
Two or three 925 358 109 44 16 3 1 
Four or more 144 35 7 3 2 1 1 
 







1 4 8 12 16 20 
One 0.90 0.68 0.50 0.36 0.26 0.17 
Two or three 0.85 0.56 0.35 0.21 NA NA 
Four or more 0.73 0.28 NA NA NA NA 
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2.2.2.2 Penetrating graft survival: keratoconus 
 
Figure 2.2.3 shows the comparison of graft survival for first versus repeat grafts for 
keratoconus. A significant difference was found across groups (Log Rank 
Statistic=644.55; df=3; p<0.001).  
Figure 2.2.3 First versus subsequent grafts for keratoconus 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
1st graft 5597 2873 1519 944 559 302 117 
2nd graft 1108 525 219 93 42 19 8 
3rd graft 217 94 35 16 8 4 3 
4th or subsequent graft 97 43 15 7 3 1 NA 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
1st graft 0.98 0.95 0.91 0.84 0.75 0.58 0.39 
2nd graft 0.96 0.86 0.68 0.53 0.40 NA NA 
3rd graft 0.93 0.71 0.57 NA NA NA NA 
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2.2.2.3 Penetrating graft survival: influence of type of corneal dystrophy 
 
Figure 2.2.4 shows the comparison of survival for grafts for Fuchs’ endothelial dystrophy 
versus other corneal dystrophies. A significant difference was found across groups (Log 
Rank Statistic=8.52; df=1; p=0.004).  
Figure 2.2.4 Type of corneal dystrophy 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
Fuchs’ endothelial dystrophy 1620 965 472 165 47 10 4 
Other dystrophy 220 134 67 33 21 15 7 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 
Fuchs’ endothelial dystrophy 0.97 0.88 0.75 0.57 0.39 
Other dystrophy 0.97 0.90 0.83 0.76 0.61 
 
The 311 ‘other’ corneal dystrophies comprised: granular dystrophy (138), lattice 
dystrophy (54), macular dystrophy (56), posterior polymorphous dystrophy (27), 
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2.2.2.4 Penetrating graft survival: influence of HSV eye disease at time of graft 
 
Figure 2.2.5 shows the survival of grafts performed for herpetic eye infection. The graph 
shows survival of grafts with a history of HSV or HZO but no perforation, to those with 
active HSV infection at the time of graft, with and without perforation. A significant 
difference was found across groups (Log Rank Statistic=33.26, df=2, p<0.001). Grafts 
without active HSV, and without perforation, exhibit better graft survival.  
Figure 2.2.5 Presence of active Herpes Simplex Virus (HSV) and perforation 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
History of HSV/HZO, no perforation 560 268 119 63 32 14 3 
HSV/HZO, with perforation 139 50 20 13 7 2 NA 
Active HSV, no perforation 53 21 9 5 3 2 1 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 
History of HSV/HZO, no perforation 0.93 0.83 0.71 0.59 0.49 
HSV/HZO, with perforation 0.86 0.59 0.51 NA NA 
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2.2.2.5 Penetrating graft survival: influence of non-herpetic infections 
 
Figure 2.2.6 shows the comparison of survival of penetrating keratoplasty for 
subcategories of non-herpetic infection. Grafts performed for viral infections and 
endophthalmitis are shown in the survival curve but were excluded from the statistical 
comparison due to low numbers. A significant difference was found between the 
remaining groups (Log Rank Statistic=31.67; df=4; p<0.001).  
Figure 2.2.6 Type of non-herpetic infection 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 6 8 10 12 
Unspecified keratitis 36 31 22 18 16 9 3 3 NA 
Bacterial keratitis 76 54 46 31 26 18 6 5 3 
Pseudomonas keratitis 22 16 12 8 7 5 5 2 2 
Fungal keratitis 30 18 12 7 6 4 2 NA NA 
Acanthamoeba keratitis 22 15 13 11 10 8 5 4 3 
 
Probability of graft survival (years post-graft) 
 
1 2 3 4 5 
Unspecified keratitis 0.89 0.89 0.82 NA NA 
Bacterial keratitis 0.80 0.74 0.70 0.66 0.66 
Pseudomonas keratitis 0.81 NA NA NA NA 
Fungal keratitis 0.54 NA NA NA NA 
Acanthamoeba keratitis 0.82 NA NA NA NA 
 
 
This concludes the subgroup-analyses. Analyses from page 44 onwards are again 
performed on the full cohort. 
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2.2.3 Penetrating graft survival: influence of Australian State where graft was 
performed 
 
Figure 2.2.7 shows the comparison of graft survival depending on the Australian State in 
which the transplantation occurred. A significant difference was found across groups (Log 
Rank Statistic=36.94; df=5; p<0.001), with all other States exhibiting better survival than 
State C (all p<0.001), and State M exhibiting better survival than State V (p=0.001). This 
variable was not retained in the multivariate analysis (see section 2.7) suggesting that 
this is not an independent factor significantly affecting graft survival.  
Figure 2.2.7 Australian State where graft was performed 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
State M 5747 2652 1161 565 313 149 36 
State K 3960 1874 854 439 203 102 40 
State V 3154 1220 488 201 88 35 14 
State J 1694 868 412 232 110 55 21 
State N 1891 980 458 261 139 78 38 
State C 423 179 80 38 15 5 4 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
State M 0.92 0.77 0.64 0.51 0.42 0.31 0.16 
State K 0.94 0.78 0.65 0.55 0.45 0.34 0.25 
State V 0.93 0.76 0.62 0.50 0.41 0.23 NA 
State J 0.92 0.78 0.67 0.56 0.43 0.32 0.17 
State N 0.92 0.77 0.65 0.57 0.49 0.39 0.33 
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2.2.4 Penetrating graft survival: influence of interstate transportation 
 
In some cases corneas are transported interstate via air freight. Figure 2.2.8 shows the 
comparison of graft survival for grafts where the surgery was performed in the same State 
as the donor cornea was sourced, compared to those where the donor cornea was from 
interstate. A significant difference was found between groups (Log Rank Statistic=18.24; 
df=1; p<0.001). Those grafts where the donor cornea had been transported interstate had 
poorer survival. Data on this variable were not provided in 7% of cases. A further category 
was thus created called “not advised”. A significant difference was still found across 
groups when this category was included (Log Rank Statistic=42.66; df=2; p<0.001). This 
variable was retained in the multivariate analysis (see section 2.7), despite indication for 
graft also being included, suggesting that this is an independent factor significantly 
affecting graft survival.  
Figure 2.2.8 Interstate transportation 
 
 
Number at risk (at years post-graft) 
 1 4 8 12 16 20 24 
Different State 876 404 183 93 48 19 11 
Same State 14607 6574 2778 1329 649 305 91 
 
Probability of graft survival (at years post-graft) 
 1 4 8 12 16 20 24 
Different State 0.88 0.68 0.58 0.49 0.43 NA NA 
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2.2.5 Penetrating graft survival: influence of recipient age (years) 
 
Figure 2.2.9 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. Data for the “0-9 years” group was combined with the “10 to 19 years” 
group, and all recipients aged 80 years and older were grouped together for analysis, due 
to the low number of recipients in these groups. Data were not available for 8 recipients. 
A significant difference was found across groups (Log Rank Statistic=1047.20; df=7; 
p<0.001). All comparisons between age groups were significantly different at the p<0.001 
level, except for recipients aged 70 to 79 years versus 80 years or older (p=0.671). In 
almost every case, the younger recipient group showed superior survival to the older 
group. The one exception was for recipients under 20 years, compared to those aged 20 
to 29 years, where the latter group had superior survival. 
The variable of recipient age was not retained in the multivariate analysis (see section 
2.7) suggesting that this is not an independent factor significantly affecting graft survival. 
Recipient age is strongly associated with indication for graft (see section 2.2.1), with the 
majority of grafts for keratoconus performed in younger recipients, and the majority of 
grafts for bullous keratopathy and failed previous grafts, performed in older recipients. 
Indication for graft has long been shown by the ACGR to be a major explanatory factor 
for likelihood of graft survival, and was retained in the multivariate model.  
 
 













Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
0 to 19 years 777 404 207 123 70 39 14 
20 to 29 years 2297 1088 571 355 218 127 48 
30 to 39 years 2070 1007 519 318 181 96 36 
40 to 49 years 1869 1003 544 336 185 96 39 
50 to 59 years 1910 996 477 234 106 42 12 
60 to 69 years 2577 1268 549 227 76 21 3 
70 to 79 years 3315 1434 478 128 32 3 NA 




Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
0 to 19 years 0.92 0.85 0.80 0.76 0.72 0.63 NA 
20 to 29 years 0.96 0.91 0.88 0.83 0.74 0.59 0.40 
30 to 39 years 0.96 0.88 0.82 0.74 0.61 0.43 0.28 
40 to 49 years 0.92 0.81 0.71 0.59 0.48 0.33 0.21 
50 to 59 years 0.92 0.76 0.62 0.48 0.37 0.25 NA 
60 to 69 years 0.92 0.71 0.55 0.41 0.29 0.18 NA 
70 to 79 years 0.90 0.68 0.50 0.34 0.27 NA NA 
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2.2.6 Penetrating graft survival: influence of donor/recipient sex match/mismatch 
 
Comparison of graft survival between the four combinations of male and female donors 
and recipients is shown in Figure 2.2.10. A significant difference was found between 
groups (Log Rank Statistic=8.34; df=3; p=0.040). Data on this variable were not provided 
in 3% of cases. A further category was thus created called “not advised”. A significant 
difference was still found across groups when this category was included (Log Rank 
Statistic=9.58; df=4; p=0.048). None of the group comparisons were significant in 
univariate analyses following Bonferroni correction, however the variable of 
donor/recipient sex match/mismatch was retained in the multivariate analysis (see section 
2.7) suggesting that this is an independent factor significantly affecting graft survival. 
Poorer survival was observed for the male/male combination, compared to female/female 
(p<0.001). 
Figure 2.2.10 Recipient sex 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
Female/female 2944 1415 618 314 170 84 36 
Female/male 3093 1353 580 309 151 64 22 
Male/female 4996 2385 1080 520 233 119 45 
Male/male 5398 2392 1043 512 262 129 43 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
Female/female 0.93 0.78 0.66 0.55 0.47 0.35 0.25 
Female/male 0.93 0.78 0.66 0.55 0.45 0.30 0.22 
Male/female 0.93 0.76 0.63 0.51 0.40 0.31 0.19 
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2.2.7 Penetrating graft survival: influence of pre- and post-graft lens status 
 
Figure 2.2.11 shows the comparison of graft survival stratified by the change of lens 
status from pre- to post-graft. “Phakic/phakic” means the eye was phakic both before and 
after the graft. “Phakic/pseudophakic” means the eye was phakic before the graft and 
pseudophakic afterwards, having undergone a triple procedure. “Other” means the eye 
was phakic, pseudophakic or aphakic before the graft and aphakic afterwards, or the eye 
was aphakic or pseudophakic before the graft and pseudophakic afterwards.  
A significant difference was found across groups (Log Rank Statistic=1817.39; df=2; 
p<0.001), with all three group comparisons significant at the p<0.001 level. This variable 
was retained in the multivariate analysis (see section 2.7), suggesting that this is an 
independent factor significantly affecting graft survival.  
Figure 2.2.11 Change in lens status from pre- to post-graft  
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
Phakic/phakic 8619 4408 2282 1321 732 383 148 
Phakic/pseudophakic 1778 947 416 153 48 15 1 
Other 6480 2419 756 262 88 26 4 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
Phakic/phakic 0.95 0.88 0.80 0.70 0.60 0.45 0.29 
Phakic/pseudophakic 0.94 0.82 0.70 0.56 0.41 NA NA 
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2.2.8 Penetrating graft survival: influence of pre-graft corneal neovascularisation 
 
Figure 2.2.12 shows the comparison of graft survival between those recipients with 
various degrees of corneal neovascularisation pre-graft and those without (Log Rank 
Statistic=1464.79; df=4; p<0.001). All group comparisons were significant at the p<0.001 
level except between survival for grafts with two or three quadrants of vascularisation 
(p=0.104). These two groups were combined for multivariate analyses. This variable was 
retained in the multivariate analysis (see section 2.7), suggesting that this is an 
independent factor significantly affecting graft survival. Grafts performed in 
neovascularised eyes showed diminished graft survival. 
Figure 2.2.12 Pre-graft corneal neovascularisation 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
None 11963 5800 2748 1401 735 379 141 
One quadrant 1369 579 212 92 39 6 1 
Two quadrants 1649 708 237 128 47 21 2 
Three quadrants 770 304 125 58 26 10 3 
Four quadrants 1126 387 132 57 21 8 NA 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
None 0.95 0.83 0.73 0.62 0.52 0.39 0.25 
One quadrant 0.93 0.73 0.57 0.44 0.31 NA NA 
Two quadrants 0.89 0.66 0.48 0.39 0.28 0.18 NA 
Three quadrants 0.87 0.63 0.47 0.35 0.27 NA NA 
Four quadrants 0.78 0.50 0.32 0.21 0.12 NA NA 
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2.2.9 Penetrating graft survival: influence of inflammation and/or steroid use at 
time of graft 
 
Figure 2.2.13 shows the comparison of graft survival between grafts performed in an eye 
with current inflammation and/or steroid use within the past two weeks, compared to those 
with neither of these factors (Log Rank Statistic=1583.42; df=1; p<0.001). Data on this 
variable were not provided in 1% of cases. A further category was thus created called 
“not advised”. A significant difference was still found across groups when this category 
was included (Log Rank Statistic=1583.10; df=2; p<0.001). This variable was retained in 
the multivariate analysis (see section 2.7), suggesting that this is an independent factor 
significantly affecting graft survival. Current inflammation and/or recent use of steroids 
was associated with poorer graft survival. 
Figure 2.2.13 Inflammation and/or steroid use at time of graft 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No inflammation/steroid use 12470 6077 2876 1487 747 374 142 
Inflammation/steroid use 4249 1637 554 235 115 47 10 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No inflammation/steroid use 0.96 0.85 0.74 0.63 0.52 0.38 0.25 
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2.2.10 Penetrating graft survival: influence of the combination of history of raised 
intraocular pressure (IOP) and raised IOP at time of graft 
 
Figure 2.2.14 shows the comparison of graft survival across groups based on whether 
the recipient had a history of raised IOP and/or raised IOP at the time of graft, in the eye 
being grafted (Log Rank Statistic=1178.55; df=1; p<0.001). This variable was retained in 
the multivariate analysis (see section 2.7), suggesting that this is an independent factor 
significantly affecting graft survival.  
“IOP never known to be raised” means there is no known history of raised IOP in the 
grafted eye and IOP was not raised at the time of graft. “IOP raised in past and/or at time 
of graft” means the eye either had a history of raised IOP, the IOP was raised at the time 
of graft, or both.  




Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
IOP never raised 14332 6822 3135 1614 827 410 150 
IOP raised 2545 954 319 122 41 15 3 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
IOP never raised 0.93 0.81 0.70 0.60 0.50 0.36 0.23 
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2.2.11 Penetrating graft survival: influence of previous contralateral graft 
 
Figure 2.2.15 shows the comparison of graft survival between grafts where the recipient 
had undergone a single previous contralateral graft, multiple previous contralateral grafts, 
and no previous contralateral grafts. Recipients in each category may have undergone 
any number of previous ipsilateral grafts (see section 2.2.2.1 for analysis of the effect of 
number of previous ipsilateral grafts). A significant difference was found across groups 
(Log Rank Statistic=131.08; df=2; p<0.001), with those having two or more prior 
contralateral grafts exhibiting poorer survival than those with none or one, and those with 
one exhibiting significantly better survival than those with none (all p<0.001). This variable 
was retained in the multivariate analysis (see section 2.7) suggesting that this is an 
independent factor significantly affecting graft survival. 
Figure 2.2.15 Previous contralateral graft 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
None 13193 5938 2558 1259 607 290 96 
One 3030 1554 771 418 238 125 53 
Two or more 654 284 124 59 23 9 2 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
None 0.92 0.76 0.62 0.52 0.43 0.30 0.18 
One 0.95 0.85 0.75 0.63 0.53 0.40 0.27 
Two or more 0.91 0.69 0.56 0.41 0.27 NA NA 
 
The majority (97%) of grafts performed for ulcer/perforation, herpetic infection, trauma 
and non-herpetic infection, which all have poor rates of survival, are only performed in 
one eye. These make up 13% of the grafts with no contralateral graft compared with <2% 
of those with a previous contralateral graft. Conversely, conditions with better survival, 
such as keratoconus or Fuchs’ endothelial dystrophy, are often bilateral and thus make 
up larger proportions of the group with previous contralateral grafts (37% vs 46%).   
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The analysis on page 54 is conducted using data only from first grafts (no previous 
ipsilateral grafts). This subgroup-analysis was not included in multivariate analyses, as it 
is collinear with indication for graft and change in lens status. 
2.2.12 Penetrating graft survival: influence of history of previous intraocular 
surgery in ipsilateral eye 
 
Figure 2.2.16 shows the comparison of graft survival between first grafts performed in an 
eye that had undergone previous intraocular surgery, compared with first grafts 
performed in an eye that had not (Log Rank Statistic=1202.46; df=1; p<0.001). While 
surgeons were not asked to specify what type of previous surgery recipients had 
undergone, in the majority of cases (6166/6646, 93%) the lens status of the eye pre-graft 
(pseudophakic or aphakic) indicated that they had undergone cataract extraction, with or 
without IOL insertion. Surgeons were unable to say if previous surgery had occurred in 
87 first grafts and these were excluded from the analysis.  
Figure 2.2.16 History of previous intraocular surgery in the ipsilateral eye 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No prior surgery 8498 4430 2261 1272 681 357 132 
Prior surgery 4321 1676 589 207 80 22 4 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No prior surgery 0.96 0.89 0.83 0.73 0.62 0.47 0.30 
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2.3 Graft Era 
 
Table 2.6 shows the number of grafts registered and followed, in blocks of five years. 
2015 to 2017 includes all grafts performed during these years, for which data had been 
entered into the ACGR by the census date. The percentages, which should be summed 
vertically, total 100. 
Table 2.6 Graft era 
 
Penetrating Corneal Graft 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  1985 to 1989 2288 (9%) 2245 (11%) 
  1990 to 1994 5018 (20%) 4539 (22%) 
  1995 to 1999 4000 (16%) 3355 (17%) 
  2000 to 2004 4357 (18%) 3610 (18%) 
  2005 to 2009 4258 (17%) 3420 (17%) 
  2010 to 2014 3398 (14%) 2732 (13%) 
  2015 to 2017 1508 (6%) 435 (2%) 
   
Total 24827 (100 %) 20336 (100 %) 
   
 
Comparisons amongst the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
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2.3.1 Penetrating graft survival: influence of graft era 
 
Figure 2.3.1 shows the comparison of graft survival between year of graft, stratified into 
five-year groups (Log Rank Statistic=58.94; df=6; p<0.001). Grafts performed from 2015 
to 2017 had significantly worse survival than those performed in the four preceding eras 
(all p<0.001), and from 1985 to 1989 (p=0.002). Those performed from 2010 to 2014 had 
significantly worse survival than those performed in the three preceding eras (all 
p<0.001). Grafts performed from 2005 to 2009 had significantly worse survival than those 
from 2000 to 2004 (p=0.001). There were no significant differences between grafts 
performed in any of the eras between 1985 and 2004. This variable was retained in the 
multivariate analysis (see section 2.7) suggesting that this is an independent factor 
significantly affecting graft survival. 
Consideration was given to the effect of follow-up lag time on this analysis. Up-to-date 
information on failed grafts is more likely to be known than for surviving grafts. This is 
because, while information on surviving grafts must be provided by a surgeon, the fact 
that a graft has failed may also be known when a registration is received for a replacement 
graft. A “lag time” operates at the furthest end of each curve in a Kaplan Meier plot. This 
effect is most pronounced in the early years following graft registration, when requests 
have not yet been made for follow-up information, and tends to reduce predictably over 
time. It can be seen, in the analysis below, that the survival curves tend to drop off 
suddenly, illustrating this skewing of the data. The variable is treated as “time variant” in 
multivariate analyses. 
 













Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
1985 to 1989 1805 1018 604 424 245 159 98 
1990 to 1994 3561 1833 992 589 385 238 55 
1995 to 1999 2707 1341 702 398 232 27 NA 
2000 to 2004 3113 1424 725 324 6 NA NA 
2005 to 2009 3036 1570 431 1 NA NA NA 
2010 to 2014 2362 589 NA NA NA NA NA 
2015 to 2017 293 NA NA NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
1985 to 1989 0.90 0.76 0.67 0.60 0.53 0.40 0.31 
1990 to 1994 0.90 0.74 0.64 0.57 0.48 0.36 0.20 
1995 to 1999 0.93 0.77 0.67 0.54 0.44 0.24 NA 
2000 to 2004 0.94 0.80 0.67 0.53 NA NA NA 
2005 to 2009 0.95 0.80 0.62 NA NA NA NA 
2010 to 2014 0.94 0.73 NA NA NA NA NA 
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2.4 Surgery and Surgeon Factors 
 
Table 2.7 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors found to be significant in univariate analyses. The sum of 
these numbers for each variable equals the total number of grafts (24,827 registered and 
20,336 followed) and the percentages, which should be summed vertically for each 
variable, total 100. 
Table 2.7 Surgery and surgeon factors, significant in univariate analyses 
 
Penetrating Corneal Graft 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Size of graft (diameter)   
  Less than 7.75 mm 3229 (13%) 2764 (14%) 
  7.75 mm to <8.25 mm 11228 (45%) 9381 (46%) 
  8.25 mm to <8.75 mm 6930 (28%) 5520 (27%) 
  8.75 mm or more 1951 (8%) 1519 (7%) 
  Not advised 1489 (6%) 1152 (6%) 
   
The Centre effect   
  Fewer than 500 registered PK 12489 (50%) 9903 (49%) 
  Surgeon Q 1792 (7%) 1713 (8%) 
  Surgeon W 1245 (5%) 1210 (6%) 
  Surgeon E 1216 (5%) 968 (5%) 
  Surgeon R 1171 (5%) 1112 (5%) 
  Surgeon T 897 (4%) 474 (2%) 
  Surgeon Y 886 (4%) 422 (2%) 
  Surgeon U 847 (3%) 766 (4%) 
  Surgeon O 685 (3%) 634 (3%) 
  Surgeon P 661 (3%) 601 (3%) 
  Surgeon A 635 (3%) 501 (2%) 
  Surgeon S 634 (3%) 563 (3%) 
  Surgeon D 578 (2%) 575 (3%) 
  Surgeon F 569 (2%) 404 (2%) 
  Surgeon G 522 (2%) 490 (2%) 
   
Surgeon volume   
  Fewer than 500 registered PK 12489 (50%) 9903 (49%) 
  500+ registered PK, <82% follow-up 4203 (17%) 2769 (14%) 
  500+ registered PK, ≥82% follow-up 8135 (33%) 7664 (38%) 
   
Total 24827 (100 %) 20336 (100 %) 
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82% was selected as the cut-off point for the follow-up categories as this (81.7%) was the 
average percentage of follow-up for all penetrating grafts.  
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Follow-up was significantly lower (p<0.05) for larger grafts. There were significant 
differences in follow-up levels between individual surgeons. Due to the nature of the 
variable, follow-up was, significantly higher for grafts performed by surgeons with 500+ 
grafts and ≥82% follow-up.   
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2.4.1 Penetrating graft survival: influence of graft size 
 
Figure 2.4.1 shows a comparison of graft survival depending on the size of the graft, 
based on the donor button diameter, as reported by surgeons. A significant difference 
was found across groups (Log Rank Statistic=198.82; df=3; p<0.001), with grafts under 
7.75 mm, or 8.75 mm or more, both exhibiting poorer survival than those within these 
measurements (all p<0.001). Data on this variable were not provided in 6% of cases. A 
further category was thus created called “not advised”. A significant difference was still 
found across groups when this category was included (Log Rank Statistic=217.81; df=4; 
p<0.001). This variable was retained in the final model, suggesting that this is an 
independent factor significantly affecting graft survival. 
Figure 2.4.1 Graft size 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
Less than 7.75 mm 2144 1027 496 291 168 80 30 
7.75 mm to < 8.25 mm 8013 3739 1686 869 444 212 73 
8.25 mm to < 8.75 mm 4617 2120 950 436 203 114 42 
8.75 mm or more 1149 483 171 70 23 3 1 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
Less than 7.75 mm 0.89 0.69 0.56 0.47 0.39 0.27 0.16 
7.75 mm to < 8.25 mm 0.94 0.80 0.68 0.57 0.48 0.35 0.22 
8.25 mm to < 8.75 mm 0.94 0.79 0.66 0.54 0.44 0.34 0.22 
8.75 mm or more 0.86 0.68 0.55 0.44 0.30 NA NA 
 
The size of penetrating grafts has changed significantly across eras. They have increased 
in size during each five-year cohort. Just 6% of grafts performed since 2010 were less 
than 7.75 mm in diameter, compared with 21% pre-2000. At the other end of the 
spectrum, 17% of grafts performed since 2010 were 8.75 mm or more, compared with 
5% pre-2000. 47% of grafts 8.75 mm or more were repeat grafts.  
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2.4.2 Penetrating graft survival: influence of the Centre effect  
 
Figure 2.4.2 shows the comparison of graft survival for 14 individual surgeons for whom 
there were 500 or more penetrating keratoplasties registered with the ACGR, and all other 
grafts (performed by 448 identified individual surgeons, Australia-wide) combined (Log 
Rank Statistic=217.76; df=14; p<0.001). This analysis indicates that there is a significant 
Centre effect. This variable was not included in the multivariate analysis as it is collinear 
with the surgeon volume and follow-up variable shown in Figure 2.4.3. 
 
Figure 2.4.2 The Centre effect 
 
 
Note: To preserve anonymity, surgeons have been identified using random letters of the 
alphabet. These identifying letters do not correspond with those used in chapters 
reporting on other types of graft, i.e. Surgeon W in this chapter is not the same surgeon 
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Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
<500 PK registered 8083 3597 1497 771 414 206 80 
Surgeon Q 1295 525 231 87 20 3 1 
Surgeon W 997 553 279 166 93 53 22 
Surgeon E 815 220 54 4 NA NA NA 
Surgeon R 956 590 357 206 123 70 18 
Surgeon T 399 185 56 24 15 8 3 
Surgeon Y 319 145 76 52 36 23 6 
Surgeon U 666 304 110 42 20 9 1 
Surgeon O 580 260 118 56 19 NA NA 
Surgeon P 555 289 115 45 7 NA NA 
Surgeon A 404 166 99 61 21 11 6 
Surgeon S 498 279 137 67 32 11 4 
Surgeon D 506 292 179 101 61 30 12 
Surgeon F 360 101 25 6 NA NA NA 
Surgeon G 444 269 121 48 7 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
<500 PK registered 0.91 0.73 0.60 0.50 0.42 0.31 0.20 
Surgeon Q 0.92 0.76 0.61 0.45 0.27 NA NA 
Surgeon W 0.93 0.79 0.67 0.60 0.53 0.42 0.33 
Surgeon E 0.95 0.77 0.55 NA NA NA NA 
Surgeon R 0.94 0.82 0.71 0.60 0.51 0.44 NA 
Surgeon T 0.93 0.78 0.61 0.44 NA NA NA 
Surgeon Y 0.90 0.70 0.58 0.47 0.35 0.26 NA 
Surgeon U 0.96 0.87 0.77 0.54 0.37 NA NA 
Surgeon O 0.95 0.80 0.71 0.64 NA NA NA 
Surgeon P 0.98 0.89 0.80 0.67 NA NA NA 
Surgeon A 0.91 0.71 0.59 0.52 0.33 NA NA 
Surgeon S 0.94 0.83 0.73 0.61 0.52 NA NA 
Surgeon D 0.97 0.87 0.78 0.72 0.66 0.39 NA 
Surgeon F 0.97 0.82 0.58 NA NA NA NA 
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2.4.3 Penetrating graft survival: influence of surgeon volume (500+ registered PK 
grafts) grouped by level of follow-up  
 
Figure 2.4.3 shows the comparison of graft survival between grafts performed by 
surgeons with 500+ registered penetrating keratoplasties with average or better (≥82%) 
follow-up, to those with lower than average follow-up (<82%), and to surgeons with fewer 
than 500 registered penetrating keratoplasties (Log Rank Statistic=127.76; df=2; 
p<0.001). Survival of grafts performed by high volume surgeons with average or better 
follow-up was significantly better than that of either of the other two groups (both 
p<0.001). This variable was retained in the multivariate analysis (see section 2.7) 
suggesting that this is an independent factor significantly affecting graft survival. 
Figure 2.4.3 Surgeon volume and level of follow-up 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
<500 registered PK 8083 3597 1497 771 414 206 80 
500+ PK, low follow-up 2297 817 310 147 72 42 15 
500+ PK, high follow-up 6497 3362 1647 818 382 176 58 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
<500 registered PK 0.91 0.73 0.60 0.50 0.42 0.31 0.20 
500+ PK, low follow-up 0.93 0.76 0.59 0.47 0.33 0.23 NA 
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2.5 Operative Procedures at the Time of Graft 
 
Table 2.8 shows the number of grafts for which specified operative procedures were 
performed at the time of graft. The sum of these numbers for each variable equals the 
total number of grafts (24,827 registered and 20,336 followed) and the percentages, 
which should be summed vertically for each variable, total 100. While only anterior 
vitrectomy at time of graft was found to be significant at the p<0.05 level, peripheral 
iridectomy at time of graft met the p<0.08 level, for inclusion in multivariate analyses. 
Table 2.8 Operating procedures at the time of graft, significant in univariate 
analyses 
 
Penetrating Corneal Graft 
Operative Procedures 
 
 Registered (%) Followed (%) 
Anterior vitrectomy at time of graft   
  No 22791 (92%) 18620 (92%) 
  Yes 2036 (8%) 1716 (8%) 
   
Peripheral iridectomy at time of graft*   
  No 23328 (94%) 19315 (95%) 
  Yes 1499 (6%) 1021 (5%) 
   
Total 24827 (100 %) 20336 (100 %) 
   
* Note: significant at p<0.08 for inclusion in multivariate analyses but not at p<0.05. 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Follow-up was significantly higher for grafts that had undergone anterior vitrectomy at the 
time of graft (p=0.007), and significantly lower for those that had undergone peripheral 
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2.5.1 Penetrating graft survival: influence of anterior vitrectomy at time of graft 
 
Figure 2.5.1 shows the comparison of survival for grafts where an anterior vitrectomy was 
performed at the time of graft, to those where one was not. A significant difference was 
found across groups (Log Rank Statistic=255.42; df=1; p<0.001). This variable was not 
retained in the final model, suggesting that this is not an independent factor significantly 
affecting graft survival. 
Figure 2.5.1 Anterior vitrectomy at time of graft 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No anterior vitrectomy 15596 7297 3284 1666 840 411 151 
Anterior vitrectomy 1281 471 170 70 28 13 2 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No anterior vitrectomy 0.93 0.78 0.66 0.55 0.46 0.33 0.21 
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2.5.2 Penetrating graft survival: influence of peripheral iridectomy at time of graft 
 
Figure 2.5.2 shows survival for grafts where a peripheral iridectomy was performed at the 
time of graft, and those where one was not. No significant difference was found between 
groups (Log Rank Statistic=3.47; df=1; p=0.063), however this variable met the p<0.08 
criteria for inclusion in the multivariate analyses. It was not retained in the final model (see 
section 2.7), suggesting that this is not an independent factor significantly affecting graft 
survival.  
Figure 2.5.2 Peripheral iridectomy at time of graft 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No peripheral iridectomy 16034 7338 3271 1672 827 415 152 
Peripheral iridectomy 843 439 183 64 29 9 1 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No peripheral iridectomy 0.93 0.77 0.64 0.54 0.44 0.32 0.20 
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2.6 Post-graft Events 
 
Table 2.9 shows the occurrence of post-graft events, and Table 2.10 shows post-graft 
surgical procedures, as reported by follow-up practitioners, found to be significant in 
univariate analyses. Please note: post-graft data may be incomplete when follow-up is 
based on a registration for a replacement graft. 
Table 2.9 Post-graft events, significant in univariate analyses 
 
Penetrating Corneal Graft 
Post-graft Events 
 
 Registered (%) Followed (%) 
Post-graft neovascularisation   
  No 23307 (94%) 18816 (93%) 
  Yes 1520 (6%) 1520 (7%) 
   
Post-graft herpetic infection   
  No 24399 (98%) 19908 (98%) 
  Yes 428 (2%) 428 (2%) 
   
Post-graft microbial keratitis   
  No 24251 (98%) 19760 (97%) 
  Yes 576 (2%) 576 (3%) 
   
Post-graft synechiae   
  No 24438 (98%) 19947 (98%) 
  Yes 389 (2%) 389 (2%) 
   
Post-graft uveitis   
  No 24544 (99%) 20053 (99%) 
  Yes 283 (1%) 283 (1%) 
   
Post-graft rise in IOP   
  No 20964 (84%) 16473 (81%) 
  Yes 3863 (16%) 3863 (19%) 
   
At least one rejection episode   
  No 20718 (83%) 16227 (80%) 
  Yes 4109 (17%) 4109 (20%) 
   
Time to removal of all sutures   
  Less than 6-months 590 (2%) 590 (3%) 
  6-months to <12 months 2155 (9%) 2155 (11%) 
  12 months to <24 months 5940 (24%) 5940 (29%) 
  24 months or more 2566 (10%) 2566 (13%) 
  Not yet removed/not advised* 13576 (55%) 9085 (45%) 
   
Total 24827 (100 %) 20336 (100 %) 
   
* Some failed grafts had ROS dates provided which were after the date of failure and thus not included in analysis.  
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Table 2.10: Post-graft surgical procedures 
3,092 penetrating keratoplasties were reported to have undergone a re-grafting 
procedure (separate to subsequent concurrent graft/s) at the date last seen. Of these, 
2,168 had not had additional post-graft operative procedures reported, while 924 had. 
 
Penetrating Corneal Graft 
Post-graft Surgical Procedures Excluding Re-graft 
 
 Number 
Cataract removal and IOL insertion 1606 
Cataract removal without IOL insertion 63 
IOL insertion (cataract removed prior to graft) 149 
IOL repositioned/removed/exchange 128 
Insertion of piggyback lens 52 
Implantable contact lens 20 
Relaxing incision 1039 
YAG laser 973 
Suture adjustment 803 
Wound repair/re-sutured 496 
PRK laser 285 
Compression sutures 391 
LASIK 177 










Retinal detachment surgery 66 
Conjunctival flap 83 
Iridectomy 23 
Iridotomy 17 
Ptosis repair 37 
Membrane peel 25 
Bleb needling/revision 28 
Intravitreal injection/s 97 
Synecholysis 26 
Concurrent subsequent graft (29 lamellar patch, 15 limbal/conjunctival) 44 
Other* 561 
  




Note: in calculating total number, cataract removal and IOL insertion are counted as two surgical 
procedures, even if done together. Where the same surgery was reported on multiple follow-ups for the 
same eye, it was only counted once. Surgeries listed in “other” are as reported to the ACGR by surgeons. 
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*Other included: Molteno tube revision/reposition (19); cryotherapy (16); ectropion repair 
(14); entropion repair (14); lid procedures (14); corneal scraping (13); punctal plugs (13); 
pterygium removal (13); scar removal (13); selective laser trabeculoplasty (12); cyst 
removal (11); amniotic membrane transplant (10); laser treatment not further specified 
(10); squint surgery (10); anterior chamber tap (9); biopsy (9); interface revision (9); 
punctal cautery (9); pupilloplasty (9); reformation of anterior chamber (9); strabismus 
surgery (9); band keratopathy removal (8); BCC removal (8); dacryocystorhinostomy (8); 
photocoagulation (8); corneal gluing (7); iris repair (7); refractive keratoplasty (7); removal 
of lens matter (7); scleral buckle (7); silicone oil insertion (7); Argon laser trabeculoplasty 
(6); blepharoplasty (6); epithelial debridement (6); foreign body removal (6); 
keratoprosthesis (6); anterior chamber washout (5); Botulinum toxin injection (5); filament 
removal (5); lensectomy (5); Molteno tube removal (5); plaque removal (5); scar removal 
(5); trabeculectomy revision (5); unspecified drainage device inserted (5); unspecified 
glaucoma surgery (5); capsulotomy (4); chalazion removal (4); corneal collagen cross-
linking (4); corneal debridement (5); iridoplasty (4); lashes epilated (4); lysis (4); 
paracentesis (4); punctal occlusion repair (4); limbal lesion removal (4); silicone oil 
removal (4); vitreous aspiration (4); drainage of choroidal haemorrhage (3); IOL re-
sutured (3);  iris removal (3); Keraring insertion (3); macular hole repair (3); retinal 
photocoagulation (3); Baerveldt tube removal (2); Beta-radiation (2); canthoplasty (2); 
Endolaser (2); hyphaema evacuation (2); unspecified glaucoma drainage device inserted 
(2); Healon inserted in anterior chamber (2); Holmm laser sclerectomy (2); prolapsed iris 
repositioned (2); punctal snip (2); pupillary membrane removal (2); retained Descemet 
membrane removal (2); retinal laser surgery (2); retinoplexy (2); scleral buckle removal 
(2); superior conjunctival resection (2); trabeculectomy revision (2); trichiasis (2); 
unspecified gas insertion (2); vitreoretinal surgery (2); vitreous haemorrhage removal (2); 
anterior segment clearance (1); aspiration of anterior chamber (1); Argon laser of blood 
vessels at graft/host junction (1); Barrier laser (1); orbital compression (1); branch artery 
occlusion repair (1); canalicular repair (1); capsulectomy (1); cathoplasty (1); Cionni ring 
insertion (1); clearance of iris from the graft (1); conjunctival injection (1); conjunctival 
keratin removal (1); conjunctival resection (1); corneal cautery (1); division of angle 
adhesions & pupil membrane (1); epithelial plugs removed (1); exenteration (1); express 
drainage (1); eye muscle surgery (1); filter surgery (1); gas/fluid exchange (1); 
intracameral antibiotics (1); intracorneal injection for epithelium downgrowth (1); iris clip 
repositioned (1); iris implant inserted (1); irrigation of hyphaema (1); Jones tube inserted 
(1); lacrimal duct reconstruction (1); lacrimal plugs (1); laser treatment for diabetic 
retinopathy (1); lateral canthoplasty (1); needling of posterior capsule (1); occlusion of 
puncta (1); opened cloudy capsule (1); punctate diothermy (1); pupil block (1); pupil 
membrane removal (1); pupillary cerclage (1); reattachment of Descemet membrane (1); 
removal of blood from vitreous cavity (1); removal of Descemet folds (1); removal of 
epithelial dystrophy (1); removal of epithelium (1); removal of exposed scleral bullae (1); 
removal of fibrous bleb (1); removal of fibrous tissue (1); removal of iris from graft/host 
junction (1); removal of pannus (1); removal of SCC (1); repair of iridotomy (1); repeat 
refiltering surgery (1); reposition of Keraring segment (1); retrobulbar alcohol (1); revision 
of astigmatic keratotomy cuts (1); revision of vitrectomy (1); Scheie's operation (1); scleral 
flap (1); silicone oil exchange (1); sphincterotomy (1); submandibular gland transplant (1); 
subretinal tissue plasminogen activator (1); suture of conjunctival fold (1); syringed tear 
ducts (1); insertion of ‘T’ lens (1); tarsal snip (1); TBL inserted (1); temporal pinguecula 
removal  (1); trabeculectomy removed (1); trabeculectomy repositioned (1); triescence 
(1); tube revision (1); tube shunt (1); unspecified secondary implant (1); viscocanalostomy 
(1); vitreolysis by laser (1); vitreous band dissection (1).  
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2.6.1 Penetrating graft survival: influence of post-graft neovascularisation 
 
Figure 2.6.1 shows the influence of post-graft neovascularisation on graft survival. A 
significant difference was found across groups (Log Rank Statistic=491.58; df=1; 
p<0.001). This variable was retained in the final model, suggesting that this is an 
independent factor significantly affecting graft survival. 




Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No neovascularisation 15670 7237 3228 1608 798 385 136 
Neovascularisation 1207 539 226 128 70 39 17 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No neovascularisation 0.93 0.79 0.67 0.56 0.46 0.34 0.22 
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2.6.2 Penetrating graft survival: influence of post-graft herpetic infection 
 
Figure 2.6.2 shows the influence of herpetic infection in a graft. A significant difference 
was found across groups (Log Rank Statistic=199.70; df=1; p<0.001). This variable was 
retained in the final model, suggesting that this is an independent factor significantly 
affecting graft survival.  
 
Figure 2.6.2 Post-graft herpetic infection 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No herpetic infection 16537 7634 3394 1710 855 420 153 
Herpetic infection 340 142 60 26 13 4 NA 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No herpetic infection 0.93 0.77 0.65 0.54 0.44 0.32 0.21 








74 Australian Corneal Graft Registry Report 2018 
2.6.3 Penetrating graft survival: influence of post-graft microbial keratitis 
 
Figure 2.6.3 shows the survival for grafts in which microbial keratitis occurred post-graft, 
including those where a stitch abscess occurred. A significant difference was found 
between groups (Log Rank Statistic=351.81; df=1; p<0.001). This variable was retained 
in the multivariate analysis (see section 2.7), suggesting that this is an independent factor 
significantly affecting graft survival.  
Figure 2.6.3 Post-graft microbial keratitis 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No microbial keratitis 16423 7590 3402 1716 861 419 152 
Microbial keratitis 454 186 52 20 7 5 1 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No microbial keratitis 0.93 0.78 0.67 0.55 0.45 0.33 0.21 
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2.6.4 Penetrating graft survival: influence of post-graft synechiae 
 
Figure 2.6.4 shows the survival for grafts where the eye developed at least one synechia 
post-graft, compared to those where it did not. A significant difference was found between 
groups (Log Rank Statistic=108.61; df=1; p<0.001). This variable was not retained in the 
multivariate analysis (see section 2.7), suggesting that this is not an independent factor 
significantly affecting graft survival.  
Figure 2.6.4 Post-graft synechia 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No synechia 16566 7648 3411 1724 866 424 153 
Synechia 311 128 43 12 2 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No synechia 0.93 0.77 0.65 0.54 0.44 0.32 0.20 
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2.6.5 Penetrating graft survival: influence of post-graft uveitis 
 
Figure 2.6.5 shows the comparison of survival of grafts in eyes which developed uveitis 
compared with those that did not. A significant difference was found across groups (Log 
Rank Statistic=35.67; df=1; p<0.001). This variable was not retained in the final model, 
suggesting that this is not an independent factor significantly affecting graft survival. 
Figure 2.6.5 Post-graft uveitis 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No uveitis 16638 7668 3415 1718 863 421 152 
Uveitis 239 108 39 18 5 3 1 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No uveitis 0.93 0.77 0.65 0.54 0.44 0.32 0.20 
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2.6.6 Penetrating graft survival: influence of post-graft raised IOP  
 
Figure 2.6.6 shows the comparison of graft survival for grafts where the eye was reported 
to have developed raised intraocular pressure post-graft to those where IOP was not 
reported as raised. A significant difference was found between groups (Log Rank 
Statistic=103.35; df=1; p<0.001). This variable was retained in the multivariate analysis 
(see section 2.7), suggesting that this is an independent factor significantly affecting graft 
survival. 
Figure 2.6.6 Post-graft raised intraocular pressure 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No raised IOP 13466 6040 2716 1396 716 360 130 
Raised IOP 3411 1736 738 340 152 64 23 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No raised IOP 0.92 0.79 0.67 0.57 0.47 0.34 0.22 
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2.6.7 Penetrating graft survival: influence of graft rejection episodes 
 
Figure 2.6.7 shows the survival for grafts where the eye underwent at least one episode 
of post-graft immunological rejection, compared to those that did not. A significant 
difference was found between groups (Log Rank Statistic=885.30; df=1; p<0.001). This 
variable was retained in the multivariate analysis (see section 2.7), suggesting that this is 
an independent factor significantly affecting graft survival.  
Figure 2.6.7 Rejection episode(s) 
 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
No Rejection 13382 6051 2627 1326 688 347 125 
Any rejection 3495 1725 827 410 180 77 28 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
No Rejection 0.94 0.82 0.71 0.61 0.52 0.38 0.23 
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2.6.8 Penetrating graft survival: influence of time to final removal of sutures 
 
Figure 2.6.8 shows the comparison of graft survival depending on the time from graft to 
final suture removal. A significant difference was found amongst groups (Log Rank 
Statistic=154.01; df=3; p<0.001). Grafts where the sutures had been removed within 6 
months had poorer survival than all other groups (all p<0.001). Additionally, grafts where 
the sutures were not removed until at least 24 months post-graft had significantly better 
survival than those where they were removed at between 6 months and 24 months (both 
p<0.001). Consideration should be given to the fact that grafts in each group must, by 
definition, have survived to the point of suture removal, meaning that all grafts in the 24 
months or more group must have survived for 2 years, and so on. This information was 
only available for 11251 (55%) of followed grafts and therefore this variable was not 
included in the multivariate analysis. 
Figure 2.6.8 Time to final removal of sutures 
 
Number at risk (years post-graft) 
 
1 4 8 12 16 20 24 
Less than 6 months 385 199 108 61 37 18 6 
6 months to <12 months 1896 895 449 273 151 84 39 
1 year to <2 years 5940 2822 1223 607 296 147 57 
2 years or more 2567 1822 866 411 201 92 33 
 
Probability of graft survival (years post-graft) 
 
1 4 8 12 16 20 24 
Less than 6 months 0.86 0.74 0.65 0.60 0.53 NA NA 
6 months to <12 months 0.98 0.87 0.78 0.70 0.61 0.45 0.32 
1 year to <2 years 1.00 0.91 0.78 0.66 0.56 0.40 0.26 
2 years or more 1.00 0.95 0.86 0.75 0.62 0.49 0.33 
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2.7 Multivariate Analysis 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all other variables in the model. This analysis was 
performed using STATA version 15. 
In the preceding univariate analyses, each registered penetrating graft, together with its 
archival follow-up records, was treated as a separate and independent entity. Some 
recipients had multiple penetrating grafts performed during the census period (registered 
by 31/7/2017), with some having repeat grafts in a single eye, some grafts in both eyes 
and some a combination of both. To control for potential inter-graft and/or inter-eye 
dependence in the multivariate analyses, the multivariate model was adjusted to allow for 
clustering by individual patient [see references 7 & 8]. 
Variables to be included in the Cox Proportional Hazards regression model were identified 
based on the results of the univariate Kaplan-Meier analyses, with a cut-off significance 
level of p<0.08 used to select variables for inclusion. Some variables which were found 
to be significant in the univariate analyses were omitted due to co-linearity, or because of 
large amounts of missing data (>25%). Each variable was initially analysed individually 
to determine if it remained significant once clustered by individual patient. Where the 
variable was no longer found to be significant (p>0.08), it was excluded from the 
multivariate analysis. 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in a 
stepwise manner, beginning with the least significant variable. The Kaplan-Meier plots, 
and additional appropriate STATA analyses, were used to assess whether each included 
variable met the assumption of proportional hazards. Where variables were found to be 
time-variant, they were treated as such in the multivariate model.  
Table 2.11 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained in 
the final model. Some variables that were found to be significant in the univariate analyses 
were excluded from the multivariate model as they were found to be co-linear with (i.e. 
were highly correlated and produced the same effect on the outcome as) another variable 
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Table 2.11 Multivariate model 
Penetrating Corneal Graft 
Multivariate Model 
Not significant in univariate analysis 
Time from enucleation to storage 




Significant in univariate analysis but excluded from multivariate model due 
to co-linearity or missing data 
The Centre effect (co-linear with surgeon experience and level of follow-up) 
Donor sex (co-linear with donor/recipient sex match/mismatch) 
Number of previous ipsilateral grafts (co-linear with indication for graft) 
Corneal endothelial cell density (missing data) 
Time to removal of sutures (missing data) 
 
Significant in univariate analysis but not retained in multivariate model 
    Peripheral iridectomy at time of graft (p>0.08 after clustering by patient) 
Eye Bank 
Cause of donor death 
Storage medium: hypothermic vs organ culture 
Time from death to enucleation 
Storage time in Optisol 
Multi-organ donor 
Recipient State 
Recipient age group 




Significant in univariate analysis AND retained in multivariate model 
    Donor age group 
Indication for graft 
    Interstate transportation of donor cornea 
Donor/recipient sex match/mismatch 
Change in lens status pre- to post-graft 
Pre-graft neovascularisation 
Pre-graft inflammation and/or steroid use 
History of raised intraocular pressure 
Number of previous contralateral grafts 
Graft era 
Graft size 
Surgeon experience and level of follow-up 
Post-graft neovascularisation 
Post-graft herpetic infection 
Post-graft microbial keratitis 
Raised intraocular pressure post-graft 
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Table 2.12 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The first level of each categorical variable was taken as the 
referent. The hazard ratios for a given variable are adjusted for all other variables in the 
model. This model included data from 24,827 penetrating keratoplasties, performed in 
18,727 recipients. Where no valid response had been provided for one of the included 
variables, these cases were classified as “not advised”. This model includes variables 
with a p-value of p<0.05, with variables eliminated in a stepwise manner, beginning with 
the least significant variable. For categorical variables, a global test was applied to 
calculate the overall p-value and Bonferroni adjusted post-hoc tests were conducted to 
determine between which groups the significant differences were observed. The overall 
model was highly significant: (Chi²=4610.75, df=56, p<0.0001).  
Table 2.12 Clustered multivariate model 
Penetrating Corneal Graft 












Indication for graft 
Failed previous graft 6292 2.81 0.17 <0.001  2.49 - 3.16 
Keratoconus 7621 1.00   <0.001  
Pseudophakic bullous keratopathy 3626 2.79 0.18 <0.001  2.45 - 3.17 
Fuchs’ endothelial dystrophy 2067 1.89 0.13 <0.001  1.65 - 2.16 
Corneal scar and/or opacity 478 1.81 0.23 <0.001  1.42 - 2.31 
Corneal ulcer 495 4.43 0.47 <0.001  3.60 - 5.44 
Herpetic eye disease 1109 1.79 0.15 <0.001  1.52 - 2.12 
Trauma 638 2.71 0.25 <0.001  2.26 - 3.24 
Non-herpetic infection 444 3.60 0.45 <0.001  2.81 - 4.61 
Corneal degeneration 223 2.22 0.40 <0.001  1.55 - 3.17 
Other bullous keratopathy 1002 3.06 0.23 <0.001  2.64 - 3.56 
Other corneal dystrophy 311 1.52 0.23 0.005  1.13 - 2.05 
Other not yet specified 521 2.33 0.25 <0.001  1.89 - 2.87 
 
Donor age group 
Under 50 years 6014 0.79 0.03 <0.001  0.73 - 0.86 
50 to 59 years 4286 0.92 0.04 0.074  0.85 - 1.01 
60 to 69 years 6167 1.00   <0.001  
70 to 79 years 5979 1.01 0.04 0.741  0.94 - 1.09 
80 years or older 2078 1.12 0.06 0.027  1.01 - 1.23 
Not advised 303 0.92 0.13 0.560  0.71 - 1.21 
 
Donor/recipient sex match/mismatch 
Female/female 4269 0.85 0.04 <0.001  0.78 - 0.93 
Female/male 4615 0.96 0.04 0.279  0.88 - 1.04 
Male/female 7222 0.93 0.03 0.060  0.87 - 1.00 
Male/male 8095 1.00   0.007  
Not advised 626 0.90 0.09 0.298  0.74 - 1.10 
       
Interstate transportation of donor cornea (tvc) 
No 21812 1.00   <0.001  
Yes 1295 1.18 0.07 0.009  1.04 - 1.33 
Not advised 1720 0.78 0.06 <0.001  0.68 - 0.90 
       
Pre-graft raised intraocular pressure 
None 20934 1.00     
In past and/or at graft 3893 1.41 0.05 <0.001  1.31 - 1.52 


















Inflammation and/or steroid use at graft (tvc) 
No 17568 1.00   <0.001  
Yes 6984 1.48 0.06 <0.001  1.36 - 2.61 
Not advised 275 2.23 0.36 <0.001  1.63 - 3.06 
       
Size of graft 
<7.75mm 3229 1.22 0.05 <0.001  1.12 - 1.32 
7.75mm to <8.25mm 11228 1.00   <0.001  
8.25mm to <8.75mm 6930 1.01 0.03 0.875  0.94 - 1.08 
8.75mm or more 1951 1.23 0.07 <0.001  1.10 - 1.38 
Not advised 1489 1.18 0.07 0.007  1.05 - 1.34 
       
Pre-graft corneal neovascularisation 
None 16795 1.00   <0.001  
One quadrant 2121 0.94 0.05 0.202  0.85 - 1.04 
Two or three quadrants 3848 1.14 0.04 0.001  1.06 - 1.23 
Four quadrants 2063 1.61 0.08 <0.001  1.46 - 1.77 
 
Number of previous contralateral grafts 
None 19557 1.00   0.001  
One 4290 0.87 0.04 <0.001  0.80 - 0.94 
Two or more 980 0.91 0.07 0.224  0.78 - 1.06 
 
Lens status pre- and post-graft 
Phakic/phakic 12220 1.00   <0.001  
Phakic/pseudophakic 2422 1.05 0.06 0.433  0.94 - 1.17 
Other 10185 1.55 0.07 <0.001  1.42 - 1.70 
 
Era in which graft was performed (tvc) 
1985 to 1989 2288 1.27 0.07 <0.001  1.14 - 1.40 
1990 to 1994 5018 1.00   <0.001  
1995 to 1999 4000 0.81 0.04 <0.001  0.74 - 0.89 
2000 to 2004 4357 0.67 0.04 <0.001  0.61 - 0.75 
2005 to 2009 4258 0.63 0.04 <0.001  0.56 - 0.70 
2010 to 2014 3398 0.62 0.04 <0.001  0.55 - 0.70 
2015 to 2017 1508 1.15 0.15 0.260  0.90 - 1.48 
 
Surgeon volume and level of follow-up (tvc) 
<500 PK registered 12489 1.00   <0.001  
500+ PK registered, <82% followed 4203 1.11 0.05 0.020  1.02 - 1.22 
500+ PK registered, 82%+ followed 8135 0.72 0.03 <0.001  0.66 - 0.77 
 
Post-graft corneal neovascularisation 
No 23307 1.00     
Yes 1520 1.44 0.06 <0.001  1.32 - 1.56 
 
Post-graft herpetic infection 
No 24399 1.00     
Yes 428 1.41 0.11 <0.001  1.21 - 1.64 
 
Post-graft microbial keratitis 
No 24251 1.00     
Yes 576 1.59 0.10 <0.001  1.40 - 1.80 
 
Post-graft significant rise in IOP (tvc) 
No 20964 1.00     
Yes 3863 0.73 0.03 <0.001  0.67- 0.80 
 
Post-graft rejection episode(s) (tvc) 
No 20718 1.00     
Yes 4109 2.32 0.09 <0.001  2.15 - 2.50 
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2.7.1 Significant differences in the penetrating keratoplasty multivariate model for 
categories with more than two groups following Bonferroni correction for 
multiple comparisons 
2.7.1.1 Indication for graft 
 
Grafts performed for keratoconus had significantly better survival than those performed 
for any other indication for graft, except other corneal dystrophy (all p <0.001). 
Grafts performed for Fuchs’ endothelial dystrophy, other corneal dystrophy, or herpetic 
infection, had significantly better survival than those performed for failed previous graft/s, 
pseudophakic bullous keratopathy, corneal ulcer, trauma, non-herpetic infection, and 
other bullous keratopathy (all comparisons p<0.001, except other corneal dystrophy vs. 
trauma, p=0.001).  
Grafts performed for corneal scar and/or opacity had better survival than those for failed 
previous graft/s, pseudophakic bullous keratopathy, corneal ulcer, non-herpetic infection, 
and other bullous keratopathy (all p<0.001).  
In addition to those indications for graft mentioned above, grafts performed for corneal 
ulcer had poorer survival than grafts performed for failed previous graft/s, pseudophakic 
bullous keratopathy, trauma, “other” indications for graft (all p<0.001), corneal 
degeneration and other bullous keratopathy (both p=0.001). 
 
2.7.1.2 Donor age group 
 
Significantly better survival was shown for the under 50 years group, compared to each 
of the other age groups (all comparisons p<0.001). 
Significantly better survival was shown for the 50 to 59 years group, compared to the 80 
years and older group (p=0.001). 
 
2.7.1.3 Donor/recipient sex match/mismatch 
 
Grafts performed in a female recipient using a donor cornea also from a female (F/F) 
exhibited significantly better survival than those performed in a male recipient using a 
male donor cornea (M/M, p<0.001), or in a male recipient using a female donor (F/M, 
p=0.019). 
 
2.7.1.4 Interstate transportation of donor cornea 
 
Grafts performed with corneas that had been transported interstate had significantly 
poorer survival than those where they had not (p=0.009). 
Grafts where it was not known whether the donor cornea had been transported interstate 
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2.7.1.5 Change in lens status pre- to post-graft 
 
Eyes that were phakic before and after graft, as well as those that underwent a triple 
procedure at graft (phakic/pseudophakic) exhibited significantly better survival than those 
with any other combination (p<0.001 in both cases). 
 
2.7.1.6 Pre-graft corneal neovascularisation 
 
The survival of grafts performed in eyes with four quadrants of pre-graft corneal 
neovascularisation had significantly poorer survival than those with fewer quadrants or 
no neovascularisation (all p<0.001).  
Grafts performed in eyes with two or three quadrants of pre-graft corneal 
neovascularisation had significantly poorer survival than those with none (p=0.001), or 
one quadrant (p<0.001). 
 
2.7.1.7 Pre-graft inflammation and/or steroid use 
 
Grafts performed in eyes with pre-graft inflammation and/or steroid use within the prior 
two weeks had significantly poorer survival than those without (p<0.001). 
Grafts performed in eyes where the presence of pre-graft inflammation and/or steroid use 
within the prior two weeks was not known to the surgeon, had significantly poorer survival 
than both those without (p<0.001) and those with (p=0.004) this pre-graft factor recorded.  
 
2.7.1.8 Number of previous contralateral grafts 
 
Grafts performed in recipients who had a history of a single previous graft performed in 
their contralateral eye exhibited significantly better survival than those with no prior 
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2.7.1.9 Graft era 
 
Grafts survival was significantly better in each subsequent era, up to 2000 to 2004. Grafts 
performed from 1990 to 1994 had better survival than those performed from 1985 to 1989 
(p<0.001). Grafts performed from 1995 to 1999 had better survival than those performed 
from 1990 to 1994 (p<0.001). Grafts performed from 2000 to 2004 had better survival 
than those performed from 1995 to 1999 (p<0.001).  
There were no significant differences in graft survival for grafts performed between 2000 
to 2004, 2005 to 2009, and 2010 to 2014 (all p>0.100). Each of these groups had 
significantly better survival than the grafts performed in each era prior to the year 2000 
(all p<0.001), and to grafts performed in the most recent era of 2015 to 2017 (p<0.001). 
The poor performance of grafts in this most recent era is likely due to the lag time effect 
discussed in section 2.3.1. 
 
2.7.1.10 Graft size 
 
Survival of grafts that were 7.75 mm but less than 8.25 mm was significantly better than 
those that were under 7.75 mm, or over 8.25 mm (both p<0.001). They also had 
significantly better survival than grafts where the size was not reported to the ACGR 
(p=0.007). 
Survival of grafts that were 8.25 mm but less than 8.75 mm was significantly better than 
those that were under 7.75 mm (p<0.001), or over 8.25 mm (p=0.001). 
 
2.7.1.11 Volume of PK registered by surgeon and level of follow-up received 
 
Grafts performed by surgeons with 500 or more PK registered with the ACGR, and above 
average (>82%) levels of follow-up had significantly better survival than those performed 
by surgeons with 500 or more PK registered with the ACGR, and below average (≤82%) 








88 Australian Corneal Graft Registry Report 2018 
2.8 Reasons for Graft Failure 
 
Of the 20,336 followed grafts, 5,687 (28%) were known to have failed by the census date. 
This equates to 23% of the 24,827 registered grafts. Surgeons were asked to indicate the 
reason for graft failure. This information was also gathered from repeat registration forms, 
where the reason for failure of the previous graft was given.  
Table 2.13 shows the reasons for failure given. Please note that for some of the reasons 
for failure given, the sub-categories do not add up to the total number of cases.  
Table 2.13 Reasons for failure 
 
Penetrating Corneal Graft 
Reasons for Graft Failure 
 
 Sub-total Total 
Rejection  1594 (28%) 
  Unspecified/endothelial cell failure 1329  
  With glaucoma 67  
  With non-herpetic infection 56  
  With herpetic infection 31  
  With vascularisation 28  
  With scarring 19  
  With other 64  
   
Endothelial cell failure 
 
1117 (20%) 
  Pseudophakic 792  
  Phakic 107  
  Aphakic 218  




  Microbial/bacterial keratitis 213  
  Endophthalmitis 72  
  Fungal keratitis 55  
  Other specified 29  
  Unspecified 82  
   
Glaucoma  293 (5%) 
  With endothelial cell failure  33  
  With other* 52  




  Perforated 121  
   
Primary graft failure  174 (3%) 
   
Trauma  147 (3%) 
  Rupture 47  
  Penetrating eye injury 13  
  Blunt force trauma 10  
  Other specified  7  
  Unspecified 70  
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Scarring/opacity  105 (2%) 
   
Other specified**  439 (8%) 
   
Unspecified  936 (16%) 
   
Total  5687 (100%) 
   
 
* Other included: corneal neovascularisation (7), epithelial defect (7), uveitis (5), anterior 
chamber haemorrhage (3), band keratopathy (3), epithelial downgrowth (3), unspecified 
infection (3), central retinal vein occlusion (2), Descemet’s membrane detachment (2), 
perforation (2), synechiae (2), blepharitis (1), cataract (1), calcification (1), corneal nebula 
(1), ICE syndrome (1), IOL complication (1), Peters’ anomaly (1) phthisical eye (1), retinal 
detachment (1), retrocorneal membrane (1), scleral necrosis (1), trichiasis (1), wound leak 
(1).  
** Other included: limbal cell/epithelial failure (67), neovascularisation (52), recurrent 
keratoconus (42), corneal melt (38), unspecified ectasia (32), phthisis (27), recurrent 
dystrophy (20), wound dehiscence (20), band keratopathy (14), descemetocoele (12), 
retinal detachment (11), retrocorneal membrane (10), choroidal haemorrhage (8), 
carcinoma (5), hypotony (6), ICE syndrome (6), epithelial downgrowth (6), calcification 
(5), uveitis (5), dry eye (4), expulsive haemorrhage (4), rubeosis iridis (4), anterior 
segment ischaemia (2), fibrous ingrowth (2), keratoglobus (2), protein deposits (2), 
Stevens-Johnson syndrome (2), surgical complications (2), synechia (2), unspecified 
inflammation (2), aniridic keratopathy (1), anterior chamber haemorrhage (1), anterior 
segment dysgenesis (1), Descemet’s detachment (1), erythroderma (1), hypopyon (1), 
keratomalacia (1), lipid keratopathy (1), meibomianitis (1), melanoma (1), necrosis (1), 
neurotrophic keratopathy (1), pemphigoid (1), Peter’s anomaly (1), pterygium (1), 
pupillary membrane (1), recurrent erosions (1), retinal occlusion (1), Sjogren’s syndrome 
(1), spontaneous graft detachment (1), striate keratopathy (1), stromal failure (1), stromal 
folds (1),  vitreous disorder (1), vitreous haemorrhage (1). 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. For penetrating grafts, the time from graft to failure is as reported by the 
surgeon. It was usually 1-2 days but seldom more than 7 days. 
Of the 174 grafts reported by surgeons to have been primary graft failures, the majority 
(139) had no further information provided, while for a further five the surgeon stated that 
the donor tissue was of poor quality. Additional specific reasons given were: epithelial 
defect in donor (4), expulsive haemorrhage (3), oedema (3), wound dehiscence (3), 
corneal perforation (2), suture related complications (2), Acanthamoeba infection (1), 
allergic conjunctivitis (1), donor tissue damaged during transportation (1), donor tissue 
damaged during dissection (1), endophthalmitis (1), enucleation due to fungal keratitis 
(1), flat anterior chamber (1), herpetic infection (1), limbal stem cell failure (1), opacity (1), 
trauma (1), undersized graft (1), unspecified infection (1). 
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2.9 Post-graft Changes in Best Corrected Visual Acuity 
 
2.9.1 All indications for graft 
 
Post-graft best corrected visual acuity (BCVA) is an important outcome for corneal graft 
recipients. A desire for improved visual acuity was specified as a reason for graft in 19,253 
(78%) of registered penetrating keratoplasties. In 62% of cases (15,430), this was the 
sole desired outcome indicated. It is likely that this was also at least part of the reason for 
graft in some of the further 3,952 (16%) grafts for which no reason was specified.  
Follow-ups occur at varying times post-graft, depending on when a surgeon sees a 
recipient. Where post-graft best corrected visual acuity (without pinhole) information was 
provided, we categorised this according to the length of time since graft. The first two 
categories were: 
• BCVA provided at between 6 and 12 months post-graft, and 
• BCVA provided at between 12 and 18 months post-graft. 
Subsequent groups were at yearly intervals. For each year point, any measurements 
provided within 6 months of that date, rounded to the nearest day, were included (e.g. for 
2-year follow-up, any BCVA given at between 730 and 913 days post-graft was included). 
We analysed post-graft visual acuity in several ways. Where more than 20 grafts had 
BCVA measurements provided, we examined: 
1. The percentage of surviving grafts achieving different levels of Snellen visual 
acuity (6/6 or better, 6/7.5 to 6/12, 6/15 to 6/24, 6/36 to 6/60, count fingers (CF) or 
hand movements (HM), and light perception (LP) or no light perception (NLP)) at 
yearly time-points post-graft. Grafts that had been reported to have failed at the 
time of last follow-up, but had prior follow-ups with BCVA measurements provided 
when the graft was surviving, had these prior data included in these analyses.  
2. The average Snellen visual acuity achieved at yearly intervals post-graft, again by 
surviving grafts. 
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Table 2.14 and Figure 2.9.1 show the reported post-graft best corrected visual acuity for 
all failed grafts at the time of last follow-up, separated by indication for graft. Visual acuity 
at time of failure was reported for 4256 (75%) of 5686 failed PK. As might be expected, 
the majority of failed grafts had accompanying poor visual acuity. 
Table 2.14 Post-graft best corrected visual acuity 
 
Penetrating Corneal Graft:  











CF or HM LP or NLP 
Failed previous graft 2 (<1%) 36 (2%) 79 (5%) 219 (14%) 992 (63%) 259 (16%) 
Keratoconus 2 (<1%) 39 (7%) 84 (15%) 158 (27%) 277 (48%) 19 (3%) 
Pseudo bullous keratopathy 0 (0%) 9 (1%) 31 (4%) 96 (13%) 487 (64%) 136 (18%) 
Fuchs’ endothelial dystrophy 1 (<1%) 10 (3%) 30 (9%) 68 (21%) 195 (59%) 25 (8%) 
Corneal scars and opacities 0 (0%) 0 (0%) 2 (4%) 11 (19%) 36 (63%) 8 (14%) 
Corneal ulcers 0 (0%) 2 (2%) 3 (3%) 9 (8%) 72 (61%) 32 (27%) 
Herpetic eye disease 0 (0%) 3 (2%) 5 (3%) 21 (11%) 119 (64%) 39 (21%) 
Trauma 0 (0%) 4 (3%) 3 (2%) 16 (10%) 103 (66%) 29 (19%) 
Non-herpetic infection 1 (1%) 2 (3%) 1 (1%) 5 (6%) 42 (54%) 27 (35%) 
Corneal degeneration 0 (0%) 1 (4%) 2 (8%) 5 (19%) 14 (54%) 4 (15%) 
Other bullous keratopathy 0 (0%) 1 (<1%) 10 (4%) 30 (12%) 164 (67%) 40 (16%) 
Other dystrophies 0 (0%) 2 (%5) 5 (13%) 10 (25%) 22 (55%) 1 (3%) 
Other specified 0 (0%) 1 (%)1 4 (4%) 14 (15%) 52 (54%) 25 (26%) 
Total 6 (<1%) 110 (3%) 259 (6%) 662 (16%) 2575 (61%) 644 (15%) 
       
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 





92 Australian Corneal Graft Registry Report 2018 
Figure 2.9.2 shows the best corrected visual acuity (without pinhole) in the grafted eye, 
as reported to the ACGR, and categorised into six levels of vision, for all penetrating 
grafts. Prior to graft more than 60% of eyes had vision of CF or worse, with another 20% 
having 6/36 to 6/60. By 2-years post-graft, approximately three-quarters of eyes with 
surviving grafts had vision of 6/24 or better, with approximately 60% having functional 
vision of 6/12 or better. This remained the case for surviving grafts followed for up to 20 
years. 
Figure 2.9.2 Best corrected visual acuity for penetrating keratoplasties, surviving 
at time of measurement 
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2.9.2 Individual indications for graft 
 
The following analyses show the post-graft best corrected (without pinhole) visual acuity 
obtained for surviving grafts performed for specific indications. Data are reported for each 
of: keratoconus, Fuchs’ endothelial dystrophy, pseudophakic bullous keratopathy, 
herpetic eye disease, trauma, and other bullous keratopathy. Figure 2.9.3 shows the 
average BCVA reported for various indications for graft pre-graft, and at yearly time points 
(six-month timeframe cohorts), up to 10 years. The dashed line shows the point where 
vision reaches 6/12, sometimes referred to as “functional” vision. 
On average, the best visual outcomes were seen for eyes grafted for keratoconus, 
followed by Fuchs’ endothelial dystrophy. It can also be seen that these grafts had better 
pre-graft visual acuity levels than grafts for other indications. Grafts performed for these 
indications had mean post-graft vision of 6/12 or better by 12-months post-graft. On 
average, levels of vision obtained post-graft for bullous keratopathy (whether 
pseudophakic or otherwise), and trauma did not reach 6/12 or better. Eyes grafted for 
herpetic eye disease with surviving grafts had average visual acuity just under 6/12 up to 
7-years post-graft. 
Figure 2.9.3 Average level of best corrected visual acuity reported at yearly time 
points for surviving penetrating keratoplasty performed for common indications 
for graft 
 
CF=count fingers at 1 metre, HM=hand movements 
Number of surviving grafts with visual acuity provided 
 Pre 1 2 3 4 5 6 7 8 9 10 
Keratoconus 6398 1707 1106 707 535 429 348 287 198 194 148 
Pseudo bullous keratopathy 2976 664 372 232 155 118 100 66 47 31 25 
Other bullous keratopathy 777 186 94 60 43 40 19 17 15 9 8 
Fuchs’ endothelial dystrophy 1792 412 309 206 152 136 128 116 75 66 53 
Herpetic eye disease 808 208 128 88 58 47 26 35 19 12 12 
Trauma 529 97 73 47 37 28 21 11 8 8 4 
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Figure 2.9.4 shows levels of best corrected visual acuity reported to the ACGR at yearly 
intervals for surviving penetrating grafts performed for keratoconus. Post-graft vision of 
6/12 or better was reported in three-quarters of surviving penetrating grafts performed for 
keratoconus that had BCVA measurements reported between 12 and 18-months post-
graft. This percentage remained consistent up until 15-years post-graft. 
 
Figure 2.9.4 Keratoconus: level of best corrected visual acuity reported at yearly 
time points for surviving grafts 
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Figure 2.9.5 shows levels of best corrected visual acuity reported to the ACGR at yearly 
intervals for surviving penetrating grafts performed for Fuchs’ endothelial dystrophy. 
Post-graft vision of 6/12 or better was reported in more than half of surviving penetrating 
grafts performed for Fuchs’ endothelial dystrophy that had BCVA measurements reported 
between 12 and 18-months post-graft. This percentage continued to increase up to 
approximately 70% by 5-years, and remained above 50% up to 13-years post-graft. 
Figure 2.9.5 Fuchs' endothelial dystrophy: level of best corrected visual acuity 
reported at yearly time points for surviving grafts 
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Figure 2.9.6 shows levels of best corrected visual acuity reported to the ACGR at yearly 
intervals for surviving penetrating grafts performed for pseudophakic bullous 
keratopathy. Post-graft vision of 6/12 or better was reported in only around one-quarter 
of surviving penetrating grafts performed for pseudophakic bullous keratopathy that had 
BCVA measurements reported between 12 and 18-months post-graft. This percentage 
remained similar over the 10-years immediately post-graft. 
Figure 2.9.6 Pseudophakic bullous keratopathy: level of best corrected visual 
acuity reported at yearly time points for surviving grafts 
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Figure 2.9.7 shows levels of best corrected visual acuity reported to the ACGR at yearly 
intervals for surviving penetrating grafts performed for non-pseudophakic (aphakic or 
phakic pre-graft) bullous keratopathy. Post-graft visual acuity was similar to that reported 
for penetrating keratoplasties performed for pseudophakic bullous keratopathy, with post-
graft vision of 6/12 or better reported in approximately one-quarter of surviving penetrating 
grafts performed for non-pseudophakic bullous keratopathy that had BCVA 
measurements reported between 12 and 18-months post-graft. This percentage 
increased slightly, peaking at above 40% at 3-years post-graft. 
 
Figure 2.9.7 Non-pseudophakic bullous keratopathy: level of best corrected visual 
acuity reported at yearly time points for surviving grafts 
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Figure 2.9.8 shows levels of best corrected visual acuity reported to the ACGR at yearly 
intervals for surviving penetrating grafts performed for herpetic eye disease. Post-graft 
vision of 6/12 or better was reported in more than half of surviving penetrating grafts 
performed for herpetic eye disease that had BCVA measurements reported between 12 
and 18-months post-graft. This percentage varied slightly over the following years, but 
remained within the 40 to 60 percent range up to 8-years post-graft.  
 
Figure 2.9.8 Herpetic eye disease: level of best corrected visual acuity reported at 
yearly time points for surviving grafts 
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Figure 2.9.9 shows levels of best corrected visual acuity reported to the ACGR at yearly 
intervals for surviving penetrating grafts performed for trauma. Post-graft vision of 6/12 
or better was reported in just under 40% of surviving penetrating grafts performed for 
trauma that had BCVA measurements reported between 12 and 18-months post-graft. 
This percentage varied markedly over the following years, from as low as 30% at 3-years 
post-graft, up to over 60% at 4-years, but returned to the 40% mark at 5 and 6-years post-
graft.  
 
Figure 2.9.9 Trauma: level of best corrected visual acuity reported at yearly time 
points for surviving grafts 
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3 Descemet’s Stripping Endothelial Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 4,736 
Descemet’s stripping endothelial keratoplasties registered with the ACGR. The 
preparation of donor material may have been automated (DSAEK) or manual (DSEK). In 
some cases, this was unspecified by the contributing surgeon. All grafts in these three 
groups were analysed together and are referred to throughout this report as DS(A)EKs. 
Kaplan-Meier survival analyses were conducted using IBM SPSS for Windows (Version 
22.0), to compare the graft survival across groups for a range of variables relating to the 
corneal donor, graft recipient, surgical procedure, surgeon, and follow-up care. 
3.1 Donor and Eye Banking Factors 
 
Table 3.1 shows the number of grafts within each of the variable sub-groups, for the donor 
factors found to be significant in univariate analyses. The sum of these numbers for each 
variable equals the total number of grafts (4,736 registered and 3,263 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Likelihood of follow-up was significantly more likely (p<0.05) in some groups that others. 
Higher rates of follow-up were received for grafts where it had been stored in hypothermic 
solution. Rates were lower for grafts performed using donor tissue that had been pre-cut 
by the eye bank and grafts where the specific type of procedure was known. Significant 
differences in follow-up were also found across groups for eye bank, death-to-enucleation 
times and enucleation-to-storage times.  
Table 3.2 shows the number of grafts within each of the variable sub-groups, for the donor 
and eye banking factors found to be non-significant in univariate analyses. The sum for 
each variable equals the total number of grafts (4,736 registered and 3,263 with follow-
up provided) and the percentages, summed vertically for each variable, total 100. The 
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Table 3.1 Donor and eye banking factors, significant in univariate analyses 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank M 1683 (36%) 1145 (35%) 
  Eye bank K 925 (20%) 576 (18%) 
  Eye bank V 1195 (25%) 937 (29%) 
  Eye bank J 515 (11%) 303 (9%) 
  Eye bank N 418 (9%) 302 (9%) 
   
Enucleation-to-storage time*   
  ≤ 3 hours 2460 (52%) 1622 (50%) 
  4 to 6 hours 535 (11%) 410 (13%) 
  7 to 12 hours 287 (6%) 214 (7%) 
  > 12 hours 402 (8%) 280 (9%) 
  Not advised 1052 (22%) 737 (23%) 
   
Storage medium   
  Hypothermic 2273 (48%) 1803 (55%) 
  Organ culture 2460 (52%) 1457 (45%) 
  Moist pot 2 (<1%) 2 (<1%) 
  Not advised 1 (<1%) 1 (<1%) 
   
Age group   
  <40 years 385 (8%) 263 (8%) 
  40 to 69 years 2891 (61%) 1981 (61%) 
  70 years and older 1460 (31%) 1019 (31%) 
   
Pre-cut by eye bank   
  No 3622 (77%) 2883 (88%) 
  Yes 1114 (24%) 380 (12%) 
   
Central corneal endothelial cell density  
  <2500 cells/mm² 271 (6%) 169 (5%) 
  2500 to 3249 cells/mm² 2240 (47%) 1430 (44%) 
  ≥ 3250 cells/mm² 694 (15%) 445 (14%) 
  Not advised 1531 (32%) 1219 (37%) 
   
Total 4736 (100%) 3263 (100%) 
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Table 3.2 Donor and eye banking factors, not significant in univariate analyses 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Death-to-enucleation time   
  ≤ 6 hours 1108 (23%) 815 (25%) 
  7 to 12 hours 1727 (36%) 1285 (39%) 
  13 to 18 hours 1271 (27%) 814 (25%) 
  > 18 hours 621 (13%) 341 (10%) 
  Not advised 9 (<1%) 8 (<1%) 
Chi²=1.19, df=3, p=0.755   
   
Storage to graft time - Organ culture   
   Up to 2 weeks 543 (11%) 302 (9%) 
   2 to 3 weeks 942 (20%) 538 (17%) 
   More than 3 weeks 281 (6%) 173 (5%) 
   Not advised 694 (15%) 444 (14%) 
   Not applicable 2276 (48%) 1806 (55%) 
Chi²=4.42, df=2, p=0.110   
   
Storage to graft time - Hypothermic   
   Within 5 days 1329 (28%) 1069 (33%) 
   6 or 7 days 512 (11%) 385 (12%) 
   More than a week 74 (2%) 56 (2%) 
   Not advised 358 (8%) 293 (9%) 
   Not applicable 2463 (52%) 1460 (45%) 
Chi²=3.02, df=2, p=0.221   
   
Donor sex   
  Male 2921 (62%) 2049 (63%) 
  Female 1815 (38%) 1214 (37%) 
Chi²=0.23, df=1, p=0.629   
   
Cause of death   
  Cardiac event 1096 (23%) 748 (23%) 
  Malignancy 1742 (37%) 1216 (37%) 
  Trauma 408 (9%) 263 (8%) 
  Respiratory event 383 (8%) 283 (9%) 
  Intracranial bleed/cerebral haemorrhage 807 (17%) 538 (16%) 
  Other specified 257 (5%) 185 (6%) 
  Live donor 1 (<1%) 1 (<1%) 
  Not advised* 42 (<1%) 29 (<1%) 
Chi²=3.58, df=5, p=0.611   
   
Multi-organ donor status   
  No 4057 (86%) 2802 (86%) 
  Yes 679 (14%) 461 (14%) 
Chi²=0.37, df=1, p=0.545   
   
Total 4736 (100%) 3263 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not advised or not applicable. 
*ACGR advised that cause of death was not yet determined but there were no medical contraindications and the eye 
had been cleared for release, by the Medical Director, in accordance with EBAANZ guidelines. 
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3.1.1 DS(A)EK survival: influence of Australian eye bank 
 
Donor corneas are retrieved, processed, stored and distributed by five eye banks around 
Australia. Figure 3.1.1 shows the comparison of graft survival for corneas provided by 
each of these eye banks. A significant difference was found across eye banks (Log Rank 
Statistic=53.50; df=4; p<0.001), with State V and State N having significantly better 
survival than all other states (all p<0.001). This variable was not retained in the final model 
(see section 3.7), suggesting that this is not an independent factor significantly affecting 
graft survival. 
Figure 3.1.1 Australian eye bank 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Eye Bank M 791 521 141 38 6 
Eye Bank K 410 247 54 10 NA 
Eye Bank V 667 475 206 69 9 
Eye Bank J 208 148 64 17 2 
Eye Bank N 230 157 54 13 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Eye Bank M 0.86 0.79 0.62 0.46 
Eye Bank K 0.87 0.78 0.60 NA 
Eye Bank V 0.90 0.85 0.77 0.68 
Eye Bank J 0.81 0.75 0.34 NA 
Eye Bank N 0.91 0.89 0.83 NA 
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3.1.2 DS(A)EK survival: influence of enucleation to storage time 
 
Figure 3.1.2 shows the comparison of graft survival across time to storage groups. Data 
were not provided for 1052 grafts and these were excluded from the analysis. The 
difference across groups was not statistically significant, (Log Rank Statistic=6.821; df=1; 
p=0.078) and no individual comparisons between groups were significant following 
Bonferroni correction (all p>0.01). This variable met the p<0.08 criteria for potential 
inclusion in the multivariate analyses, however following further analyses in which the 
data were clustered by patient (see refences 7 & 8), this was no longer the case 
(p=0.083). This variable was therefore excluded from multivariate analyses and is not an 
independent factor significantly affecting graft survival. 
Figure 3.1.2 Time from enucleation to storage of donor cornea  
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Up to 3 hours 1156 766 253 67 7 
4 to 6 hours 292 194 72 24 2 
7 to 12 hours 156 105 40 8 4 
More than 12 hours 195 132 50 18 2 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Up to 3 hours 0.87 0.81 0.69 0.57 
4 to 6 hours 0.88 0.81 0.73 0.60 
7 to 12 hours 0.90 0.88 0.76 NA 
More than 12 hours 0.87 0.82 0.69 NA 
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3.1.3 DS(A)EK survival: influence of corneal storage media 
 
In Australia, two storage media are commonly used to preserve donor corneas prior to 
transplantation. Data were not analysed for 2 grafts where the donor eye was stored in a 
moist pot and 1 graft where the storage method was not specified. Figure 3.1.3 shows 
the comparison of graft survival for corneas stored in hypothermic medium compared to 
organ culture medium. A significant difference was found across groups (Log Rank 
Statistic=23.82; df=1; p<0.001). Following further analyses in which the data were 
clustered by patient [see references 7 & 8], this variable was no longer found to be 
significant (p=0.237). This variable was therefore excluded from multivariate analyses 
and is not an independent factor significantly affecting graft survival. 
Figure 3.1.3 Corneal storage media 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Organ culture 1008 601 90 9 NA 
Hypothermic 1297 945 427 138 18 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Organ culture 0.87 0.78 0.59 NA 
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3.1.4 DS(A)EK survival: influence of donor age (years) 
 
 
Figure 3.1.4 shows the comparison of graft survival depending on donor age. Donors 
aged under 10 years or over 90 years are rare, and so these data were combined with 
the adjacent age groups. A significant difference was found across groups (Log Rank 
Statistic=19.90; df=7; p=0.006). 
Further analyses, comparing age groups to those next in the sequence showed no 
significant differences between grafts performed with tissue from the three donor groups 
aged under 40 years (p=0.113), those aged 40 to 69 (p=0.826), and those aged 70 and 
over (p=0.885). The difference in survival across these three groups was significant (Log 
Rank Statistic=16.76; df=2; p<0.001), with survival for grafts performed with tissue from 
donors aged under 40 years significantly better than those aged 40 to 69 years (p=0.003) 
and 70 years or older (p<0.001). Donor age groups were thus categorised into these three 
groups for multivariate analysis. This variable was retained in the final model (see section 
3.7), suggesting that this is an independent factor significantly affecting graft survival. 
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Number at risk (years post-graft) 
 
1 2 4 6 8 
Under 20 years 25 18 6 3 1 
20 to 29 years 48 35 11 4 NA 
30 to 39 years 116 72 29 6 1 
40 to 49 years 203 141 51 11 NA 
50 to 59 years 440 288 90 32 4 
60 to 69 years 759 498 167 43 7 
70 to 79 years 548 372 121 35 4 
80 years or older 167 123 44 13 1 
 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Under 20 years 0.94 NA NA NA 
20 to 29 years 0.91 0.88 NA NA 
30 to 39 years 0.88 0.85 0.76 NA 
40 to 49 years 0.85 0.80 0.71 NA 
50 to 59 years 0.89 0.83 0.68 0.57 
60 to 69 years 0.87 0.81 0.68 0.56 
70 to 79 years 0.87 0.79 0.66 0.53 
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3.1.5 DS(A)EK survival: influence of pre-cut donor tissue 
 
Donor tissue for endothelial grafts is increasingly pre-cut by eye banks. Figure 3.1.5 
shows the comparison of graft survival between those DS(A)EK grafts that were pre-cut 
by the eye bank and those that were cut by the surgeon. A significant difference was 
found across groups (Log Rank Statistic=6.96; df=1; p=0.008). This variable was not 
retained in the final model (see section 3.7), suggesting that this is not an independent 
factor significantly affecting graft survival. 
Figure 3.1.5 Pre-cut donor tissue 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Not pre-cut 2107 1494 517 147 18 
Pre-cut 199 53 2 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Not pre-cut 0.88 0.82 0.69 0.57 
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3.1.6 DS(A)EK survival: influence of donor central corneal endothelial cell density 
 
Endothelial cell count (ECC) was reported for 68% of DSAEKs. Reported ECC ranged 
from 1700 to 4597 cells/mm². Comparison of graft survival across donor ECC groups is 
shown in Figure 3.1.6. Preliminary analyses examined survival based on groupings of 
250 cells/mm² increments. Based on the results, three ECC groups were created for the 
final comparison. A significant difference was found across groups (Log Rank 
Statistic=28.58; df=2; p<0.001) with grafts performed using donor tissue with cell counts 
under 2500 cells/mm² having significantly poorer survival than the other groups (both 
p<0.001).  
Data on this variable were not provided in 32% of cases. A further category was thus 
created called “not advised”. A significant difference was still found across groups when 
this category was included (Log Rank Statistic=87.02; df=3; p<0.001). ECC was thus 
categorised into these four groups for multivariate analysis. This variable was retained in 
the final model (see section 3.7), suggesting that this is an independent factor significantly 
affecting graft survival. 
Figure 3.1.6 Endothelial cell density 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Under 2500 cells/mm² 109 63 12 2 NA 
2500 to 3249 cells/mm² 986 647 188 50 7 
3250 or more cells/mm² 325 213 69 13 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Under 2500 cells/mm² 0.78 0.66 NA NA 
2500 to 3249 cells/mm² 0.86 0.78 0.62 0.51 
3250 or more cells/mm² 0.89 0.83 0.69 NA 
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3.2 Recipient Factors 
 
Table 3.3 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors examined in this report that were found to be significant predictors of 
graft survival in univariate analyses. The sum of these numbers for each variable equals 
the total number of grafts (4,736 registered and 3,263 followed) and the percentages, 
which should be summed vertically for each variable, total 100. 
Table 3.3 Recipient factors, significant in univariate analyses 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Recipient factors 
 
 Registered (%) Followed (%) 
Indication for graft   
  Failed previous graft 993 (21%) 640 (20%) 
  Pseudophakic bullous keratopathy  1283 (27%) 865 (27%) 
  Fuchs’ endothelial dystrophy  2282 (48%) 1603 (49%) 
  Other bullous keratopathy 136 (3%) 84 (3%) 
  Trauma 70 (1%) 49 (2%) 
  Other* 32 (<1%) 22 (<1%) 
   
Australian State where graft was performed   
  State M 1666 (35%) 1138 (35%) 
  State K 849 (18%) 523 (16%) 
  State V 1121 (24%) 873 (27%) 
  State J 627 (13%) 388 (12%) 
  State N 393 (8%) 278 (9%) 
  State C 80 (2%) 63 (2%) 
   
Interstate transportation   
  No 4533 (96%) 3109 (95%) 
  Yes 203 (4%) 154 (5%) 
   
Recipient age group   
  Under 50 years 238 (5%) 152 (5%) 
  50 to 59 years 480 (10%) 334 (10%) 
  60 to 69 years 1204 (25%) 867 (27%) 
  70 to 79 years 1477 (31%) 1007 (31%) 
  80 years or older 1337 (28%) 903 (28%) 
   
Recipient sex   
  Female 2700 (57%) 1858 (57%) 
  Male 2036 (43%) 1405 (43%) 
   
Donor/recipient sex match   
  Female/female 1016 (21%) 680 (21%) 
  Female/male 799 (17%) 534 (16%) 
  Male/female 1684 (36%) 1178 (36%) 
  Male/male 1237 (26%) 871 (27%) 
   
Change in lens status   
  Phakic/phakic 182 (4%) 124 (4%) 
  Phakic/pseudophakic 1137 (24%) 810 (25%) 
  Other combination 3417 (72%) 2329 (71%) 
   
 
Descemet’s Stripping (Automated) Endothelial Keratoplasty 
111 Australian Corneal Graft Registry Report 2018 
   
 Registered (%) Followed (%) 
Pre-graft neovascularisation   
  No 4231 (89%) 2952 (90%) 
  Yes 505 (11%) 311 (10%) 
   
Pre-graft inflammation and/or steroid use   
  No 3464 (73%) 2362 (72%) 
  Yes 1203 (25%) 863 (26%) 
  Not advised 69 (1%) 38 (1%) 
   
History of raised intraocular pressure   
  IOP never known to be raised 3851 (81%) 2674 (82%) 
  IOP raised in past and/or at graft 885 (19%) 589 (18%) 
   
Prior contralateral corneal graft/s   
  None 3610 (76%) 2489 (76%) 
  One 933 (20%) 653 (20%) 
  Two or more 193 (4%) 121 (4%) 
   
Total 4736 (100%) 3263 (100%) 
   
 
*Other included: ICE syndrome (14), posterior polymorphous dystrophy (3), herpetic 
infection (3), non-herpetic infection (2), complications from retinal detachment (1), 
congenital corneal dystrophy (1), congenital glaucoma (1), Descemet’s membrane 
detachment (1), Descemet’s membrane tear (1), granular dystrophy (1), primary 
endotheliopathy (1), Riegers’ anomaly (1), toxic anterior segment syndrome (1), and 
unspecified corneal dystrophy (1). 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Likelihood of follow-up was significantly more likely (p<0.05) in some groups that others. 
Grafts in eyes where pre-graft inflammation and/or steroid use was reported, and in grafts 
where donor tissue had been transported interstate, were more likely to have been 
followed. Significant differences in follow-up were also found across groups for graft 
State, pre-graft corneal neovascularisation, and recipient age groups. 
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Table 3.4 shows the number of grafts within each of the variable sub-groups, for the 
recipient factor found to be non-significant in univariate analyses. The sum for each 
variable equals the total number of grafts (4,736 registered and 3,263 with follow-up 
provided) and the percentages, summed vertically, total 100. The result of the Kaplan-
Meier survival analysis is also provided.  
Table 3.4 Recipient factors, not significant in univariate analyses 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Recipient Factors 
 
 Registered (%) Followed (%) 
Eye grafted   
  Left 2305 (49%) 1575 (48%) 
  Right 2431 (51%) 1688 (52%) 
Chi²=0.00, df=1, p=0.988   
   
Total 4736 (100%) 3263 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not advised or not applicable. 
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3.2.1 DS(A)EK survival: influence of indication for graft 
 
Figure 3.2.1 shows the comparison of graft survival depending on indication for graft. All 
repeat grafts were analysed together, regardless of original pathology. A significant 
difference was found across groups (Log Rank Statistic=76.52; df=5; p<0.001), with grafts 
performed for Fuchs’ endothelial dystrophy having significantly better survival than those 
performed for the other four specified indications for graft groups (all p<0.003). This 
variable was retained in multivariate analysis (see section 3.7) suggesting that this is an 
independent factor significantly affecting graft survival.  
Figure 3.2.1 Indication for graft 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Failed previous graft 437 274 70 19 4 
Pseudophakic bullous keratopathy 584 371 118 29 2 
Fuchs’ endothelial dystrophy 1180 839 314 93 12 
Other bullous keratopathy 55 35 8 3 NA 
Trauma 35 19 7 2 NA 
Other indication* 15 9 2 1 NA 
*See list on page 111 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Failed previous graft 0.84 0.74 0.54 NA 
Pseudophakic bullous keratopathy 0.88 0.79 0.62 0.45 
Fuchs’s endothelial dystrophy 0.89 0.85 0.79 0.69 
Other bullous keratopathy 0.83 0.74 NA NA 
Trauma 0.90 NA NA NA 
Other indication NA NA NA NA 
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3.2.2 DS(A)EK survival: subcategory analyses 
 
The analyses on pages 114 and 115 are of subcategories in an individual indication for 
graft cohort. The nature of the variables mean that a large percentage of the cohort do 
not have relevant data. These subgroup-analyses are therefore not included in 
multivariate analyses. The overarching variable “indication for graft” was included. 
3.2.2.1 DS(A)EK survival: influence of the number of previous ipsilateral grafts 
 
Survival was compared across groups based on the number of previous grafts in the 
same eye (range 1 to 6), as shown in Figure 3.2.2. This difference was significant (Log 
Rank Statistic=5.60, df=1, p=0.018). Previous grafts may not have been Descemet’s 
stripping (automated) endothelial keratoplasties. Survival of first grafts is included in the 
Kaplan-Meier plot for visual reference but these data were excluded from the log rank 
calculation. 
Figure 3.2.2 Number of previous ipsilateral grafts 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
One 311 202 59 16 3 
Two or more 127 73 11 3 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
One 0.84 0.75 0.59 NA 
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3.2.2.2 DS(A)EK survival: influence of previous penetrating keratoplasty 
 
Survival was compared across groups of second grafts (one prior ipsilateral graft) based 
on whether the previous graft in the same eye was a penetrating keratoplasty. The type 
of previous graft was not known to the ACGR for 130 grafts and these were excluded 
from the analysis. A significant difference in survival was found (Log Rank Statistic=8.92, 
df=1, p=0.003). Three grafts had a previous surviving concurrent graft, while the rest were 
repeat grafts.  
Figure 3.2.3 Prior penetrating keratoplasty in eye 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 6 
Prior lamellar 167 111 56 29 15 6 
Prior PK 84 48 28 18 9 5 
 
Probability of graft survival (years post-graft) 
 
1 2 3 4 
Prior lamellar 0.88 0.82 0.72 0.63 
Prior PK 0.79 0.66 0.55 NA 
 
 
This concludes the subgroup-analyses. Analyses from page 116 onwards are again 
performed on the full cohort. 
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3.2.3 DS(A)EK survival: influence of Australian State where graft was performed 
 
Figure 3.2.4 shows the comparison of graft survival depending on the Australian State in 
which the transplantation occurred. A significant difference was found across groups (Log 
Rank Statistic=78.76; df=5; p<0.001), with survival of grafts performed in State C worse 
than those performed in any other State, and survival of grafts performed in State V or 
State N significantly better than those performed in State M, State K or State J (all 
p<0.001). This variable was retained in the multivariate analysis (see section 3.7) 
suggesting that this is an independent factor significantly affecting graft survival.  
Figure 3.2.4 Australian State where graft was performed 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
State M 788 522 143 38 6 
State K 375 222 45 10 NA 
State V 619 431 176 60 8 
State J 276 206 102 27 4 
State N 211 141 43 10 NA 
State C 37 25 10 2 NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
State M 0.87 0.79 0.63 0.46 
State K 0.88 0.80 0.62 NA 
State V 0.90 0.86 0.78 0.69 
State J 0.82 0.76 0.67 0.56 
State N 0.91 0.90 0.85 NA 
State C 0.70 0.54 NA NA 
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3.2.4 DSAEK survival: influence of interstate transportation 
 
In some cases corneas are transported interstate via air freight. Figure 3.2.5 shows the 
comparison of graft survival for grafts where the surgery was performed in the same State 
as the donor cornea was sourced, compared to those where the donor cornea was from 
interstate. A significant difference was found between groups (Log Rank Statistic=5.29; 
df=1; p=0.021). This variable was not retained in the final model (see section 3.7), 
suggesting that this is not an independent factor significantly affecting graft survival. 
Figure 3.2.5 Interstate transportation 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Different State 111 89 51 12 2 
Same State 2195 1458 468 135 16 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Different State 0.79 0.70 0.63 NA 
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3.2.5 DS(A)EK survival: influence of recipient age (years) 
 
Figure 3.2.6 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. Data for recipients aged under 40, and those aged over 90, were 
combined with the next category, due to small numbers in these groups. A significant 
difference was found across groups (Log Rank Statistic=13.69; df=4; p=0.008), with 
recipients under 50 years of age having significantly poorer survival than those aged 60 
to 69 years (p=0.001). This variable was not retained in the final model (see section 3.7), 
suggesting that this is not an independent factor significantly affecting graft survival. 
Figure 3.2.6 Recipient age 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Under 50 years 108 74 29 7 2 
50 to 59 years 257 172 63 10 1 
60 to 69 years 643 471 161 58 6 
70 to 79 years 719 474 165 48 8 
80 years or older 579 356 101 24 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Under 50 years 0.82 0.76 0.56 NA 
50 to 59 years 0.88 0.79 0.63 NA 
60 to 69 years 0.88 0.83 0.73 0.62 
70 to 79 years 0.87 0.81 0.70 0.59 
80 years or older 0.87 0.81 0.68 0.56 
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3.2.6 DS(A)EK survival: influence of recipient sex 
 
Comparison of graft survival between male and female transplant recipients is shown in 
Figure 3.2.7. A significant difference was found between groups (Log Rank Statistic=9.74; 
df=1; p=0.002). This variable was retained in the final model, suggesting that this is an 
independent factor significantly affecting graft survival. 
Figure 3.2.7 Recipient sex 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Female 1316 903 319 89 14 
Male 990 644 200 58 4 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Female 0.89 0.83 0.72 0.59 
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3.2.7 DS(A)EK survival: influence of donor/recipient sex match/mismatch 
 
Comparison of graft survival across groups based on donor/recipient sex combinations is 
shown in Figure 3.2.8. A significant difference was found across groups (Log Rank 
Statistic=10.07; df=3; p=0.018), however none of the individual comparisons were 
significantly different following Bonferroni correction (all p>0.008). This variable was not 
retained in the final model (see section 3.7), suggesting that this is not an independent 
factor significantly affecting graft survival. 
Figure 3.2.8 Donor/recipient sex match/mismatch 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Female/female 477 306 111 31 6 
Female/male 380 247 79 23 1 
Male/female 839 597 208 58 8 
Male/male 610 397 121 35 3 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Female/female 0.89 0.83 0.73 0.59 
Female/male 0.85 0.79 0.67 0.58 
Male/female 0.89 0.83 0.71 0.59 
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3.2.8 DS(A)EK survival: influence of pre- and post-graft lens status 
 
Figure 3.2.9 shows the comparison of graft survival stratified by the change of lens status 
from pre- to post-graft. “Phakic/phakic” means the eye was phakic both before and after 
the graft. “Phakic/pseudophakic” means the eye was phakic before the graft and 
pseudophakic afterwards, having undergone a triple procedure. “Other” means the eye 
was phakic, pseudophakic or aphakic before the graft and aphakic afterwards, or the eye 
was aphakic or pseudophakic before the graft and pseudophakic afterwards.  
A significant difference was found across groups (Log Rank Statistic=51.11; df=2; 
p<0.001), with grafts performed in eyes that underwent a triple procedure having 
significantly better survival than those in either of the other two groups (both p<0.001). 
This variable was retained in the multivariate analysis (see section 3.7), suggesting that 
this is an independent factor significantly affecting graft survival.  
Figure 3.2.9 Change in lens status from pre- to post-graft  
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Phakic/phakic 84 60 21 7 NA 
Phakic/pseudophakic 619 438 169 49 2 
Other 1603 1049 329 91 16 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Phakic/phakic 0.82 0.75 0.63 NA 
Phakic/pseudophakic 0.91 0.89 0.82 0.74 
Other 0.86 0.79 0.64 0.50 
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3.2.9 DS(A)EK survival: influence of pre-graft corneal neovascularisation 
 
Figure 3.2.10 shows the comparison of graft survival between those recipients with 
corneal neovascularisation pre-graft and those without (Log Rank Statistic=24.11; df=1; 
p<0.001). Recipients with pre-graft neovascularisation had poorer graft survival than 
those with avascular corneas. This variable was not retained in the final model (see 
section 3.7), suggesting that this is not an independent factor significantly affecting graft 
survival. 
Figure 3.2.10 Pre-graft corneal neovascularisation 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
No neovascularisation 2106 1432 490 141 16 
Neovascularisation 200 115 29 6 2 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No neovascularisation 0.88 0.82 0.70 0.58 
Neovascularisation 0.82 0.72 0.53 NA 
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3.2.10 DS(A)EK survival: influence of inflammation and/or steroid use at time of 
graft 
 
Figure 3.2.11 shows the comparison of graft survival between grafts performed in an eye 
with current inflammation and/or steroid use within the past two weeks, compared to those 
with neither of these factors. This information was not known for 69 grafts and these were 
excluded from the analysis. The difference was significant (Log Rank Statistic=23.41; 
df=1; p<0.001). Following further analyses where the data were clustered by patient [see 
references 7 & 8], this variable was no longer found to be significant (p=0.134). This 
variable was therefore excluded from multivariate analyses and is not an independent 
factor significantly affecting graft survival. 
Figure 3.2.11 Inflammation and/or steroid use at time of graft 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
No inflammation/steroid use 1667 1129 392 117 12 
Inflammation/steroid use 617 402 121 30 6 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No inflammation/steroid use 0.88 0.82 0.72 0.62 
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3.2.11 DS(A)EK survival: influence of history of raised intraocular pressure (IOP)  
 
Figure 3.2.12 shows the comparison of graft survival between groups based on whether 
the recipient had a history of raised intraocular pressure (Log Rank Statistic=53.83; df=1; 
p<0.001). This was irrespective of whether IOP was raised at the time of graft. This 
variable was retained in the final model (see section 3.7), suggesting that this is an 
independent factor significantly affecting graft survival. 
Figure 3.2.12 History of raised intraocular pressure 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
No raised IOP 1898 1304 454 130 15 
Raised IOP 408 243 65 17 3 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No raised IOP 0.88 0.83 0.73 0.62 
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3.2.12 DS(A)EK survival: influence of previous contralateral graft 
 
Figure 3.2.13 shows the comparison of graft survival between grafts where the recipient 
had undergone a previous contralateral graft and those where they had not. A significant 
difference was found across groups (Log Rank Statistic=15.10; df=2; p=0.001), with grafts 
performed in recipients who had undergone one prior corneal graft in the contralateral 
eye having better survival than those who had undergone none or more than one (both 
p=0.001). This variable was not retained in the final model (see section 3.7), suggesting 
that this is not an independent factor significantly affecting graft survival. 
Figure 3.2.13 Previous contralateral graft/s 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
None 1746 1170 394 118 18 
One 470 319 109 25 NA 
Two or more 90 58 16 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
None 0.87 0.80 0.67 0.55 
One 0.90 0.85 0.77 0.64 
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The analysis on page 126 is conducted using data only from first grafts (no previous 
ipsilateral grafts). This subgroup-analysis was not included in multivariate analyses, as it 
is collinear with indication for graft and change in lens status. 
3.2.13 DS(A)EK survival: influence of history of previous intraocular surgery in 
ipsilateral eye 
 
Figure 3.2.14 shows the comparison of graft survival between first grafts performed in an 
eye that had undergone previous intraocular surgery, compared with first grafts 
performed in an eye that had not (Log Rank Statistic=29.46; df=1; p<0.001). While 
surgeons were not asked to specify what type of previous surgery recipients had 
undergone, in the majority of cases (2559/3790, 68%) the lens status of the eye pre-graft 
(pseudophakic or aphakic) indicated that they had undergone cataract extraction, with or 
without IOL insertion. Surgeons were unable to say if previous surgery had occurred in 
10 first grafts and these were excluded from the analysis.  
Figure 3.2.14 History of previous intraocular surgery in the ipsilateral eye 
 
Number at risk (years post-graft) 
 
1 2 5 6 8 
No prior surgery 626 456 176 52 2 
Prior surgery 1238 813 272 76 12 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No prior surgery 0.91 0.89 0.82 0.71 
Prior surgery 0.87 0.80 0.67 0.54 
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3.3 Graft Era 
 
Table 3.5 shows the number of grafts registered and followed, in blocks of two years. The 
percentages, which should be summed vertically, total 100. 
Table 3.5 Graft era 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  Pre 2006 2 (<1%) 2 (<1%) 
  2006/2007 103 (2%) 91 (3%) 
  2008/2009 545 (12%) 509 (16%) 
  2010/2011 858 (18%) 748 (23%) 
  2012/2013 1154 (24%) 966 (30%) 
  2014/2015 1253 (26%) 910 (28%) 
  2016/2017 821 (17%) 37 (1%) 
   
Total 4736 (100%) 3263 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses and 
found to be significant (p<0.001). Level of follow-up reduces as time since graft reduces, 
with 94% of grafts performed in 2008/09 followed, 87% of grafts performed in 2010/11, 
and 84% of grafts performed in 2012/13, compared with 73% of grafts performed in 
2014/15 and just 5% of grafts performed in 2016/17.  
Consideration was given to the effect of follow-up lag time on this analysis. Up-to-date 
information on failed grafts is more likely to be known than for surviving grafts. This is 
because, while information on surviving grafts must be provided by a surgeon, the fact 
that a graft has failed may also be known when a registration is received for a replacement 
graft. A “lag time” operates at the furthest end of each curve in a Kaplan Meier plot. This 
effect is most pronounced in the early years following graft registration, when requests 
have not yet been made for follow-up information, and tends to reduce predictably over 
time. In consequence, the variable is treated as “time variant” in multivariate analyses. 
Of the grafts performed in 2016/2017 just six of the grafts with follow-up were surviving 
at the time of follow-up. This equates to 16% of followed grafts, and <1% of registered 
grafts from this cohort. The remaining 31 grafts were early failures, the majority of which 
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3.3.1 DS(A)EK survival: influence of era of graft 
 
Figure 3.3.1 shows the comparison of graft survival between eras of graft, stratified into 
two-year groups. The two grafts performed pre-2006 were combined with the 2006/2007 
group for this analysis. The difference across groups was significant (Log Rank 
Statistic=57.38; df=5; p<0.001), with grafts performed in 2016/2017 having significantly 
worse survival than those performed in any other era (all p<0.001, see comment 
regarding “lag time” on page 127), and grafts performed prior to 2008 having significantly 
worse survival than those performed in 2008/2009, 2010/2011 or 2014/2015 (all 
p<0.001). This variable was retained in the final model (see section 3.7), suggesting that 
this is an independent factor significantly affecting graft survival. 
Figure 3.3.1 Graft era 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Pre 2008 55 47 28 15 9 
2008/2009 390 311 194 104 9 
2010/2011 557 445 252 28 NA 
2012/2013 726 534 45 NA NA 
2014/2015 577 210 NA NA NA 
2016/2017 1 NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Pre 2008 0.67 0.62 0.54 NA 
2008/2009 0.88 0.83 0.73 0.63 
2010/2011 0.87 0.81 0.72 0.57 
2012/2013 0.89 0.83 0.59 NA 
2014/2015 0.90 0.80 NA NA 
2016/2017 NA NA NA NA 
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3.4 Surgery and Surgeon Factors 
 
Table 3.6 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors examined in this report, which were found to be significant 
in univariate analyses. The sum of these numbers for each variable equals the total 
number of grafts (4,736 registered and 3,263 followed) and the percentages, which 
should be summed vertically for each variable, total 100. 
69% was selected as the cut-off point for the follow-up categories as this (68.9%) was the 
average percentage of follow-up for all DS(A)EK, regardless of surgeon experience.   
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Likelihood of follow-up was significantly more likely (p<0.05) in some groups that others. 
Lower rates of follow-up had been received for grafts performed using forceps. Significant 
differences in follow-up were also found across groups for graft and incision size, with 
larger grafts more likely to have follow-up. There were significant differences in follow-up 
levels between individual surgeons. Due to the nature of the variable, follow-up was, 
logically, significantly higher (p<0.001) for grafts performed by surgeons with 100+ 
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Table 3.6 Surgery and surgeon factors, significant in univariate analyses 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Size of graft (diameter)   
  Less than 8.25 mm 1361 (29%) 857 (26%) 
  8.25 mm or more 2974 (63%) 2114 (65%) 
  Not advised 401 (8%) 292 (9%) 
   
Size of incision   
  Up to 4.0 mm 481 (10%) 274 (8%) 
  4.1 mm to 4.5 mm 353 (7%) 195 (6%) 
  4.6 mm to 5.0 mm 818 (17%) 521 (16%) 
  5.1 mm or more 912 (19%) 684 (21%) 
  Not advised 2172 (46%) 1589 (49%) 
   
Use of forceps   
  No 1362 (29%) 520 (16%) 
  Yes 626 (13%) 355 (11%) 
  Not advised 2748 (58%) 2388 (73%) 
   
Use of viscoelastic   
  No 1543 (33%) 589 (18%) 
  Yes 230 (5%) 97 (3%) 
  Not advised 2963 (63%) 2577 (79%) 
   
The Centre effect   
  Fewer than 100 registered DS(A)EK 1663 (35%) 1051 (32%) 
  Surgeon H 507 (11%) 386 (12%) 
  Surgeon J 380 (8%) 291 (9%) 
  Surgeon K 239 (5%) 229 (7%) 
  Surgeon L 220 (5%) 176 (5%) 
  Surgeon Z 201 (4%) 147 (5%) 
  Surgeon X 166 (4%) 129 (4%) 
  Surgeon C 158 (3%) 136 (4%) 
  Surgeon V 150 (3%) 119 (4%) 
  Surgeon B 140 (3%) 104 (3%) 
  Surgeon N 135 (3%) 92 (3%) 
  Surgeon M 128 (3%) 115 (4%) 
  Surgeon Q 115 (2%) 22 (<1%) 
  Surgeon W 114 (2%) 70 (2%) 
  Surgeon E 111 (2%) 42 (1%) 
  Surgeon R 104 (2%) 74 (2%) 
  Surgeon T 105 (2%) 46 (1%) 
  Surgeon Y 100 (2%) 34 (1%) 
   
Surgeon volume   
  Fewer than 100 registered DS(A)EK 1663 (35%) 1051 (32%) 
  100+ registered DS(A)EK, <69% follow-up 1886 (40%) 1520 (47%) 
  100+ registered DS(A)EK, ≥69% follow-up 1187 (25%) 692 (21%) 
   
Total 4736 (100%) 3263 (100%) 
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Table 3.7 shows the number of grafts within each of the variable sub-groups, for the donor 
and eye banking factors found to be non-significant in univariate analyses. The sum for 
each variable equals the total number of grafts (4,736 registered and 3,263 with follow-
up provided) and the percentages, summed vertically for each variable, total 100. The 
result of the Kaplan-Meier survival analysis is also provided for each variable. 
Table 3.7 Surgery and surgeon factors, not significant in univariate analyses 
 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Surgery and Surgeon Factors 
 
 
 Registered (%) Followed (%) 
Type of graft   
  DSEK 2571 (54%) 2044 (63%) 
  DSAEK 1936 (41%) 1080 (33%) 
  UT-DSAEK* 75 (2%) 19 (<1%) 
  Not advised 154 (3%) 120 (4%) 
Chi²=1.55, df=2, p=0.460   
   
Use of glide   
  No 320 (7%) 173 (5%) 
  Yes 2590 (55%) 1459 (45%) 
  Not advised 1826 (39%) 1631 (50%) 
Chi²=2.28, df=1, p=0.131   
   
Use of anterior chamber maintainer   
  No 1157 (24%) 459 (14%) 
  Yes 616 (13%) 227 (7%) 
  Not advised 2963 (63%) 2577 (79%) 
Chi²=0.66, df=1, p=0.418   
   
Donor lenticule folded   
  No 1751 (37%) 673 (21%) 
  Yes 55 (1%) 35 (1%) 
  Not advised 2930 (32%) 2555 (78%) 
Chi²=0.16, df=1, p=0.687   
   
Total 4736 (100%) 3263 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not advised. 
*UT-DSEK = Ultra-thin Descemet’s Stripping Endothelial Keratoplasty 
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3.4.1 DS(A)EK survival: influence of graft size 
 
Figure 3.4.1 shows a comparison of graft survival depending on the size of the graft, 
based on the donor button diameter, as reported by surgeons. This information was not 
reported for 401 grafts. A significant difference was found across groups (Log Rank 
Statistic=69.98; df=1; p<0.001). Data on this variable were not provided in 8% of cases. 
A further category was thus created called “not advised”. A significant difference was still 
found across groups when this category was included (Log Rank Statistic=68.80; df=2; 
p<0.001). Graft size was thus categorised into these four groups for multivariate analysis. 
This variable was retained in the final model (see section 3.7), suggesting that this is an 
independent factor significantly affecting graft survival. 
Figure 3.4.1 Graft size 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
Less than 8.25 mm 566 338 90 32 5 
8.25 mm or more 1530 1052 350 100 11 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Less than 8.25 mm 0.81 0.72 0.55 0.44 
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3.4.2 DS(A)EK survival: influence of size of incision 
 
Figure 3.4.2 shows a comparison of graft survival depending on the size of the incision 
made to insert the donor lenticule, as reported by surgeons. This information was not 
reported for 2172 grafts. A significant difference was found across groups (Log Rank 
Statistic=15.18; df=3; p=0.002), with grafts with an incision size up to 4.0 mm having 
significantly better survival than those with an incision size of 4.1 mm to 5.0 mm (p=0.006) 
and 5.1 mm or more (p<0.001). Data on this variable were not provided in 46% of cases. 
A further category was thus created called “not advised”. A significant difference was still 
found across groups when this category was included (Log Rank Statistic=19.64; df=4; 
p=0.001). Incision size was thus categorised into these four groups for multivariate 
analysis. This variable was retained in the final model (see section 3.7), suggesting that 
this is an independent factor significantly affecting graft survival. 
Figure 3.4.2 Size of incision 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 6 
Up to 4.0 mm 190 113 34 6 2 NA 
4.1 mm to 4.5 mm 130 70 20 2 NA NA 
4.6 mm to 5.0 mm 380 227 83 14 2 NA 
5.1 mm or more 481 351 226 139 84 29 
 
Probability of graft survival (years post-graft) 
 
1 2 3 4 5 6 
Up to 4.0 mm 0.93 0.90 0.83 NA NA NA 
4.1 mm to 4.5 mm 0.85 0.79 0.73 NA NA NA 
4.6 mm to 5.0 mm 0.90 0.83 0.74 NA NA NA 
5.1 mm or more 0.84 0.78 0.70 0.63 0.57 0.51 
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3.4.3 DS(A)EK survival: influence of use of forceps 
 
Figure 3.4.3 shows a comparison of graft survival depending on whether forceps were 
used to perform the graft, as reported by surgeons. This information was not reported for 
2748 grafts. A significant difference was found across groups (Log Rank Statistic=5.41; 
df=1; p=0.020). This variable was not included in the multivariate analyses due to the high 
percentage (58%) of missing data.  
Figure 3.4.3 Use of forceps 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
No forceps 288 66 3 1 NA 
Forceps 228 123 30 2 1 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
No forceps 0.85 0.74 NA 
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3.4.4 DS(A)EK survival: influence of use of viscoelastic 
 
Figure 3.4.4 shows a comparison of graft survival depending on the use of viscoelastic, 
as reported by surgeons. This information was not reported for 2963 grafts. A significant 
difference was found across groups (Log Rank Statistic=5.00; df=1; p=0.025). This 
variable was not included in the multivariate analyses due to the high percentage (63%) 
of missing data.  
Figure 3.4.4 Use of viscoelastic 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 
No viscoelastic 325 81 4 1 
Viscoelastic 55 8 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 
No viscoelastic 0.85 0.74 
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3.4.5 DS(A)EK survival: influence of the Centre effect  
 
Figure 3.4.5 shows the comparison of graft survival for individual surgeons which there 
were 100 or more DS(A)EKs registered, and all other grafts (performed by 101 surgeons) 
combined (Log Rank Statistic=194.30; df=17; p<0.001). This analysis indicates that there 
is a significant Centre effect. This variable was not included in the multivariate analysis 
as it was collinear with the surgeon volume and follow-up variable shown in Figure 3.4.6. 
Figure 3.4.5 The Centre effect 
 
 
Note: To preserve anonymity, surgeons have been identified using random letters of the 
alphabet. These identifying letters do not correspond with those used in chapters 
reporting on other types of graft, i.e. Surgeon W in this chapter is not necessarily the 
same surgeon identified as Surgeon W in the chapter on penetrating keratoplasty.  
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Number at risk (years post-graft) 
 
1 2 4 6 8 
<100 DS(A)EK registered 698 405 107 28 3 
Surgeon H 306 213 75 34 7 
Surgeon J 195 144 42 9 1 
Surgeon K 194 160 89 27 4 
Surgeon L 141 107 41 10 NA 
Surgeon Z 113 79 18 2 1 
Surgeon X 90 64 36 8 NA 
Surgeon C 88 69 29 6 NA 
Surgeon V 73 50 7 NA NA 
Surgeon B 71 47 10 3 NA 
Surgeon N 69 44 3 2 NA 
Surgeon M 74 53 29 16 1 
Surgeon Q 10 9 5 NA NA 
Surgeon W 61 38 17 6 1 
Surgeon E 32 17 NA NA NA 
Surgeon R 42 23 6 NA NA 
Surgeon T 38 21 3 NA NA 
Surgeon Y 11 4 1 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
<100 DS(A)EK registered 0.82 0.74 0.60 0.47 
Surgeon H 0.97 0.96 0.90 0.84 
Surgeon J 0.90 0.84 0.64 NA 
Surgeon K 0.90 0.85 0.75 0.64 
Surgeon L 0.93 0.92 0.89 NA 
Surgeon Z 0.91 0.83 NA NA 
Surgeon X 0.84 0.78 0.68 NA 
Surgeon C 0.91 0.88 0.71 NA 
Surgeon V 0.81 0.74 NA NA 
Surgeon B 0.94 0.88 NA NA 
Surgeon N 0.94 0.91 NA NA 
Surgeon M 0.82 0.70 0.61 NA 
Surgeon Q NA NA NA NA 
Surgeon W 0.94 0.78 NA NA 
Surgeon E 0.83 NA NA NA 
Surgeon R 0.89 0.89 NA NA 
Surgeon T 0.89 0.84 NA NA 
Surgeon Y NA NA NA NA 
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3.4.6 DS(A)EK survival: influence of surgeon volume (25+ followed DS(A)EKs) 
grouped by level of follow-up  
 
Figure 3.4.6 shows the comparison of graft survival between grafts performed by 
surgeons with 100+ DS(A)EKs with average or better (≥69%) follow-up, to those with 
lower than average follow-up (<69%), and to low volume (<100) surgeons. This 
comparison was significant (Log Rank Statistic=61.06; df=2; p<0.001), with grafts 
performed by surgeons with 100+ DS(A)EKs with average or better (≥69%) follow-up 
having significantly better survival than the other two groups (both p<0.001). This variable 
was retained in the multivariate analysis (see section 3.7) suggesting that this is an 
independent factor significantly affecting graft survival. 




Number at risk (years post-graft) 
 
1 2 4 6 8 
<100 registered DS(A)EK 698 405 107 28 3 
100+ DS(A)EK, low follow-up 1081 796 308 77 7 
100+ DS(A)EK, high follow-up 527 346 104 41 8 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
<100 registered DS(A)EK 0.82 0.74 0.60 0.47 
100+ DS(A)EK, low follow-up 0.89 0.83 0.71 0.57 
100+ DS(A)EK, high follow-up 0.91 0.87 0.78 0.68 
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3.5 Operative Procedures at the Time of Graft 
 
Table 3.8 shows the number of grafts for which certain operative procedures were 
performed at the time of graft. The sum of these numbers for each variable equals the 
total number of grafts (4,736 registered and 3,263 followed) and the percentages, which 
should be summed vertically for each variable, total 100. Neither of these factors were 
found to be significant in univariate analyses. The result of the Kaplan-Meier survival 
analysis is also provided for each variable. 
Table 3.8 Operative procedures at graft, not significant in univariate analyses 
 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Surgery and Surgeon Factors 
 
 
 Registered (%) Followed (%) 
Peripheral iridectomy at time of graft   
  No 4420 (93%) 3061 (94%) 
  Yes 316 (7%) 202 (6%) 
Chi²=0.34, df=1, p=0.854   
   
Anterior vitrectomy at time of graft   
  No 4653 (98%) 3211 (98%) 
  Yes 83 (2%) 52 (2%) 
Chi²=0.00, df=1, p=0.982   
   
Total 4736 (100%) 3263 (100%) 
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3.6 Post-graft Events 
 
Table 3.9 shows the occurrence of post-graft events, which were found to be significant 
in univariate analyses. Only 15 grafts had post-graft herpetic infection reported, 12 had 
post-graft synechia, and 11 had post-graft uveitis, and so the impact of these factors was 
not further analysed.  
Table 3.9 Post-graft events, significant in univariate analyses 
 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Post-graft Events 
 
 Registered (%) Followed (%) 
Post-graft neovascularisation   
  No 4668 (99%) 3195 (98%) 
  Yes 68 (1%) 68 (2%) 
   
Post-graft microbial keratitis   
  No 4713 (99%) 3240 (99%) 
  Yes 23 (1%) 23 (1%) 
   
Post-graft rise in IOP   
  No 4248 (90%) 2775 (85%) 
  Yes 488 (10%) 488 (15%) 
   
At least one rejection episode   
  No 4474 (94%) 3001 (92%) 
  Yes 262 (6%) 262 (8%) 
   
Total 4736 (100 %) 3263 (100 %) 
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Table 3.10 shows the time at which suture removal was reported to have occurred post-
graft, categorised in five time-frame groups. This was non-significant in univariate 
analysis and the result of the Kaplan-Meier survival analysis is also provided. The sum of 
these numbers for each variable equals the total number of grafts (4,736 registered and 
3,263 followed) and the percentages, which should be summed vertically for each 
variable, total 100.  
Table 3.10 Post-graft events, not significant in univariate analyses 
 
 




 Registered (%) Followed (%) 
Time to removal of sutures   
  Within 1 month post-graft 73 (2%) 73 (2%) 
  Between 1 and 2 months post-graft 247 (5%) 247 (8%) 
  Between 2 and 3 months post-graft 117 (2%) 117 (4%) 
  Between 3 and 6-months post-graft 145 (3%) 145 (4%) 
  Over 6-months post-graft 122 (3%) 122 (4%) 
  Not yet removed/not advised 4032 (85%) 2559 (78%) 
Chi²=5.37, df=4, p=0.252   
   
Total 4736 (100%) 3263 (100%) 
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Table 3.11 shows post-graft surgical procedures, as reported by follow-up practitioners. 
Please note: post-graft data may be incomplete when follow-up is based on a registration 
for a replacement graft. 
Table 3.11 Post-graft surgical procedures 
643 DS(A)EK were reported to have undergone a re-grafting procedure (separate to 
subsequent concurrent graft/s) at the date last seen. Of these 561 had not had additional 
post-graft operative procedures reported, while 49 had. 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 




YAG laser 158 
Cataract removal/IOL insertion (50 both, 2 cataract only, 8 IOL only) 60 
IOL exchange/removal/reposition 19 
PRK laser  10 
Trabeculectomy 22 
Intravitreal injection/s 22 
Graft revision/wound repair 8 
Cyclodiode 8 
Tube insertion (Baerveldt: 8, 2 Molteno: 2, unspecified:4) 14 
Vitrectomy 19 
Graft repositioned 5 
Bleb needling/revision 5 
Insertion of piggyback lens 5 
Other* 100 
  
Total number of surgical procedures (number of grafts) 708 (587) 
  
 
* Other included: Iridotomy (4), membrane peel (4), removal of air bubble (4), concurrent 
subsequent lamellar patch graft (3), eyelid repair (3), keratectomy (3), ptosis repair (3), removal 
of remnant lens material (3), selective laser trabeculoplasty (3), anterior chamber tap (2), anterior 
stromal puncture (2), capsulotomy (2), ectropion repair (2), endolaser (2), epithelial debridement 
(2), evisceration (2), filter surgery (2), keratotomy (2), LASIK (2), macular hole repair (2), needling 
of trabeculectomy (2), punctal plug (2), pupilloplasty (2), removal of folds in Descemet’s 
membrane (2), air-bubble adjustment (1), anterior chamber washout (1), amniotic membrane 
transplant (1), concurrent subsequent limbal graft (1), conjunctival resection (1), corneal 
diathermy (1), corneal scraping (1), cryotherapy (1), electrolysis (1), floater surgery (1), gas 
insertion (1), glaucoma tube repositioning (1), glaucoma tube revision and extension (1), gold 
weight insertion (1), Hughes flap (1), intraocular contact lens inserted (1), iridectomy (1), 
iridoplasty (1), iris prolapse repositioning (1), Molteno tube repositioning (1), pars planta tube 
insertion (1), pupilotomy (1), reformation of anterior chamber (1), relaxing incision (1), removal of 
band keratopathy (1), removal of basal cell carcinoma (1), removal of conjunctival melanoma (1),  
removal of epithelial cyst (1), removal of iris prosthesis (1), removal of upper tarsal concretions 
(1), retinal detachment repair (1), retinal laser surgery (1), retinoplexy (1), revision of Descemet’s 
endothelial keratoplasty (1), scleral buckle removal (1), silicone oil inserted (1), silicone tube 
insertion (1), surgery for angle closure (1), suture adjustment (1), tarsorrhaphy (1), trabecular 
bypass stent (1), triescence (1), vitreous tap  (1).  
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3.6.1 DS(A)EK survival: influence of post-graft corneal neovascularisation 
 
Figure 3.6.1 shows the comparison of graft survival for grafts where the eye was reported 
to have had corneal neovascularisation post-graft to those that did not. A significant 
difference was found between groups (Log Rank Statistic=100.79; df=1; p<0.001). This 
variable was retained in the multivariate analysis (see section 3.7) suggesting that this is 
an independent factor significantly affecting graft survival. 
 
Figure 3.6.1 Post-graft corneal neovascularisation 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
No neovascularisation 2265 1522 508 141 16 
Neovascularisation 41 25 11 6 2 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No neovascularisation 0.88 0.82 0.70 0.58 
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3.6.2 DS(A)EK survival: influence of post-graft microbial keratitis  
 
Figure 3.6.2 shows the comparison of graft survival for grafts where the eye was reported 
to have had microbial keratitis post-graft to those that did not. A significant difference was 
found between groups (Log Rank Statistic=5.89; df=1; p=0.015). This variable was not 
retained in the multivariate analysis (see section 3.7) suggesting that this is not an 
independent factor significantly affecting graft survival. 
Figure 3.6.2 Post-graft microbial keratitis 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
No microbial keratitis 2292 1541 516 146 18 
Microbial keratitis 14 6 3 1 NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No microbial keratitis 0.87 0.81 0.69 0.57 




Descemet’s Stripping (Automated) Endothelial Keratoplasty 
145 Australian Corneal Graft Registry Report 2018 
3.6.3 DS(A)EK survival: influence of post-graft raised IOP  
 
Figure 3.6.3 shows the comparison of graft survival for grafts where the eye was reported 
to have had raised intraocular pressure post-graft to those where the IOP remained in the 
normal range. A significant difference was found between groups (Log Rank 
Statistic=6.40; df=1; p=0.0011). This variable was retained in the multivariate analysis 
(see section 3.7) suggesting that this is an independent factor significantly affecting graft 
survival. 
Figure 3.6.3 Post-graft raised intraocular pressure 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
No raised IOP 1898 1250 422 116 17 
Raised IOP 408 297 97 31 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No raised IOP 0.86 0.80 0.69 0.57 
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3.6.4 DS(A)EK survival: influence of graft rejection episodes 
 
Figure 3.6.4 shows the survival for grafts where the eye underwent at least one incidence 
of post-graft immunological rejection, compared to those that did not have any rejection 
episodes. A significant difference was found between groups (Log Rank Statistic=44.57; 
df=1; p<0.001). This variable was retained in the multivariate analysis (see section 3.7) 
suggesting that this is an independent factor significantly affecting graft survival. 
Figure 3.6.4 Rejection episode(s) 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 
No Rejection 2094 1399 460 121 13 
Any rejection 212 148 59 26 5 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No Rejection 0.88 0.83 0.72 0.59 
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3.7 Multivariate Analysis 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all other variables in the model. This analysis was 
performed using STATA version 11. 
In the preceding univariate analyses, each registered DS(A)EK, together with its archival 
follow-up records, was treated as a separate and independent entity. Some recipients 
had multiple DS(A)EK performed during the census period (up to 31/7/2017), with some 
having repeat grafts in a single eye, some grafts in both eyes and some a combination of 
both. To control for potential inter-graft and/or inter-eye dependence in the multivariate 
analyses, the multivariate model was adjusted to allow for clustering by individual patient 
[see references 7 & 8]. 
Variables to be included in the Cox Proportional Hazards regression model were identified 
based on the results of the univariate Kaplan-Meier analyses, with a cut-off significance 
level of p<0.08 used to select variables for inclusion. Some variables that were found to 
be significant in the univariate analyses were omitted due to co-linearity, or because of 
large amounts of missing data (>50%). Where data were missing for 1% to 50% of cases, 
additional groups for each if these categorical variables were created, called “not 
advised”. Each variable was initially analysed individually to determine if it remained 
significant once clustered by individual patient. Where the variable was no longer found 
to be significant (p>0.08), it was excluded from the multivariate analysis. 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in a 
stepwise manner, beginning with the least significant variable. For categorical variables 
with more than two groups, Bonferroni adjustment was applied to determine if significant 
differences were present between groups. The Kaplan-Meier plots, and additional 
appropriate STATA analyses, were used to assess whether each included variable met 
the assumption of proportional hazards. Where variables were found to be time-variant, 
they were treated as such in the multivariate model.  
Table 3.12 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained in 
the final model.  
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Table 3.12 Multivariate model 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Multivariate Model 
 
Not significant in univariate analysis 
Donor sex 
Cause of donor death 
Multi-organ donor 
Time from death to enucleation 
Storage time in Optisol 
Storage time in organ culture 
Eye grafted 
Graft type 
Peripheral iridectomy at time of graft 
Anterior vitrectomy at time of graft 
Use of glide during surgery 
Use of anterior chamber maintainer during surgery 
Donor lenticule folded 
Descemet’s membrane stripped by surgeon 
 
Significant in univariate analysis but excluded from multivariate model due 
to collinearity or missing data 
The centre effect (collinear with surgeon experience and level of follow-up) 
Use of forceps at time of graft (missing data) 
Use of viscoelastic at time of graft (missing data) 
 
Significant in univariate analysis but not retained in multivariate model 
Time from enucleation to storage (p>0.08 after clustering by patient) 
Storage medium (p>0.08 after clustering by patient) 
Pre-graft inflammation and/or steroid use (p>0.08 after clustering by patient) 
Donor/recipient sex match/mismatch 
Eye bank  
Cornea pre-cut by eye bank 
Pre-graft neovascularisation 
Recipient age group 
Previous contralateral graft(s) 
Interstate transportation 
Post-graft microbial keratitis 
 
Significant in univariate analysis AND retained in multivariate model 
Donor age group 
Endothelial cell density 
Indication for graft 
Australian State where graft was performed 
Recipient sex 
Raised intraocular pressure prior to and/or at graft 
Graft year  
Graft size 
Incision size 
Surgeon experience and level of follow-up 
Change in lens status pre- to post-graft 
Post-graft neovascularisation 
Raised intraocular pressure post-graft 
Post-graft rejection episode(s) 
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Table 3.13 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The group of each categorical variable with the highest 
number of cases was taken as the referent. The hazard ratios for a given variable are 
adjusted for all other variables in the model. This model included data from the 4,736 
Descemet’s stripping (automated) endothelial keratoplasties, performed in 3,755 
recipients. Where no valid response had been provided for one of the included variables, 
these cases were classified as “not advised”.  
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, 
a global test was applied to calculate the overall p-value. Bonferroni adjustment was 
applied for within-group comparisons. The overall model was highly significant: 
(Chi²=608.46, p<0.0001). 
Table 3.13 Clustered multivariate model 
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Donor age group   
Under 40 385 0.65 0.11 0.014  0.47 - 0.92 
40 to 69 2891 1.00   0.003  
70 or older 1460 1.16 0.09 0.048  1.00 - 1.35 
 
Central endothelial cell count   
Under 2500 cells/mm² 271 4.70 0.22 <0.001  1.31 - 2.20 
2500 to 3249 cells/mm² 2240 1.00   <0.001  
3250 cells/mm² or more 694 0.84 0.10 0.127  0.67 - 1.06 
Not advised 1531 0.74 0.15 0.137  0.50 - 1.10 
 
Indication for graft 
Failed previous graft 933 1.35 0.14 0.004  1.10 - 1.65 
Pseudophakic bullous keratopathy 1283 1.11 0.11 0.293  0.91 - 1.36 
Fuchs’ endothelial dystrophy 2282 1.00   0.004  
Other bullous keratopathy 136 1.87 0.39 0.003  1.24 - 2.82 
Trauma 70 1.56 0.34 0.042  1.02 - 2.39 
Other specified indication 32 1.65 0.74 0.269  0.68 - 3.99 
       
Australian State where graft was performed (tvc) 
State M 1666 1.00   <0.001  
State K 849 0.85 0.12 0.234  0.64 - 1.11 
State V 1121 1.37 0.30 0.146  0.89 - 2.11 
State J 627 1.52 0.21 0.002  1.16 - 1.98 
State N 393 1.08 0.29 0.788  0.64 - 1.82 
State C 80 2.32 0.45 <0.001  1.58 - 3.39 
       
Recipient sex 
Female 2700 1.00     
Male 2036 1.25 0.09 0.002  1.08 - 1.44 
 
Raised intraocular pressure in past and/or at graft 
No 3851 1.00     
Yes 885 1.40 0.13 <0.001  1.17 - 1.67 
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Graft year (tvc) 
Pre 2008 105 3.57 0.76 <0.001  2.34 - 5.43 
2008/2009 545 1.84 0.29 <0.001  1.35 - 2.52 
2010/2011 858 1.37 0.19 0.022  1.05 - 1.80 
2012/2013 1154 1.15 0.13 0.225  0.92 - 1.43 
2014/2015 1253 1.00   <0.001  
2016/2017 821 3.46 0.87 <0.001  2.11 - 5.68 
 
Size of graft 
<8.25 mm 1361 1.63 0.13 <0.001  1.39 - 1.92 
8.25 mm or larger 2974 1.00   <0.001  
Not advised 401 1.24 0.16 0.106  0.96 - 1.60 
 
Size of incision 
Up to 4.0 mm 481 0.61 0.12 0.010  0.42 - 1.10 
4.1 mm to 4.5 mm 353 0.87 0.15 0.428  0.62 - 1.23 
4.6 mm to 5.0 mm 818 0.83 0.11 0.165  0.64 - 1.08 
5.1 mm or larger 912 1.25 0.12 0.019  1.04 - 1.50 
Not advised 2172 1.00   0.001  
 
Experience of surgeon and percentage of follow-up (tvc) 
< 100 DS(A)EK registered  1663 1.71 0.20 <0.001  1.35 - 2.15 
100+ DS(A)EK registered, <69% followed 545 1.97 0.28 <0.001  1.49 - 2.61 
100+ DS(A)EK registered, 69%+ followed 2528 1.00   <0.001  
       
Change in lens status pre- to post-graft 
Phakic post-graft 182 0.91 0.15 0.569  0.65 - 1.27 
Phakic pre-graft, pseudophakic after 1137 0.69 0.08 0.001  0.55 - 0.86 
Other* 3417 1.00   0.005  
       
Post-graft corneal neovascularisation 
No 4668 1.00     
Yes 68 2.14 0.32 <0.001  1.60 - 2.88 
 
Post-graft rise in intraocular pressure (tvc) 
No 4248 1.00     
Yes 488 0.39 0.06 <0.001  0.29 - 0.54 
 
Post-graft rejection episode(s) 
No 4474 1.00     
Yes 262 1.92 0.18 <0.001  1.59 - 2.31 
 
tvc = time variant coefficient 
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3.7.1 Significant differences in the Descemet’s stripping (automated) endothelial 
keratoplasty multivariate model for categories with more than two groups 
following Bonferroni correction for multiple comparisons 
 
3.7.1.1 Indication for graft  
 
Grafts performed for Fuchs’ endothelial dystrophy had significantly better survival than 
those performed for other (non-pseudophakic) bullous keratopathy (p=0.003), or failed 
previous graft (p=0.004).  
Grafts performed for pseudophakic bullous keratopathy had significantly better survival 
than those performed for other (non-pseudophakic) bullous keratopathy (p=0.015). 
 
3.7.1.2 Donor age group  
 
Significantly better survival was shown for the under 40 years age category compared to 
the 40 to 69 years category (p=0.014) and the 70 years and older category (p=0.001). 
 
3.7.1.3 Central endothelial cell count 
 
Grafts where the central endothelial cell count was less than 2500 cells/mm², exhibited 
significantly poorer survival than those with cell counts between 2500 and 3249 
cells/mm², or 3250 cells/mm² or more (both p<0.001). 
 
3.7.1.4 Australian State where graft was performed  
 
Grafts performed in State C had significantly poorer survival than those performed in 
State M or State K (both p<0.001), or in State N (p=0.005). 
Grafts performed in State J had significantly poorer survival than those performed in State 
M (p=0.002) or State K (p<0.001). 
 
3.7.1.5 Change in lens status pre- to post-graft  
 
Eyes that underwent a triple procedure at graft (phakic/pseudophakic) exhibited 
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3.7.1.6 Graft era  
 
Grafts performed prior to 2008 had significantly poorer survival than those performed in 
2008/2009, 2010/2011, 2012/2013 or 2014/2015 (all p<0.001).  
Grafts performed in 2008/2009 had significantly poorer survival than those performed in 
2012/2013 (p=0.001) or 2014/2015 (p<0.001). 
Grafts performed in 2016/2017 had significantly poorer survival than those performed in 
2008/2009, 2010/2011, 2012/2013 and 2014/2015 (all p<0.001).  
 
3.7.1.7 Graft size 
 
Grafts that were smaller than 8.25mm had significantly poorer survival than those that 
were 8.25mm or larger (p<0.001). 
 
3.7.1.8 Incision size 
 
Grafts where the incision size was greater than 5.0mm had significantly poorer survival 
than those where the incision size was 4.0mm or smaller (p<0.001), and those where the 
incision size was 4.6mm to 5.0mm in size (p=0.002). 
Grafts where the incision size was not provided to the ACGR had significantly poorer 
survival than those where the incision size was 4.0mm or smaller (p=0.010), 
 
3.7.1.9 Volume of DS(A)EK registered by surgeon and level of follow-up received  
 
Grafts performed by surgeons with 100 or more DS(A)EK registered with the ACGR, and 
above average (>69%) levels of follow-up had significantly better survival than those 
performed by surgeons with 100 or more DS(A)EK registered with the ACGR, and below 
average (≤69%) levels of follow-up, and surgeons with fewer than 100 DS(A)EK 
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3.8 Reasons for Graft Failure 
 
Of the 3,263 followed grafts, 791 (24%) were known to have failed by the census date. 
This equates to 17% of the 4,736 registered grafts. Surgeons were asked to indicate the 
reason for graft failure. This information was also gathered from repeat registration forms, 
where the reason for failure of the previous graft was given. Table 3.14 shows the reasons 
for failure given.  
Table 3.14 Reasons for graft failure 
 
Descemet’s Stripping (Automated) Endothelial Corneal Graft 
Reasons for Graft Failure 
 
  Endothelial cell failure 252 (32%) 
  Primary graft failure 221 (28%) 
  Rejection 106 (13%) 
  Infection: Non herpetic (20), HSV (3) 23 (3%) 
  Scarring  18 (2%) 
  Glaucoma 15 (2%) 
  Other specified* 46 (6%) 
  Unspecified 110 (14%) 
  
  Total 791 (100%) 
  
 
* Other included: Descemet’s folds/wrinkles (8), Graft detachment (7), ICE syndrome (6), 
trauma (6), astigmatism (4), corneal ulcer (4), band keratopathy (2), contraction of graft 
(1), epithelial defect (1), floppy iris syndrome (1), fibrosis (1), hyphaema (1), iris adhesion 
(1), limbal stem cell failure (1), pupillary block (1), suprachoroidal haemorrhage (1). 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. For lamellar procedures, primary graft failure is recorded as reported by 
surgeons. Additional information is collected to ascertain whether this occurred within 28 
days of the graft. Where surgeons indicate that the failure was due to surgical 
complications, this is also recorded. 
Of the 221 grafts reported by surgeons to have been primary graft failures, the majority 
(155) had no further information provided. Specific reasons given were: failure to 
adhere/graft detachment (28), surgical trauma/complication (11), endothelial failure (7), 
folds in Descemet’s membrane (6), oedema (4), endophthalmitis (2), rejection (2), 
scar/opacity (2), endothelial defect (1), epithelial defect (1), fungal infection in donor tissue 
(1), and presence of Fuchs’ endothelial dystrophy in the donor tissue (1). 
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3.9 Post-graft Changes in Best Corrected Visual Acuity 
 
3.9.1 All indications for graft 
 
Post-graft best corrected visual acuity (BCVA) is an important outcome for corneal graft 
recipients. A desire for improved visual acuity was specified as a reason for graft in 4,423 
(93%) of registered Descemet’s stripping (automated) endothelial keratoplasties. In 75% 
of cases (3,571), this was the sole desired outcome indicated. It is likely that this was also 
at least part of the reason for graft in some of the further 201 (4%) grafts for which no 
reason was specified.  
Follow-ups occur at varying times post-graft, depending on when a surgeon sees a 
recipient. Where post-graft best corrected visual acuity (without pinhole) information was 
provided, we categorised this according to the length of time since graft. The first two 
categories were: 
• BCVA provided at between 6 and 12 months post-graft, and 
• BCVA provided at between 12 and 18 months post-graft. 
Subsequent groups were at yearly intervals. For each year point, any measurements 
provided within 6-months of that date, rounded to the nearest day, were included (e.g. for 
2-year follow-up, any BCVA given at between 730 and 913 days post-graft was included). 
We analysed post-graft visual acuity in several ways. Where more than 20 grafts had 
BCVA measurements provided, we examined: 
1. The percentage of surviving grafts achieving different levels of Snellen visual 
acuity (6/6 or better, 6/7.5 to 6/12, 6/15 to 6/24, 6/36 to 6/60, count fingers (CF) 
or hand movements (HM), and light perception (LP) or no light perception 
(NLP)) at yearly time-points post-graft. Grafts that had been reported to have 
failed at the time of last follow-up, but had prior follow-ups with BCVA 
measurements provided when the graft was surviving, had these prior data 
included in these analyses.  
2. The average Snellen visual acuity achieved at yearly intervals post-graft, again 
by surviving grafts. 
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Table 3.15 and Figure 3.9.1 show the reported post-graft best corrected visual acuity for 
all failed grafts at the time of last follow-up, separated by indication for graft. Visual acuity 
at time of failure was reported for 694 (88%) of 791 failed DS(A)EK. As might be expected, 
the majority of failed grafts had accompanying poor visual acuity. 
Table 3.15 Post-graft best corrected visual acuity 
 
Descemet’s Stripping (Automated) Endothelial Keratoplasty:  











CF or HM LP or NLP 
Failed previous graft 1 (<1%) 5 (3%) 6 (3%) 42 (23%) 114 (63%) 14 (8%) 
Pseudo bullous keratopathy 0 (0%) 4 (2%) 15 (8%) 36 (18%) 134 (67%) 11 (6%) 
Fuchs’ endothelial dystrophy 0 (0%) 17 (6%) 52 (19%) 66 (25%) 129 (48%) 3 (1%) 
Other bullous keratopathy 0 (0%) 1 (%4) 2 (9%) 3 (13%) 14 (61%) 3 (13%) 
Trauma 0 (0%) 0 (0%) 2 (12%) 2 (12%) 12 (71%) 1 (6%) 
Other specified 0 (0%) 0 (0%) 0 (0%) 1 (20%) 3 (60%) 1 (20%) 
Total 1 (<1%) 27 (4%) 77 (11%) 150 (%) 406 (59%) 33 (5%) 
       
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
Figure 3.9.1 Best corrected visual acuity at time of last follow-up for failed 
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Figure 3.9.2 shows the best corrected visual acuity in the grafted eye, as reported to the 
ACGR, and categorised into six levels of vision, for all surviving Descemet’s stripping 
(automated) endothelial keratoplasties. Prior to graft over one-third of eyes (36%) had 
vision of CF or worse, with almost another quarter (24%) having 6/36 to 6/60. By 2-years 
post-graft, approximately 80% of eyes with surviving grafts had vision of 6/24 or better, 
with more than half having functional vision of 6/12 or better. This remained the case for 
surviving grafts followed for up to 7-years post-graft. 
Figure 3.9.2 Best corrected visual acuity for Descemet's stripping (automated) 
endothelial keratoplasties, surviving at time of measurement 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
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3.9.2 Individual indications for graft 
 
The following analyses show the post-graft best corrected visual acuity obtained for 
surviving grafts performed for specific indications. Data are reported for each of: Fuchs’ 
endothelial dystrophy, and pseudophakic bullous keratopathy. Figure 3.9.3 shows the 
average BCVA reported for various indications for graft - pre-graft, at 6-months post-graft 
and at yearly time points (6-month timeframe cohorts), up to 7-years post-graft. The 
dashed line shows the point where vision reaches 6/12, sometimes referred to as 
“functional” vision. 
On average, the best visual outcomes were seen for eyes grafted for Fuchs’ endothelial 
dystrophy. It can also be seen that these grafts had better pre-graft visual acuity levels 
than grafts for pseudophakic bullous keratopathy. Grafts performed for Fuchs’ endothelial 
dystrophy had mean post-graft vision of 6/12 or better by 12-months post-graft. On 
average, levels of vision obtained post-graft for pseudophakic bullous keratopathy did not 
reach 6/12 or better up to 5-years post-graft.  
Figure 3.9.3 Average level of best corrected visual acuity reported at yearly time 
points for surviving grafts performed for common indications for graft 
 
CF=count fingers at 1 metre, HM=hand movements 
 
Number of surviving grafts with visual acuity provided 
 
Pre-graft 1 2 3 4 5 6 
Pseudophakic bullous keratopathy 1209 167 115 57 27 24 11 
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Figure 3.9.4 shows levels of best corrected visual acuity reported to the ACGR, at yearly 
intervals for surviving Descemet’s stripping (automated) endothelial keratoplasties for 
Fuchs’ endothelial dystrophy. Post-graft vision of 6/12 or better was reported in almost 
two-thirds (63%) of surviving Descemet’s stripping (automated) endothelial 
keratoplasties performed for Fuchs’ endothelial dystrophy that had BCVA measurements 
reported between 12 and 18-months post-graft. This percentage remained above 60% 
up to 6-years post-graft. More than 90% of grafts achieved vision of 6/24 or better over 
this period of follow-up. 
Figure 3.9.4 Fuchs' endothelial dystrophy: level of best corrected visual acuity 
reported at yearly time points for surviving grafts 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
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Figure 3.9.5 shows levels of best corrected visual acuity reported to the ACGR, at yearly 
intervals for surviving Descemet’s stripping (automated) endothelial keratoplasties for 
pseudophakic bullous keratopathy. Post-graft vision of 6/12 or better was reported in one-
third (63%) of surviving Descemet’s stripping (automated) endothelial keratoplasties 
performed for pseudophakic bullous keratopathy that had BCVA measurements reported 
between 12 and 18-months post-graft. This percentage peaked 4-years post-graft, at 
52%. Approximately 70% of grafts achieved vision of 6/24 or better over 5-years post-
graft. 
Figure 3.9.5 Pseudophakic bullous keratopathy: level of best corrected visual 
acuity reported at yearly time points for surviving grafts 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
 
 
Descemet’s Membrane Endothelial Keratoplasty 
161 Australian Corneal Graft Registry Report 2018 
4 Descemet’s Membrane Endothelial Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 1,250 
Descemet’s membrane endothelial keratoplasties (DMEK) registered with the ACGR 
since 6th December 2007. Kaplan-Meier survival analyses were conducted using IBM 
SPSS for Windows (Version 22.0), to compare the graft survival across groups for a range 
of variables relating to the corneal donor, graft recipient, surgical procedure, surgeon, and 
follow-up care. 
 
4.1 Donor and Eye Banking Factors 
 
Table 4.1 shows the number of grafts within each of the variable sub-groups, for the donor 
factors found to be significant in univariate analyses. The sum of these numbers for each 
variable equals the total number of grafts (1,250 registered and 600 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 4.1 Donor and eye banking factors, significant in univariate analyses 
 
Descemet’s Membrane Endothelial Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank M 457 (37%) 158 (26%) 
  Eye bank K 64 (5%) 9 (2%) 
  Eye bank V 602 (48%) 361 (60%) 
  Eye bank J 122 (10%) 72 (12%) 
  Eye bank N 5 (<1%) 0 (0%) 
   
Donor sex*   
  Female 464 (37%) 237 (40%) 
  Male 786 (63%) 363 (61%) 
   
Age group   
  <50 years 132 (11%) 65 (11%) 
  50 to 59 years 239 (19%) 119 (20%) 
  60 to 69 years 442 (35%) 202 (34%) 
  70 to 79 years 345 (28%) 163 (27%) 
  80 years and older 92 (7%) 51 (9%) 
   
Prepared by eye bank (pre-cut)   
  No 1128 (90%) 568 (95%) 
  Yes 122 (10%) 32 (5%) 
   
Total 1250 (100%) 600 (100%) 
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Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Likelihood of follow-up was significantly less likely (p<0.05) in some groups than others. 
Lower rates of follow-up were received for grafts where donor tissue had been pre-cut by 
the eye bank. Significant differences in follow-up were also found across groups for eye 
bank, possibly relating to how recently the technique had started being used in certain 
States. 
Table 4.2 shows the number of grafts within each of the variable sub-groups, for the donor 
and eye banking factors found to be non-significant in univariate analyses. The sum for 
each variable equals the total number of grafts (1,250 registered and 600 with follow-up 
provided) and the percentages, summed vertically for each variable, total 100. The result 
of the Kaplan-Meier survival analysis is also provided for each variable. There were 
insufficient data for comparisons to be made between those grafts where the donor tissue 
had been transported interstate and those where it had not. 
Table 4.2 Donor and eye banking factors, not significant in univariate analyses 
 
Descemet’s Membrane Endothelial Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Death-to-enucleation time   
  ≤ 6 hours 174 (14%) 69 (12%) 
  7 to 12 hours 435 (35%) 205 (34%) 
  13 to 18 hours 462 (37%) 252 (42%) 
  > 18 hours 177 (14%) 74 (12%) 
  Not advised 2 (%) 0 (0%) 
Chi²=0.82, df=3, p=0.845   
   
Enucleation-to-storage time   
  ≤ 3 hours 595 (48%) 304 (51%) 
  4 to 6 hours 245 (20%) 143 (24%) 
  7 to 12 hours 96 (8%) 56 (9%) 
  > 12 hours 77 (6%) 25 (4%) 
  Not advised 237 (19%) 72 (12%) 
Chi²=3.74, df=3, p=0.290   
   
Storage medium   
  Optisol 747 (60%) 443 (74%) 
  Organ culture 503 (40%) 157 (26%) 
Chi²=0.33, df=1, p=0.568   
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 Registered (%) Followed (%) 
Storage to graft time - Organ culture   
   Up to 2 weeks 111 (9%) 29 (5%) 
   2 to 3 weeks 179 (14%) 66 (11%) 
   More than 3 weeks 56 (4%) 21 (4%) 
   Not advised 157 (13%) 41 (7%) 
   Not applicable 747 (60%) 443 (74%) 
Chi²=5.00, df=2, p=0.082   
 
Storage to graft time - Hypothermic   
   Within 5 days 449 (36%) 287 (48%) 
   6 or 7 days 191 (15%) 111 (19%) 
   More than a week 27 (2%) 14 (2%) 
   Not advised 80 (6%) 31 (5%) 
   Not applicable 503 (40%) 157 (26%) 
Chi²=0.68, df=2, p=0.713   
   
Cause of donor death   
  Cardiac event 274 (22%) 127 (21%) 
  Malignancy 566 (45%) 301 (50%) 
  Trauma 82 (7%) 28 (5%) 
  Respiratory event  85 (7%) 38 (6%) 
  Intracranial bleed/cerebral haemorrhage 190 (15%) 80 (13%) 
  Other specified 45 (4%) 24 (4%) 
  Live donor 1 (<1%) 0 (0%) 
  Not advised* 7 (<1%) 2 (<1%) 
Chi²=1.28, df=5, p=0.937   
   
Multi-organ donor status   
  No 1139 (91%) 553 (92%) 
  Yes 111 (9%) 47 (8%) 
Chi²=1.73, df=1, p=0.189   
   
Central corneal endothelial cell density  
  <2500 cells/mm² 20 (2%) 10 (2%) 
  2500 to 2749 cells/mm² 57 (5%) 15 (3%) 
  2750 to 2999 cells/mm² 132 (11%) 48 (8%) 
  3000 to 3249 cells/mm² 226 (18%) 76 (13%) 
  3250 to 3499 cells/mm² 132 (11%) 54 (9%) 
  ≥ 3500 cells/mm² 72 (6%) 35 (6%) 
  Not advised 611 (49%) 362 (60%) 
Chi²=9.07, df=5, p=0.106   
   
Total 1250 (100%) 600 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not advised or not applicable. 
*ACGR advised that cause of death was not yet determined but there were no medical contraindications and the eye 
had been cleared for release, by the Medical Director, in accordance with EBAANZ guidelines. 
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4.1.1 DMEK survival: influence of Australian eye bank 
 
Donor corneas are retrieved, processed, stored and distributed by five eye banks around 
Australia. Figure 4.1.1 shows the comparison of graft survival for corneas provided by 
each of these eye banks. One eye bank had only supplied 5 corneas for use in DMEK 
procedures and these were excluded from the analysis. A significant difference was found 
across eye banks (Log Rank Statistic=11.57; df=3; p=0.009), with Eye Bank J having 
significantly better survival than Eye Bank V (p=0.001). This variable was not included in 
the multivariate analysis (see section 4.7) as it is collinear with the individual surgeon 
variable shown in Figure 4.4.2. 
Figure 4.1.1 Australian eye bank 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
Eye Bank M 71 23 4 1 1 
Eye Bank K 3 1 NA NA NA 
Eye Bank V 149 74 27 6 2 
Eye Bank J 53 16 1 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
Eye Bank M 0.61 0.56 NA 
Eye Bank K NA NA NA 
Eye Bank V 0.61 0.54 0.52 
Eye Bank J 0.87 NA NA 
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4.1.2 DMEK survival: influence of donor sex 
 
Almost two-thirds of corneal donors were male. Figure 4.1.2 shows the comparison of 
graft survival depending on donor sex. While a significant difference was not found 
between groups at the p<0.05 level, the result met the p<0.08 criteria for inclusion in the 
multivariate analysis (Log Rank Statistic=3.64; df=1; p=0.056). This variable was not 
included in the multivariate analysis (see section 4.7), as it is collinear with the variable 
analysing donor/recipient sex match/mismatch (see section 4.2.5), which was included. 
Figure 4.1.2 Donor sex 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
Female 100 49 16 4 1 
Male 176 65 16 3 2 
 
Probability of graft survival (years post-graft) 
 
1 2 
Female 0.59 0.52 
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4.1.3 DMEK survival: influence of donor age (years) 
 
Figure 4.1.3 shows the comparison of graft survival depending on donor age, stratified by 
10 year age groups. Due to low numbers, all donors aged under 50 years were 
categorised together, as well as all donors aged 80 years and over. A significant 
difference was found across groups (Log Rank Statistic=12.89; df=4; p=0.012), with 
survival for grafts performed with tissue from donors aged under 50 years significantly 
poorer than those aged 60 to 69 years (p=0.001) and 70 to 79 years (p=0.004). This 
variable was retained in the final multivariate model (see section 4.7), suggesting that this 
is an independent factor significantly affecting graft survival.  
Figure 4.1.3 Donor age 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
Under 50 years 23 11 6 1 1 
50 to 59 years 51 16 4 1 NA 
60 to 69 years 102 37 13 1 NA 
70 to 79 years 81 41 7 3 2 
80 years or older 19 9 2 1 NA 
 
Probability of graft survival (years post-graft) 
 
1 2 
Under 50 years 0.45 NA 
50 to 59 years 0.61 NA 
60 to 69 years 0.69 0.62 
70 to 79 years 0.69 0.61 
80 years or older NA NA 
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4.1.4 DMEK survival: influence of preparatrion of donor tissue (pre-cut) by eye 
bank  
 
Donor tissue for endothelial grafts is increasingly prepared (pre-cut) by eye banks. Figure 
4.1.4 shows the comparison of graft survival between those DMEK grafts that were pre-
cut by the eye bank and those that were wholly cut by surgeons. A significant difference 
was found across groups (Log Rank Statistic=7.44; df=1; p=0.006). This variable was 
retained in the final multivariate model (see section 4.7), suggesting that this is an 
independent factor significantly affecting graft survival. 
Figure 4.1.4 Preparation of donor tissue (pre-cut) by eye bank  
 
 
Number at risk (years post-graft) 
 
6 months 1 2 3 4 5 
Not prepared  325 254 111 32 7 3 
Prepared (pre-cut) 27 22 3 NA NA NA 
 
Probability of graft survival (years post-graft) 
 
6 months 1 2 3 
Not prepared  0.67 0.63 0.56 0.50 
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4.2 Recipient Factors 
 
Table 3.3 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors examined in this report that were found to be significant predictors of 
graft survival in univariate analyses. The sum of these numbers for each variable equals 
the total number of grafts (1,250 registered and 600 followed) and the percentages, which 
should be summed vertically for each variable, total 100. 
Table 4.3 Recipient factors, significant in univariate analyses 
 
Descemet’s Membrane Endothelial Corneal Graft 
Recipient factors 
 
 Registered (%) Followed (%) 
Prior ipsilateral corneal graft/s   
  None 935 (75%) 416 (69%) 
  One 223 (18%) 131 (22%) 
  Two or more 92 (7%) 53 (9%) 
   
Australian State where graft was performed   
  State M 451 (36%) 152 (25%) 
  State K 54 (4%) 7 (<1%) 
  State V 601 (48%) 360 (60%) 
  State J 132 (11%) 80 (13%) 
  State N 5 (<1%) 0 (0%) 
  Other 7 (<1%) 1 (<1%)  
   
Recipient age group   
  Under 50 years 66 (5%) 38 (6%) 
  50 to 59 years 140 (11%) 62 (10%) 
  60 to 69 years 356 (28%) 180 (30%) 
  70 to 79 years 436 (35%) 205 (34%) 
  80 years or older 252 (20%) 115 (19%) 
   
Recipient sex   
  Female 709 (57%) 335 (56%) 
  Male 541 (43%) 265 (44%) 
   
Donor/recipient sex match   
  Female/female 246 (20%) 122 (20%) 
  Female/male 218 (17%) 115 (19%) 
  Male/female 463 (37%) 213 (36%) 
  Male/male 323 (26%) 150 (25%) 
   
 1250 (100%) 600 (100%) 
   
 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
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Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Significant differences (p<0.05) in follow-up were found across groups for graft State, and 
number of previous ipsilateral grafts. 
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Table 4.4 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors found to be non-significant in univariate analyses. The sum for each 
variable equals the total number of grafts (1,250 registered and 600 with follow-up 
provided) and the percentages, summed vertically, total 100. The result of the Kaplan-
Meier survival analysis is also provided.  
Table 4.4 Recipient factors, not significant in univariate analyses 
 
Descemet’s Membrane Endothelial Corneal Graft 
Recipient Factors 
 
 Registered (%) Followed (%) 
Indication for graft   
  Failed previous graft 315 (25%) 184 (31%) 
  Pseudophakic bullous keratopathy  214 (17%) 89 (15%) 
  Fuchs’ endothelial dystrophy  680 (54%) 309 (52%) 
  Other* 41 (3%) 18 (3%) 
Chi²=0.24, df=3, p=0.971   
   
Eye grafted   
  Left 628 (50%) 307 (51%) 
  Right 621 (50%) 293 (49%) 
  Not advised 1 (<1%) 0 (0%) 
Chi²=0.07, df=1, p=0.786   
   
Pre-graft inflammation and/or steroid 
use 
  
  No 792 (63%) 391 (65%) 
  Yes 444 (36%) 206 (34%) 
  Not advised 14 (1%) 3 (<1%) 
Chi²=0.25, df=1, p=0.614   
   
History of raised intraocular pressure   
  IOP never known to be raised 1081 (86%) 528 (88%) 
  IOP raised in past and/or at graft 169 (14%) 72 (12%) 
Chi²=0.21, df=1, p=0.649   
   
Pre-graft neovascularisation   
  No 1080 (86%) 537 (90%) 
  Yes 170 (14%) 63 (11%) 
Chi²=1.82, df=1, p=0.178   
   
Prior contralateral corneal graft/s   
  None 855 (68%) 408 (68%) 
  One 306 (24%) 141 (24%) 
  Two or more 89 (7%) 51 (9%) 
Chi²=1.15, df=2, p=0.564   
   
Change in lens status   
  Phakic/phakic 64 (5%) 36 (6%) 
  Phakic/pseudophakic 275 (22%) 137 (23%) 
  Other combination 911 (73%) 427 (71%) 
Chi²=2.07, df=2, p=0.356   
   
Total 1250 (100%) 600 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not advised or not applicable. 
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*Other included: trauma (15), ICE syndrome (6), aphakic bullous keratopathy (3), corneal 
oedema (3), bullous keratopathy (2), congenital corneal dystrophy (2),  surgical 
complications (2), congenital Descemet’s membrane rupture (1), endophthalmitis (1), 
posterior polymorphous dystrophy (1), Fuchs’ heterochromatic iridocyclitis (1), 
pseudoexfoliation syndrome (1), Rieger’s anomaly (1), retrocorneal membrane (1), and 
unspecified endothelial dystrophy (1).  
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4.2.1 DMEK survival: influence of the number of previous ipsilateral grafts 
 
Survival was compared across groups based on the number of previous grafts in the 
same eye (range 1 to 7), as shown in Figure 4.2.1. Previous grafts may not have been 
Descemet’s membrane endothelial keratoplasties. The difference across groups was 
significant (Log Rank Statistic=7.77, df=2, p=0.021), with eyes that had undergone one 
prior graft having superior survival to those having undergone two or more (p=0.004). 
This variable was not retained in the multivariate analysis suggesting that this is not an 
independent factor significantly affecting graft survival. 
Figure 4.2.1 Number of previous ipsilateral grafts 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
None 192 80 20 4 1 
One 64 26 9 2 1 
Two or more 20 8 3 1 1 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
None 0.64 0.59 0.54 
One 0.69 0.65 NA 
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4.2.2 DMEK survival: influence of Australian State where graft was performed 
 
Figure 4.2.2 shows the comparison of graft survival depending on the Australian State in 
which the transplantation occurred. Twelve grafts that were not performed in the four 
included States were excluded from the analysis due to low numbers in these groups.  A 
significant difference was found across groups (Log Rank Statistic=20.33; df=3; p<0.001), 
with State J having significantly better survival than State M (p=0.001) and State V 
(p<0.001). State M had significantly better survival than State K (p<0.001). However, the 
poor survival of grafts from State K is likely due to the lack of follow-up provided for these 
grafts, with just a single graft from this State having had follow-up provided by the surgeon 
(the other 6 followed grafts were known to have failed due to having regrafts registered 
with the ACGR). This variable was retained in the multivariate analysis suggesting that 
this is an independent factor significantly affecting graft survival.  
Figure 4.2.2 Australian State where graft was performed 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
State M 66 19 4 1 1 
State K 1 NA NA NA NA 
State V 149 74 27 6 2 
State J 60 21 1 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
State M 0.60 NA NA 
State K NA NA NA 
State V 0.61 0.54 0.52 
State J 0.88 0.83 NA 
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4.2.3 DMEK survival: influence of recipient age (years) 
 
Figure 4.2.3 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. Data for recipients aged under 50 were combined due to small 
numbers in these groups. A significant difference was found across groups (Log Rank 
Statistic=11.29; df=4; p=0.023). Significantly poorer survival was observed for grafts 
performed in recipients under 50 years old, compared to those aged 60 to 69 years 
(p=0.003), or 70 to 79 years (p=0.004). This variable was retained in the final multivariate 
model (see section 4.7), suggesting that this is an independent factor significantly 
affecting graft survival.  
Figure 4.2.3 Recipient age 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
Under 50 years 12 8 2 NA NA 
50 to 59 years 34 16 4 1 NA 
60 to 69 years 90 36 14 5 3 
70 to 79 years 96 37 9 1 NA 
80 years or older 44 17 3 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 
Under 50 years NA NA 
50 to 59 years 0.68 NA 
60 to 69 years 0.66 0.63 
70 to 79 years 0.66 0.60 
80 years or older 0.60 NA 
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4.2.4 DMEK survival: influence of recipient sex 
 
Comparison of graft survival between male and female transplant recipients is shown in 
Figure 4.2.4. A significant difference was found between groups (Log Rank Statistic=6.71; 
df=1; p=0.010). This variable was not included in the multivariate analysis (see section 
4.7), as it is collinear with the variable analysing donor/recipient sex match/mismatch (see 
section 4.2.5), which was included. 
Figure 4.2.4 Recipient sex 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
Female 169 70 22 4 2 
Male 107 44 10 3 1 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
Female 0.68 0.62 0.58 
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4.2.5 DMEK survival: influence of donor/recipient sex match/mismatch 
 
Further analysis examined whether there was any effect of a cornea being transplanted 
into a recipient of a different sex to the donor. Comparison of graft survival across groups 
based on donor/recipient sex combinations is shown in Figure 4.2.5. A significant 
difference was found across groups (Log Rank Statistic=9.78; df=3; p=0.021). Grafts 
performed in females using male donor tissue had significantly better survival than those 
performed in males using female donor tissue (p=0.002). This variable was not retained 
in the final multivariate model, suggesting that this is not an independent factor 
significantly affecting graft survival. 
Figure 4.2.5 Donor/recipient sex match/mismatch 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
Female/female 55 28 8 2 1 
Female/male 45 21 8 2 NA 
Male/female 114 42 14 2 1 
Male/male 62 23 2 1 1 
 
Probability of graft survival (years post-graft) 
 
1 2 
Female/female 0.64 0.55 
Female/male 0.55 0.48 
Male/female 0.71 0.66 
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4.3 Graft Era 
 
Table 4.5 shows the number of grafts registered and followed, in blocks of two years. The 
first two DMEK registered were performed in December of 2007 and these have been 
combined with the 2008/2009 group. The percentages, which should be summed 
vertically, total 100. 
Table 4.5 Graft era 
 
Descemet’s Membrane Endothelial Corneal Graft 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  2007/2008/2009 45 (4%) 28 (5%) 
  2010/2011 127 (10%) 99 (17%) 
  2012/2013 239 (19%) 158 (26%) 
  2014/2015 412 (33%) 258 (43%) 
  2016/2017 427 (34%) 57 (10%) 
   
Total 1250 (100%) 600 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses and 
found to be significant (p<0.001). Level of follow-up reduces as time since graft reduces, 
with 78% of grafts performed in 2010/11 followed, 66% of grafts performed in 2012/13, 
and 63% of grafts performed in 2014/15, compared with just 10% of grafts performed in 
2016/17.  
Consideration was given to the effect of follow-up lag time on this analysis. Up-to-date 
information on failed grafts is more likely to be known than for surviving grafts. This is 
because, while information on surviving grafts must be provided by a surgeon, the fact 
that a graft has failed may also be known when a registration is received for a replacement 
graft. A “lag time” operates at the furthest end of each curve in a Kaplan Meier plot. This 
effect is most pronounced in the early years following graft registration, when requests 
have not yet been made for follow-up information, and tends to reduce predictably over 
time.  
Of the grafts performed in 2016/2017 just twenty-one of the grafts with follow-up were 
surviving at the time of follow-up. This equates to 37% of followed grafts, and 5% of 
registered grafts from this cohort. The remaining 36 grafts were early failures, the majority 
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4.3.1 DMEK survival: influence of era of graft 
 
Figure 4.3.1 shows the comparison of graft survival between years of graft, stratified into 
two-year groups, with the two grafts performed in 2007 combined with those from 
2008/2009. The difference across groups was significant (Log Rank Statistic=13.42; df=4; 
p=0.009), with grafts performed in 2016/2017 having significantly poorer survival than 
those performed in 2007/2008/2009 and 2014/2015 (both p=0.001). This finding is thus 
likely due to the lag time discussed on the previous page. This variable was retained in 
the final multivariate model (see section 4.7), suggesting that this is an independent factor 
significantly affecting graft survival.  
Figure 4.3.1 Graft era 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
2007/2008/2009 15 3 1 NA NA 
2010/2011 50 21 7 4 3 
2012/2013 68 46 20 3 NA 
2014/2015 129 44 3 NA NA 
2016/2017 14 NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
2007/2008/2009 NA NA NA 
2010/2011 0.62 0.58 NA 
2012/2013 0.59 0.51 0.45 
2014/2015 0.71 0.66 NA 
2016/2017 NA NA NA 
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4.4 Surgery and Surgeon Factors 
 
Table 4.6 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors examined in this report, which were found to be significant 
in univariate analyses. Only four grafts were reported to have been done using forceps, 
three using viscoelastic, and two using an anterior chamber maintainer. Thus, the impact 
of these factors was not further analysed. The sum of these numbers for each variable 
equals the total number of grafts (1,250 registered and 600 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 4.6 Surgery and surgeon factors, significant in univariate analyses 
 
Descemet’s Membrane Endothelial Corneal Graft 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Size of graft (diameter)   
  Less than 8.5 mm 683 (55%) 388 (65%) 
  8.5 mm to <8.75 mm 160 (13%) 70 (12%) 
  8.75 mm or more 340 (27%) 99 (17%) 
  Not advised 67 (5%) 43 (7%) 
   
The Centre effect   
  Fewer than 25 registered DMEK 94 (8%) 32 (5%) 
  Surgeon F 367 (29%) 271 (45%) 
  Surgeon D 364 (29%) 115 (19%) 
  Surgeon S 131 (10%) 80 (13%) 
  Surgeon A 56 (4%) 10 (2%) 
  Surgeon P 56 (4%) 20 (3%) 
  Surgeon O 35 (3%) 11 (2%) 
  Surgeon U 30 (2%) 4 (<1%) 
  Surgeon Y 30 (2%) 18 (3%) 
  Surgeon T 31 (2%) 13 (2%) 
  Surgeon R 28 (2%) 18 (3%) 
  Surgeon E 28 (2%) 8 (1%) 
   
Surgeon volume   
  Fewer than 25 registered DMEK 94 (8%) 32 (5%) 
  25+ registered DMEK, < 48% follow-up 600 (48%) 181 (30%) 
  25+ registered DMEK, ≥ 48% follow-up 556 (44%) 387 (65%) 
   
Total 1250 (100%) 600 (100%) 
   
 
48% was selected as the cut-off point for the follow-up categories as this (48.0%) was the 
average percentage of follow-up for all DMEK, regardless of surgeon experience.   
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
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Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Likelihood of follow-up was significantly more likely (p<0.05) in some groups that others. 
Significant differences in follow-up were also found across groups for graft size, with 
grafts in the range of 8mm to 8.25mm most likely to have follow-up. There were significant 
differences in follow-up levels between individual surgeons. Due to the nature of the 
variable, follow-up was, logically, significantly higher (p<0.001) for grafts performed by 
surgeons with 25+ followed grafts and ≥48% follow-up. 
Table 4.7 shows the number of grafts within each of the variable sub-groups, for the donor 
and eye banking factors found to be non-significant in univariate analyses. The sum for 
each variable equals the total number of grafts (1,250 registered and 600 with follow-up 
provided) and the percentages, summed vertically for each variable, total 100. The result 
of the Kaplan-Meier survival analysis is also provided for each variable. 
Table 4.7 Surgery and surgeon factors, not significant in univariate analyses 
 
 
Descemet’s Membrane Endothelial Corneal Graft 
Surgery and Surgeon Factors 
 
 
 Registered (%) Followed (%) 
Size of incision   
  Up to 2.4 mm 185 (15%) 79 (13%) 
  2.5 mm to 2.7 mm 229 (18%) 129 (22%) 
  2.8 mm to 3.9 mm 102 (8%) 49 (8%) 
  4.0 mm or more 216 (17%) 81 (14%) 
  Not advised 518 (41%) 262 (44%) 
Chi²=2.99, df=3, p=0.393   
   
Use of glide   
  No 719 (58%) 245 (41%) 
  Yes 36 (3%) 17 (3%) 
  Not advised 495 (40%) 338 (56%) 
Chi²=0.60, df=1, p=0.439   
   
Donor lenticule folded   
  No 718 (57%) 246 (41%) 
  Yes 44 (4%) 22 (4%) 
  Not advised 488 (39%) 332 (55%) 
Chi²=1.87, df=1, p=0.172   
   
Total 1250 (100%) 600 (100%) 
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4.4.1 DMEK survival: influence of graft size 
 
Figure 4.4.1 shows a comparison of graft survival depending on the size of the graft, 
based on the donor button diameter, as reported by surgeons. This information was not 
reported for 67 grafts. A significant difference was found across groups (Log Rank 
Statistic=12.39; df=2; p=0.002), with grafts of 8.75mm or more having significantly worse 
survival than those that were less than 8.5mm (p=0.008) or 8.5mm to <8.75mm 
(p<0.001). Data on this variable were not provided in 5% of cases. A further category was 
thus created called “not advised”. A significant difference was still found across groups 
when this category was included (Log Rank Statistic=14.47; df=3; p=0.002). Graft size 
was thus categorised into these four groups for multivariate analysis. This variable was 
not retained in the final multivariate model, suggesting that this is not an independent 
factor significantly affecting graft survival. 
Figure 4.4.1 Graft size 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
Less than 8.5 mm 189 82 25 5 1 
8.5 mm to < 8.75 mm 39 15 3 1 1 
8.75 mm or more 34 11 2 1 1 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
Less than 8.5 mm 0.67 0.60 0.58 
8.5 mm to < 8.75 mm 0.80 NA NA 
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4.4.2 DMEK survival: influence of the Centre effect  
 
Figure 4.4.2 shows the comparison of graft survival for individual surgeons (shown in 
ascending order of number of grafts registered) for which there were 25 or more DMEKs 
registered, and all other grafts (performed by 33 surgeons) combined (Log Rank 
Statistic=54.87; df=11; p<0.001). This analysis indicates that there is a significant Centre 
effect. This variable was not included in the multivariate analysis (see section 4.7), as it 
is collinear with the variable analysing surgeon volume and level of follow-up (see section 
4.4.3), and Australian State where the graft was performed (see section 4.2.2), which 
were included. 
Figure 4.4.2 The Centre effect 
 
 
Note: To preserve anonymity, surgeons have been identified using random letters of the 
alphabet. These identifying letters do not correspond with those used in chapters 
reporting on other types of graft, i.e. Surgeon A in this chapter is not necessarily the same 
surgeon identified as Surgeon A in the chapter on penetrating keratoplasty.  
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Number at risk (years post-graft) 
 
1 2 3 4 5 
<25 DMEK registered 10 2 NA NA NA 
Surgeon F 121 70 27 6 2 
Surgeon D 50 16 4 1 1 
Surgeon S 60 21 NA NA NA 
Surgeon A NA NA NA NA NA 
Surgeon P 4 NA NA NA NA 
Surgeon O 8 NA NA NA NA 
Surgeon U 1 NA NA NA NA 
Surgeon Y 7 3 NA NA NA 
Surgeon T 4 NA NA NA NA 
Surgeon R 9 2 NA NA NA 
Surgeon E 2 NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
<25 DMEK registered NA NA NA 
Surgeon F 0.64 0.57 0.55 
Surgeon D 0.59 NA NA 
Surgeon S 0.88 0.83 NA 
Surgeon A NA NA NA 
Surgeon P NA NA NA 
Surgeon O NA NA NA 
Surgeon U NA NA NA 
Surgeon Y NA NA NA 
Surgeon T NA NA NA 
Surgeon R NA NA NA 
Surgeon E NA NA NA 
 
Note: For the majority of surgeons, there is very limited data for follow-up to one year. 
This is primarily due to the grafts being performed very recently and follow-up not yet 
being requested. As such, the curves in the Kaplan-Meier survival graph appear to have 
severe early drops in survival for these surgeons (e.g. Surgeon A, Surgeon U). This is 
due to the majority of grafts with follow-up for these surgeons, being those that have failed 
and been regrafted.  
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4.4.3 DMEK survival: influence of surgeon volume (25+ followed DS(A)EKs) 
grouped by level of follow-up  
 
Figure 4.4.3 shows the comparison of graft survival between grafts performed by 
surgeons with 25+ DMEKs with average or better (≥48%) follow-up, to those with lower 
than average follow-up (<48%), and to low volume (<25) surgeons (Log Rank 
Statistic=12.40; df=2; p=0.002). Grafts performed by surgeons with fewer than 25 DMEK 
registered with the ACGR had significantly poorer survival than surgeons with 25+ 
registered and either low levels of follow-up (p=0.014), or high levels of follow-up 
(p=0.004). Following further analyses where the data were clustered by patient [see 
references 7 & 8], this variable was no longer found to be significant (p=0.202). This 
variable was therefore excluded from multivariate analyses and was not an independent 
factor significantly affecting graft survival. 




Number at risk (years post-graft) 
 
1 2 3 4 5 
<25 registered DMEK  10 2 NA NA NA 
25+ DMEK, low follow-up 69 16 4 1 1 
25+ DMEK, high follow-up 197 96 28 6 2 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
<25 registered DMEK  NA NA NA 
25+ DMEK, low follow-up 0.59 NA NA 
25+ DMEK, high follow-up 0.68 0.62 0.60 
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4.5 Operative Procedures at the Time of Graft 
 
Table 4.8 shows the number of grafts for which certain operative procedures were 
performed at the time of graft. The sum of these numbers for each variable equals the 
total number of grafts (1,250 registered and 600 followed) and the percentages, which 
should be summed vertically for each variable, total 100. Only 10 grafts had an anterior 
vitrectomy at the time of graft. Thus, this factor was not further analysed. 
Table 4.8 Operative procedures at graft, significant in univariate analyses 
 
 
Descemet’s Membrane Endothelial Corneal Graft 
Surgery and Surgeon Factors 
 
 
 Registered (%) Followed (%) 
Peripheral iridectomy at time of graft   
  No 1126 (90%) 543 (90%) 
  Yes 124 (10%) 57 (10%) 
   
Total 1250 (100%) 600 (100%) 
   
 
Chi² analysis revealed no significant difference in rates of follow-up across sub-groups.  
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4.5.1 DMEK survival: influence of peripheral iridectomy at time of graft 
 
Figure 4.5.1 shows a comparison of graft survival depending on whether a peripheral 
iridectomy was also performed at the time of the graft. A significant difference was found 
across groups (Log Rank Statistic=3.86; df=1; p=0.049). This variable was not retained 
in the final multivariate model, suggesting that this is not an independent factor 
significantly affecting graft survival. 
Figure 4.5.1 Peripheral iridectomy at time of graft 
 
 
Number at risk (years post-graft) 
 
1 2 3 4 5 
No peripheral iridectomy 243 107 31 7 3 
Peripheral iridectomy 33 7 1 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 3 
No peripheral iridectomy 0.63 0.56 0.51 
Peripheral iridectomy 0.81 NA NA 
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4.6 Post-graft Events 
 
Table 4.9 shows the occurrence of post-graft events, neither of which were found to be 
significant in univariate analyses. The sum of these numbers for each variable equals the 
total number of grafts (1,250 registered and 600 followed) and the percentages, which 
should be summed vertically for each variable, total 100. The result of the Kaplan-Meier 
survival analysis is also provided for each variable.  
Only 18 grafts had post-graft corneal neovascularisation, two had post-graft herpetic 
infection, three had post-graft microbial keratitis, three had post-graft synechia, and three 
had post-graft uveitis reported. Thus, these factors was not further analysed. All of the 
grafts with a date of suture removal reported (n=23) were surviving and thus no further 
analyses was possible for this variable.  
Table 4.9 Post-graft events, not significant in univariate analyses 
 
 
Descemet’s Membrane Endothelial Corneal Graft 
Post-graft Events 
 
 Registered (%) Followed (%) 
Post-graft rise in IOP   
  No 1203 (96%) 553 (92%) 
  Yes 47 (4%) 47 (8%) 
Chi²=0.31, df=1, p=0.580   
   
At least one rejection episode   
  No 1228 (98%) 578 (96%) 
  Yes 22 (2%) 22 (4%) 
Chi²=0.49, df=1, p=0.483   
   
Total 1250 (100 %) 600 (100 %) 
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Table 4.10 shows post-graft surgical procedures, as reported by follow-up practitioners. 
Please note: post-graft data may be incomplete when follow-up is based on a registration 
for a replacement graft. 
Table 4.10 Post-graft surgical procedures 
243 DMEK were reported to have undergone a re-grafting procedure at the date last seen. 
Of these 219 had not had additional post-graft operative procedures reported, while 24 
had. 
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YAG laser 28 
Cataract removal/IOL insertion (10 both, 2 IOL only) 12 
Vitrectomy 11 
IOL exchange/removal/reposition 9 
Trabeculectomy 6 
Membrane peel 4 
Intravitreal injection/s 3 
Insertion of piggyback lens 2 




Total number of surgical procedures (number of grafts) 235 (184) 
  
 
* Other included: air removed to reverse pupil block (1), blepharoplasty (1), collagen cross 
linking (1), corneal scraping (1), cyclodiode (1), drainage device inserted (1), entropion 
repair (1), graft repositioned (1), intraocular contact lens inserted (1), iridectomy (1), 
iridoplasty (1), macular hole repair (1), ptosis repair (1), removal of air bubble (1), removal 
of scar (1), retinal detachment surgery (1), suturing of IOL (1), synechiolysis (1). 
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4.7 Multivariate Analysis 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all other variables in the model. This analysis was 
performed using STATA version 11. 
In the preceding univariate analyses, each registered DMEK, together with its archival 
follow-up records, was treated as a separate and independent entity. Some recipients 
had multiple DMEK performed during the census period (up to 31/7/2017), with some 
having repeat grafts in a single eye, some grafts in both eyes and some a combination of 
both. To control for potential inter-graft and/or inter-eye dependence in the multivariate 
analyses, the multivariate model was adjusted to allow for clustering by individual patient 
[see references 7 & 8]. 
Variables to be included in the Cox Proportional Hazards regression model were identified 
based on the results of the univariate Kaplan-Meier analyses, with a cut-off significance 
level of p<0.08 used to select variables for inclusion. Some variables that were found to 
be significant in the univariate analyses were omitted due to co-linearity. Where data were 
missing for 1% to 50% of cases, additional groups for each if these categorical variables 
were created, called “not advised”. Each variable was initially analysed individually to 
determine if it remained significant once clustered by individual patient. Where the 
variable was no longer found to be significant (p>0.08), it was excluded from the 
multivariate analysis. 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in a 
stepwise manner, beginning with the least significant variable. For categorical variable 
with more than two groups, Bonferroni adjustment was applied to determine if significant 
differences were present between groups. The Kaplan-Meier plots, and additional 
appropriate STATA analyses, were used to assess whether each included variable met 
the assumption of proportional hazards. Where variables were found to be time-variant, 
they were treated as such in the multivariate model.  
Table 4.11 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained in 
the final model.  
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Table 4.11 Multivariate model 
 
Descemet’s Membrane Endothelial Corneal Graft 
Multivariate Model 
 
Not significant in univariate analysis 
Storage medium 
Time from death to enucleation 
Time from enucleation to storage 
Storage time in Optisol 
Storage time in organ culture 
Cause of donor death 
Multi-organ donor 
Endothelial cell density 
Indication for graft 
Eye grafted 
Change in lens status pre- to post-graft 
Raised intraocular pressure prior to and/or at graft 
Pre-graft inflammation and/or steroid use 
Pre-graft neovascularisation 
Previous contralateral graft(s) 
Incision size 
Use of glide during surgery 
Donor lenticule folded 
Descemet’s membrane stripped by surgeon 
Raised intraocular pressure post-graft 
Post-graft rejection episode(s) 
 
Significant in univariate analysis but excluded from multivariate model due 
to collinearity 
Donor sex (with donor/recipient sex match/mismatch) 
Recipient sex (with donor/recipient sex match/mismatch) 
Eye bank (with Australian State where graft was performed) 
The Centre effect (with surgeon experience and level of follow-up) 
 
Significant in univariate analysis but not retained in multivariate model 
Surgeon experience and level of follow-up 
Peripheral iridectomy at time of graft 
Graft size 
Previous ipsilateral graft/s 
Donor/recipient sex match/mismatch 
 
Significant in univariate analysis AND retained in multivariate model 
Donor age group 
Cornea pre-cut by eye bank 
Recipient age group 
Graft year 
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Table 4.12 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The group of each categorical variable with the highest 
number of cases was taken as the referent. The hazard ratios for a given variable are 
adjusted for all other variables in the model. This model included data from the 1,238 
Descemet’s membrane endothelial keratoplasties, performed in 903 recipients, with 
appropriate data available for each included variable (12 cases that were not performed 
in one of the four included States were excluded from the analysis). 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, 
a global test was applied to calculate the overall p-value. The overall model was highly 
significant: (Chi²=139.31, p<0.0001). 
Table 4.12 Clustered multivariate model 
 
Descemet’s Membrane Endothelial Corneal Graft 















Donor age group 
0 to 49 years 131 1.92 0.40 0.002  1.28 - 2.88 
50 to 59 years 236 1.28 0.25 0.201  0.88 - 1.86 
60 to 69 years 439 1.00   0.008  
70 to 79 years 340 0.96 0.17 0.831  0.69 - 1.35 
80 years or older 92 1.04 0.28 0.881  0.62 - 1.75 
       
Cornea pre-cut by eye bank   
No 1123 1.00     
Yes 115 0.14 0.07 <0.001  0.05 - 0.39 
 
Recipient age group 
0 to 49 years 66 2.19 0.47 <0.001  1.43 - 3.34 
50 to 59 years 137 0.86 0.18 0.470  0.58 - 1.29 
60 to 69 years 353 0.96 0.17 0.817  0.68 - 1.36 
70 to 79 years 432 1.00   <0.001  
80 years or older 250 1.29 0.23 0.161  0.90 - 1.83 
       
Graft year  
Pre 2010 45 0.24 0.09 <0.001  0.11 - 0.49 
2010/2011 127 0.37 0.10 <0.001  0.22 - 0.63 
2012/2013 239 0.45 0.11 0.001  0.28 - 0.71 
2014/2015 411 0.36 0.08 <0.001  0.23 - 0.54 
2016/2017 416 1.00   <0.001  
 
Australian State where graft was performed 
State M 451 0.80 0.16 0.260  0.55 - 1.18 
State K 54 7.02 2.40 <0.001  3.59 - 13.73 
State V 601 1.00   <0.001  
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4.7.1 Significant differences in the Descemet’s membrane endothelial 
keratoplasty multivariate model for categories with more than two groups 
following Bonferroni correction for multiple comparisons 
 
4.7.1.1 Donor age group  
 
Significantly poorer survival was found for the under 50 years age category, compared to 
the 60 to 69 years (p=0.002), and 70 to 79 years (p=0.001) categories. 
 
4.7.1.2 Australian State where graft was performed 
 
Grafts performed in State K had significantly poorer survival than those performed in State 
M, State V or State J (all p<0.001). The poor performance of grafts in this category is 
likely due to the lack of follow-up provided for these grafts, with just a single graft from 
this State having had follow-up provided by the surgeon (the other 6 followed grafts were 
known to have failed due to having regrafts registered with the ACGR). 
 
4.7.1.3 Recipient age group 
 
Significantly poorer survival was found for the under 50 years age category, compared to 
the 50 to 59 years, 60 to 69 years, and 70 to 79 years age groups (all p<0.001). 
 
4.7.1.4 Graft era  
 
Graft survival was significantly poorer for the most recent grafts, performed in 2016 and 
2017, compared to all other years (all p<0.001, except 2012/2013 where p=0.001). The 
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4.8 Reasons for Graft Failure 
 
Of the 921 followed grafts, 251 (27%) were known to have failed by the census date. This 
equates to 20% of the 1,250 registered grafts. Surgeons were asked to indicate the 
reason for graft failure. This information was also gathered from repeat registration forms, 
where the reason for failure of the previous graft was given. Table 4.13 shows the reasons 
for failure given.  
Table 4.13 Reasons for graft failure 
 
Descemet’s Membrane Endothelial Corneal Graft 
Reasons for Graft Failure 
 
  Primary graft failure 160 (64%) 
  Endothelial cell failure 46 (18%) 
  Rejection 9 (4%) 
  Scarring  5 (2%) 
  Other specified* 14 (6%) 
  Unspecified 17 (7%) 
  
  Total 251 (100%) 
  
 
* Other included: Infection (3), folds (2), persistent graft detachment (2), trauma (2), 
astigmatism (1), glaucoma (1), keratoconus (1), retained Descemet’s membrane (1), 
wound dehiscence (1). 
Primary graft non-functions are defined as grafts that never clear in the post-operative 
period. For lamellar procedures, primary graft failure is recorded as reported by surgeons. 
Additional information is collected to ascertain whether this occurred as “early failure, 
within 28 days of the graft. Where surgeons indicate that the failure was due to surgical 
complications, this is also recorded. 
Of the 160 grafts reported by surgeons to have been primary graft failures, the majority 
(89) had no further information provided. Specific reasons given were: failure to 
adhere/graft detachment (39), surgical trauma/complication (12), endothelial failure (7), 
folds in Descemet’s membrane (4), upside down insertion (4), oedema (2), haemorrhage 
(1), rejection (1), and ulcer (1). 
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4.9 Post-graft Changes in Best Corrected Visual Acuity 
 
4.9.1 All indications for graft 
 
Post-graft best corrected visual acuity (BCVA) is an important outcome for corneal graft 
recipients. A desire for improved visual acuity was specified as a reason for graft in 1,194 
(96%) of registered Descemet’s membrane endothelial keratoplasties. In 85% of cases 
(1,060), this was the sole desired outcome indicated. It is likely that this was also at least 
part of the reason for graft in some of the further 45 (4%) grafts where no reason was 
specified.  
Follow-ups occur at varying times post-graft, depending on when a surgeon sees a 
recipient. Where post-graft best corrected visual acuity (without pinhole) information was 
provided, we categorised this according to the length of time since graft. The first two 
categories were: 
• BCVA provided at between 6 and 12 months post-graft, and 
• BCVA provided at between 12 and 18 months post-graft. 
Subsequent groups were at yearly intervals. For each year point, any measurements 
provided within 6-months of that date, rounded to the nearest day, were included (e.g. for 
2-year follow-up, any BCVA given at between 730 and 913 days post-graft was included). 
We analysed post-graft best corrected visual acuity in several ways. Where more than 20 
grafts had BCVA measurements provided, we examined: 
1. The percentage of surviving grafts achieving different levels of Snellen visual 
acuity (6/6 or better, 6/7.5 to 6/12, 6/15 to 6/24, 6/36 to 6/60, count fingers (CF) 
or hand movements (HM), and light perception (LP) or no light perception 
(NLP)) at yearly time-points post-graft. Grafts that had been reported to have 
failed at the time of last follow-up, but had prior follow-ups with BCVA 
measurements provided when the graft was surviving, had these prior data 
included in these analyses.  
2. The average Snellen visual acuity achieved at yearly intervals post-graft, again 
by surviving grafts. 
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Table 4.14 and Figure 4.9.1 show the reported post-graft best corrected visual acuity for 
all failed grafts at the time of last follow-up, separated by indication for graft. Visual acuity 
at time of failure was reported for 223 (89%) of 251 failed DMEK. As might be expected, 
the majority of failed grafts had accompanying poor visual acuity.  
Table 4.14 Post-graft best corrected visual acuity 
 
Descemet’s Membrane Endothelial Keratoplasty:  











CF or HM LP or NLP 
Failed previous graft 1 (1%) 6 (8%) 5 (7%) 14 (20%) 44 (62%) 1 (1%) 
Pseudo bullous keratopathy 0 (0%) 1 (3%) 1 (3%) 3 (9%) 27 (84%) 0 (0%) 
Fuchs’ endothelial dystrophy 0 (0%) 3 (3%) 13 (12%) 17 (15%) 79 (70%) 1 (<1%) 
Other specified 0 (0%) 0 (0%) 0 (0%) 1 (14%) 6 (86%) 0 (0%) 
Total 1 (<1%) 10 (4%) 19 (9%) 35 (16%) 156 (70%) 2 (1%) 
       
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
 
Figure 4.9.1 Best corrected visual acuity at time of last follow-up for failed 
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Figure 4.9.2 shows the best corrected visual acuity in the grafted eye, as reported to the 
ACGR, and categorised into six levels of vision, for all surviving Descemet’s membrane 
endothelial keratoplasties. Prior to graft almost one-third of eyes (31%) had vision of CF 
or worse, with almost another fifth (18%) having 6/36 to 6/60. By 2-years post-graft, over 
90% of eyes with surviving grafts had vision of 6/24 or better, with more than 80 percent 
having functional vision of 6/12 or better.  
 
Figure 4.9.2 Best corrected visual acuity for Descemet's membrane endothelial 
keratoplasties, surviving at time of measurement 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
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4.9.2 Individual indications for graft 
 
The only indication for graft with sufficient data to examine the visual outcomes 
individually was Fuchs’ endothelial dystrophy. Figure 4.9.3 shows levels of best corrected 
visual acuity reported to the ACGR, at yearly intervals for surviving Descemet’s 
membrane endothelial keratoplasties for Fuchs’ endothelial dystrophy. Post-graft vision 
of 6/12 or better was reported in the vast majority (90%) of surviving Descemet’s 
membrane endothelial keratoplasties performed for Fuchs’ endothelial dystrophy that had 
BCVA measurements reported between 12 and 18-months post-graft. This percentage 
remained above 85% at 2-years post-graft.  
 
Figure 4.9.3 Fuchs' endothelial dystrophy: level of best corrected visual acuity 
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5 Deep Anterior Lamellar Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 1,531 
deep anterior lamellar keratoplasties (DALK) registered with the ACGR. Kaplan-Meier 
survival analyses were conducted using IBM SPSS for Windows (Version 22.0), to 
compare the graft survival across groups for a range of variables relating to the corneal 
donor, graft recipient, surgical procedure, surgeon, and follow-up care. 
 
5.1 Donor and Eye Banking Factors 
 
Table 5.1 shows the number of grafts within each of the variable sub-groups, for the donor 
factors examined in this report that we found to be significant in univariate analyses. The 
sum of these numbers for each variable equals the total number of grafts (1,531 
registered and 921 followed) and the percentages, which should be summed vertically for 
each variable, total 100. 
Table 5.1 Donor and eye banking factors, significant in univariate analyses 
 
Deep Anterior Lamellar Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Storage-to-graft time - organ culture 
   Up to 2 weeks 140 (9%) 74 (8%) 
   2 to 3 weeks 220 (14%) 114 (12%) 
   More than 3 weeks 82 (5%) 43 (5%) 
   Not advised 276 (18%) 131 (14%) 
   Not applicable 813 (53%) 559 (61%) 
   
Total 1531 (100%) 921 (100%) 
   
 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
were examined using Chi² analyses. Likelihood of follow-up was significantly less likely 
(p<0.001) for grafts using the Melles technique.  
Table 5.2 shows the number of grafts within each of the variable sub-groups, for the donor 
and eye banking factors found to be non-significant in univariate analyses. The sum for 
each variable equals the total number of grafts (1,351 registered and 921 with follow-up 
provided) and the percentages, summed vertically for each variable, total 100. The result 
of the Kaplan-Meier survival analysis is also provided for each variable.  
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Table 5.2 Donor and eye banking factors, not significant in univariate analyses 
 
Deep Anterior Lamellar Corneal Graft 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank M 723 (47%) 335 (36%) 
  Eye bank K 272 (18%) 201 (22%) 
  Eye bank V 343 (22%) 264 (29%) 
  Eye bank J 79 (5%) 38 (4%) 
  Eye bank N 113 (7%) 82 (9%) 
  Not advised* 1 (<1%) 1 (<1%) 
Chi²=5.58, df=4, p=0.233   
   
Death-to-enucleation time   
  ≤ 3 hours 151 (10%) 117 (19%) 
  4 to 6 hours 234 (15%) 140 (15%) 
  7 to 9 hours 261 (17%) 145 (16%) 
  10 to 12 hours 304 (20%) 194 (21%) 
  13 to 15 hours 204 (13%) 128 (14%) 
  16 to 18 hours 170 (11%) 89 (10%) 
  > 18 hours 202 (13%) 105 (11%) 
  Not advised 5 (<1%) 3 (<1%) 
Chi²=9.08, df=6, p=0.169   
   
Enucleation-to-storage time   
  ≤ 3 hours 707 (46%) 411 (45%) 
  4 to 6 hours 157 (10%) 114 (12%) 
  7 to 12 hours 84 (5%) 58 (6%) 
  > 12 hours 122 (8%) 94 (10%) 
  Not advised 461 (30%) 244 (26%) 
Chi²=2.31, df=3, p=0.510   
   
Storage medium   
  Optisol 809 (53%) 559 (61%) 
  Organ culture 718 (47%) 362 (39%) 
  Moist pot 4 (<1%) 0 (0%) 
Chi²=0.07, df=1, p=0.792   
   
Storage-to-graft time - Optisol   
  Within 5 days 406 (27%) 288 (31%) 
  6 to 7 days 140 (9%) 97 (11%) 
  Longer than 1 week 78 (5%) 61 (7%) 
  Not advised 185 (12%) 113 (12%) 
  Not applicable 722 (47%) 362 (39%) 
Chi²=0.33, df=2, p=0.847   
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 Registered (%) Followed (%) 
Deswelling time - organ culture   
  Less than 2 days 127 (8%) 25 (3%) 
  2 to 3 days 49 (3%) 9 (1%) 
  Longer than 3 days 46 (3%) 9 (1%) 
  Not advised 587 (38%) 448 (49%) 
  Not applicable 722 (47%) 362 (39%) 
Chi²=0.83, df=2, p=0.659   
   
Sex of donor   
  Female 658 (43%) 398 (43%) 
  Male 873 (57%) 523 (57%) 
Chi²=0.90, df=1, p=0.343   
   
Age group   
  Under 20 years 45 (3%) 27 (3%) 
  20 to 29 years 54 (4%) 34 (4%) 
  30 to 39 years 82 (5%) 48 (5%) 
  40 to 49 years 148 (10%) 76 (8%) 
  50 to 59 years 308 (20%) 171 (19%) 
  60 to 69 years 457 (30%) 277 (30%) 
  70 to 79 years 324 (21%) 208 (23%) 
  80 years or older 113 (7%) 80 (9%) 
Chi²=4.48, df=7, p=0.723   
   
Cause of death   
  Cardiac event 342 (22%) 220 (24%) 
  Malignancy 571 (37%) 341 (37%) 
  Trauma 129 (8%) 76 (8%) 
  Respiratory event 109 (7%) 69 (7%) 
  Intracranial/cerebral haemorrhage 278 (18%) 159 (17%) 
  Other specified 78 (5%) 42 (5%) 
  Not advised** 24 (2%) 14 (2%) 
Chi²=5.47, df=5, p=0.361   
   
Multi-organ donor status   
  No 1314 (86%) 794 (86%) 
  Yes 217 (14%) 127 (14%) 
Chi²=1.87, df=1, p=0.171   
   
Central corneal endothelial cell density 
  <2500 cells/mm² 122 (8%) 66 (7%) 
  2500 to 2749 cells/mm² 142 (9%) 81 (9%) 
  2750 to 2999 cells/mm² 195 (13%) 93 (10%) 
  3000 to 3249 cells/mm² 262 (17%) 141 (15%) 
  3250 to 3499 cells/mm² 195 (13%) 103 (11%) 
  ≥ 3500 cells/mm² 118 (8%) 64 (7%) 
  Not advised 497 (32%) 457 (50%) 
Chi²=3.25, df=5, p=0.662   
   
Total 1531 (100%) 921 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not advised or not applicable, or 
categories with fewer than 20 grafts. 
* One autograft with no eye bank given 
** ACGR advised that cause of death was not yet determined but there were no medical contraindications and the eye 
had been cleared for release, by the Medical Director, in accordance with EBAANZ guidelines.  
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5.1.1 DALK survival: influence of storage time to graft – organ culture medium 
 
Organ culture storage can allow preservation times of up to four weeks. Figure 5.1.1 
shows the comparison of graft survival across storage time for those corneas stored in 
organ culture medium. Data were not provided for 276 grafts. These were excluded from 
the analysis. No significant difference was found across groups (Log Rank Statistic=5.22; 
df=2; p=0.074), and none of the subgroup analyses were significant after Bonferroni 
correction (all p>0.016). While the difference met the p<0.08 criteria for potential inclusion 
in multivariate analysis, the high proportion of the cohort that it was not relevant to (53%) 
and the additional rate of missing data (18%) meant that data were only available for 28% 
of DALK and it was thus excluded from multivariate analysis. 
Figure 5.1.1 Time from storage to graft, organ culture medium storage 
 
Number at risk (years post-graft) 
 
1 2 4 6 
Less than 2 weeks 65 40 6 4 
2 to 3 weeks 100 65 20 5 
More than 3 weeks 35 22 2 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 
Less than 2 weeks 0.98 0.98 NA 
2 to 3 weeks 0.96 0.96 0.86 
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5.2 Recipient Factors 
 
Table 5.3 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors examined in this report that were found to be significant predictors of 
graft survival in univariate analyses. The sum of these numbers for each variable equals 
the total number of grafts (1,531 registered and 921 followed) and the percentages, which 
should be summed vertically for each variable, total 100. 
Table 5.3 Recipient factors, significant in univariate analyses 
 
Deep Anterior Lamellar Corneal Graft 
Recipient Factors 
 
 Registered (%) Followed (%) 
Indication for graft   
  Failed previous graft 66 (4%) 38 (4%) 
  Keratoconus 1161 (76%) 688 (75%) 
  Herpetic eye disease 63 (4%) 47 (5%) 
  Corneal degenerations 58 (4%) 32 (3%) 
  Corneal dystrophies 41 (3%) 22 (2%) 
  Non-herpetic infections 53 (3%) 37 (4%) 
  Corneal scars and opacities 36 (2%) 24 (3%) 
  Other* 53 (3%) 33 (4%) 
   
Recipient age group   
  <20 years 106 (7%) 62 (7%) 
  20 to 29 years 490 (32%) 293 (32%) 
  30 to 39 years 395 (26%) 240 (26%) 
  40 to 49 years 225 (15%) 130 (14%) 
  50 to 59 years 140 (9%) 87 (9%) 
  60 to 69 years 97 (6%) 61 (7%) 
  70 years or older 78 (5%) 48 (5%) 
   
Change in lens status pre- to post-graft   
  Phakic/Phakic 1442 (94%) 866 (94%) 
  Other 89 (6%) 55 (6%) 
   
Pre-graft neovascularisation   
  None 1363 (89%) 815 (88%) 
  One quadrant 64 (4%) 42 (5%) 
  Two quadrants 61 (4%) 38 (4%) 
  Three quadrants 22 (1%) 14 (2%) 
  Four quadrants 21 (1%) 12 (1%) 
   
Pre-graft inflammation and/or steroid use   
  No 1384 (90%) 823 (89%) 
  Yes 133 (9%) 91 (10%) 
  Not advised 14 (1%) 7 (1%) 
   
Total 1531 (100%) 921 (100%) 
   
 
* Other included: trauma (18), corneal ulcer/perforation (8), keratoglobus (6), interstitial 
keratitis (5), congenital abnormality (4), descemetocoele (4), metabolic deposits (4), 
irregular astigmatism (1), limbal dermoid (1), Wegener’s granulomatosis (1).  
Comparisons between the percentages of grafts registered and followed in each category 
showed no significant differences across groups (all p>0.05).  
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Table 5.4 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors found to be non-significant in univariate analyses. The sum for each 
variable equals the total number of grafts (1,531 registered and 921 with follow-up 
provided) and the percentages, summed vertically, total 100. The result of the Kaplan-
Meier survival analysis is also provided. 
Table 5.4 Recipient factors, not significant in univariate analyses 
 
Deep Anterior Lamellar Corneal Graft 
Recipient Factors 
 
 Registered (%) Followed (%) 
Australian State where graft was performed   
  State M 727 (47%) 340 (37%) 
  State K 268 (18%) 199 (22%) 
  State V 326 (21%) 249 (27%) 
  State J 91 (6%) 45 (5%) 
  State N 98 (6%) 73 (8%) 
  State C 18 (1%) 15 (2%) 
  Other 3 (<1%) 0 (0%) 
Chi²=5.96, df=4, p=0.202   
   
Interstate transportation   
  No 1482 (97%) 890 (97%) 
  Yes 45 (3%) 30 (3%) 
  Not advised 4 (<1%) 1 (<1%) 
Chi²=0.01, df=1, p=0.919   
   
Recipient sex   
  Female 582 (38%) 364 (40%) 
  Male 949 (62%) 557 (60%) 
Chi²=0.84, df=1, p=0.360   
   
Donor/recipient sex match/mismatch   
  Female/female 246 (16%) 143 (16%) 
  Female/male 412 (27%) 255 (28%) 
  Male/female 336 (22%) 221 (24%) 
  Male/male 537 (35%) 302 (33%) 
Chi²=2.23, df=3, p=0.527   
   
Eye in which graft was performed   
  Left 773 (50%) 475 (52%) 
  Right 758 (50%) 446 (48%) 
Chi²=0.52, df=1, p=0.473   
   
Prior existing contralateral graft   
  No 1277 (83%) 799 (87%) 
  Yes 254 (17%) 122 (13%) 
Chi²=0.14, df=1, p=0.710   
   
Total 1531 (100%) 921 (100%) 
   
Note: Kaplan-Meier analyses did not include categories with fewer than 20 grafts. Fifteen eyes undergoing deep 
anterior lamellar keratoplasty had a history of corneal cross-linking. This was an insufficient number for survival 
comparisons with those that had not. 
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5.2.1 DALK survival: influence of indication for graft 
 
Figure 5.2.1 shows the comparison of graft survival depending on the indication for graft. 
A significant difference was found across groups (Log Rank Statistic=45.37; df=7; 
p<0.001), with survival of grafts performed for keratoconus significantly better than those 
performed for failed previous grafts, herpetic infections or non-herpetic infections (all 
p<0.001), and other specified indications (p=0.001). This variable was not retained in the 
final multivariate model (see section 5.7), suggesting that this is not an independent factor 
significantly affecting graft survival. 
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Number at risk (years post-graft) 
 
1 2 4 6 8 10 
Failed previous graft 27 19 11 5 3 1 
Keratoconus 586 360 123 46 11 5 
Herpetic infection 39 32 16 4 1 NA 
Corneal degeneration 26 17 8 1 NA NA 
Corneal dystrophy 19 13 7 3 1 1 
Corneal scars & opacities 21 13 5 4 NA NA 
Non-herpetic infection 27 16 4 2 NA NA 
Other indication 24 14 1 NA NA NA 
 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Failed previous graft 0.87 NA NA NA 
Keratoconus 0.96 0.94 0.89 0.86 
Herpetic infection 0.89 0.84 NA NA 
Corneal degeneration 0.91 NA NA NA 
Corneal dystrophy NA NA NA NA 
Corneal scars & opacities 0.96 NA NA NA 
Non-herpetic infection 0.83 NA NA NA 
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5.2.2 DALK survival: influence of recipient age 
 
Figure 5.2.2 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. Data for recipients aged under 20, and 70 and over, were combined 
due to small numbers in these groups. A significant difference was found across groups 
(Log Rank Statistic=31.19; df=6; p<0.001), with recipients aged 70 years or older having 
poorer survival than those aged 20 to 29 years, 30 to 39 years (both p<0.001) or 40 to 49 
years (p=0.002), and recipients aged 60 to 69 years having poorer survival than those 
aged 20 to 29 years (p=0.002).  
Further analyses, showed no significant differences between the groups under 60 years 
(overall p=0.386, all individual comparisons p>0.05). These groups were categorised 
together for multivariate analysis. This variable was retained in the final multivariate model 
(see section 5.7), suggesting that this is an independent factor significantly affecting graft 
survival. 
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Number at risk (years post-graft) 
 
1 2 4 6 8 10 
Less than 20 years 53 36 16 5 NA NA 
20 to 29 years 248 150 53 20 3 2 
30 to 39 years 202 122 39 14 7 3 
40 to 49 years 225 110 67 21 9 3 
50 to 59 years 75 58 21 10 1 1 
60 to 69 years 54 34 17 5 2 NA 
70 years or older 27 17 8 2 NA NA 
 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Less than 20 years 0.97 0.93 NA NA 
20 to 29 years 0.96 0.95 0.89 0.85 
30 to 39 years 0.93 0.90 0.88 NA 
40 to 49 years 0.94 0.92 0.84 NA 
50 to 59 years 0.98 0.95 0.78 NA 
60 to 69 years 0.92 0.85 NA NA 
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5.2.3 DALK survival: influence of change in lens status 
 
Figure 5.2.3 shows the comparison of graft survival stratified by the change of lens status 
from pre- to post-graft. “Phakic/phakic” means the eye was phakic both before and after 
the graft. “Other” means the eye was phakic, pseudophakic or aphakic before the graft, 
and either aphakic or pseudophakic afterwards.  
A significant difference was found across groups (Log Rank Statistic=11.78; df=1; 
p=0.001). This variable was not retained in the final multivariate model (see section 5.7), 
suggesting that this is not an independent factor significantly affecting graft survival. 
Figure 5.2.3 Change in lens status from pre- to post-graft 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
Phakic/phakic 730 457 165 62 16 7 
Other 39 27 10 3 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Phakic/phakic 0.95 0.92 0.85 0.79 
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5.2.4 DALK survival: influence of pre-graft corneal neovascularisation 
 
Figure 5.2.4 shows the comparison of graft survival between those recipients with various 
levels of corneal neovascularisation pre-graft and those without (Log Rank 
Statistic=53.35; df=4; p<0.001), with those with avascular corneas having significantly 
better survival than those with 2 or 4 quadrants of neovascularisation (both p<0.001), and 
those with 1 quadrant having better outcomes than those with 4 (p=0.004). Recipients 
with avascular corneas pre-graft, or one quadrant of pre-graft neovascularisation, had 
better graft survival than those with greater levels of corneal neovascularisation (Log 
Rank Statistic=50.02; df=1; p<0.001). This variable was recategorised for the multivariate 
analysis, according to this finding. This variable was retained in the multivariate analysis 
(see section 5.7), suggesting that this is an independent factor significantly affecting graft 
survival. 
Figure 5.2.4 Pre-graft corneal neovascularisation 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
None 691 424 154 59 15 7 
One quadrant 36 24 8 2 1 NA 
Two quadrants 22 18 8 4 NA NA 
Three quadrants 12 11 5 NA NA NA 
Four quadrants 8 7 NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
None 0.95 0.93 0.87 0.80 
One quadrant 0.95 0.95 NA NA 
Two quadrants 0.70 NA NA NA 
Three quadrants NA NA NA NA 
Four quadrants NA NA NA NA 
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5.2.5 DALK survival: influence of pre-graft inflammation and/or steroid use 
 
Figure 5.2.5 shows the comparison of graft survival depending on whether the eye grafted 
had a history of inflammation and/or steroid use pre-graft. A significant difference was 
found across groups (Log Rank Statistic=27.26; df=1; p<0.001). This variable was 
retained in the multivariate analysis (see section 5.7), suggesting that this is an 
independent factor significantly affecting graft survival. 
Figure 5.2.5 Pre-graft inflammation and/or steroid use 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
No inflammation/steroid use 698 432 154 58 14 6 
Inflammation/steroid use 64 46 19 6 2 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No inflammation/steroid use 0.96 0.93 0.86 0.78 








Deep Anterior Lamellar Keratoplasty 
213 Australian Corneal Graft Registry Report 2018 
5.3 Graft Era 
 
Table 5.5 shows the number of grafts registered and followed, in blocks of two years. The 
percentages, which should be summed vertically, total 100. 
Table 5.5 Graft Era 
 
Deep Anterior Lamellar Corneal Graft 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  2000 to 2004 35 (2%) 31 (3%) 
  2005 to 2009 362 (24%) 275 (30%) 
  2010 to 2014 804 (53%) 542 (59%) 
  2015 to 2017 330 (22%) 73 (8%) 
   
Total 1531 (100%) 921 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses and 
found to be significant (p<0.001). Follow-up was lower for grafts performed in more recent 
years. 
Consideration was given to the effect of follow-up lag time on this analysis. Up-to-date 
information on failed grafts is more likely to be known than for surviving grafts. This is 
because, while information on surviving grafts must be provided by a surgeon, the fact 
that a graft has failed may also be known when a registration is received for a replacement 
graft.   
  
Deep Anterior Lamellar Keratoplasty 
214 Australian Corneal Graft Registry Report 2018 
5.3.1 DALK survival: influence of era of graft 
 
Figure 5.3.1 shows the influence of year of graft, stratified into five-year groups. The 
difference in survival was significant (Log Rank Statistic=12.75; df=3; p=0.005), with 
those performed in 2015 to 2017 exhibiting poorer survival than those performed from 
2005 to 2009 (p<0.001) or 2010 to 2014 (p=0.003). This finding is likely due to the lag 
time discussed on the previous page. This variable was retained in the final multivariate 
model (see section 5.7), suggesting that this is an independent factor significantly 
affecting graft survival. 
Figure 5.3.1 Graft era 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
2000 to 2004 25 20 17 13 12 7 
2005 to 2009 241 157 82 43 4 NA 
2010 to 2014 457 305 76 9 NA NA 
2015 to 2017 46 2 NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
2000 to 2004 0.87 0.87 NA NA 
2005 to 2009 0.96 0.94 0.87 0.78 
2010 to 2014 0.94 0.92 0.82 NA 
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5.4 Surgery and Surgeon Factors 
 
Table 5.6 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors examined in this report that were found to be significant 
predictors of graft survival in univariate analyses. The sum of these numbers for each 
variable equals the total number of grafts (1,531 registered and 921 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 5.6 Surgery and surgeon factors, significant in univariate analyses 
 
Deep Anterior Lamellar Corneal Graft 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Graft type   
   Big bubble 371 (24%) 244 (26%) 
   Melles 443 (29%) 156 (17%) 
   Not advised 717 (47%) 521 (57%) 
   
The Centre effect   
  Fewer than 30 registered DALK 463 (30%) 304 (33%) 
  Surgeon M 422 (28%) 109 (12%) 
  Surgeon N 101 (7%) 79 (9%) 
  Surgeon B 95 (6%) 87 (9%) 
  Surgeon V 76 (5%) 53 (6%) 
  Surgeon C 74 (5%) 52 (6%) 
  Surgeon X 64 (4%) 52 (6%) 
  Surgeon Z 56 (4%) 35 (4%) 
  Surgeon L 51 (3%) 43 (5%) 
  Surgeon K 47 (3%) 40 (4%) 
  Surgeon J 46 (2%) 40 (4%) 
  Surgeon H 36 (2%) 27 (3%) 
   
Total 1531 (100%) 921(100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each category 
showed no significant differences.  
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Table 5.7 shows the number of grafts within each of the variable sub-groups, for the 
surgeon and surgery factors found to be non-significant in univariate analyses. The sum 
for each variable equals the total number of grafts (1,531 registered and 921 with follow-
up provided) and the percentages, summed vertically, total 100. The result of the Kaplan-
Meier survival analyses are also provided. 
Table 5.7 Surgery and surgeon factors, not significant in univariate analyses 
 
Deep Anterior Lamellar Corneal Graft 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Graft size   
  Less than 8.0 mm 169 (11%) 109 (12%) 
  8.0 mm to <8.25 mm 286 (19%) 192 (21%) 
  8.25 mm to <8.5 mm 303 (20%) 224 (24%) 
  8.5 mm to <8.75mm 204 (13%) 112 (12%) 
  8.75 mm or more 463 (30%) 199 (22%) 
  Not advised 106 (7%) 85 (9%) 
Chi²=7.86, df=4, p=0.097   
   
Surgeon volume   
  Fewer than 30 registered DALK 463 (30%) 304 (33%) 
  30+ registered DALK 1068 (70%) 617 (67%) 
Chi²=0.235, df=1, p=0.628   
   
Total 1531 (100%) 921(100%) 
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5.4.1 DALK survival: influence of graft type 
 
Two different techniques are frequently employed by surgeons to perform DALK grafts. 
Surgeons have been asked to indicate whether they utilise the “Melles” manual dissection 
technique, or the “Big Bubble” technique introduced by Anwar and Teichman. This 
information is not always provided. The overall comparison of the three groups was 
significant (Log Rank Statistic=8.64; df=2; p=0.013) and is shown in Figure 5.4.1. 
A significant difference was found in the outcomes from the two different techniques (Log 
Rank Statistic=6.15; df=1; p=0.013) and grafts where the technique used was not 
specified exhibited significantly better survival than “Melles” dissection (p=0.008). This 
variable was not retained in the final multivariate model (see section 5.7), suggesting that 
this is not an independent factor significantly affecting graft survival. 
Figure 5.4.1 Type of graft 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
Big bubble 207 129 17 1 NA NA 
Melles dissection 116 57 11 1 NA NA 
Not specified 446 298 147 63 16 7 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Big bubble 0.94 0.93 NA NA 
Melles dissection 0.92 0.89 NA NA 
Not specified 0.95 0.92 0.85 0.79 
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5.4.2 DALK survival: influence of the Centre effect 
 
Figure 5.4.2 shows the comparison of graft survival for individual surgeons (shown in 
random order) who had 30 or more deep anterior lamellar keratoplasties registered with 
the ACGR, and all other grafts (performed by 72 surgeons) combined (Log Rank 
Statistic=42.91; df=11; p<0.001). This analysis indicates that there was a significant 
Centre effect. This variable was retained in the final multivariate model (see section 5.7), 
suggesting that this is an independent factor significantly affecting graft survival. 
Figure 5.4.2 The Centre effect 
 
 
Note: To preserve anonymity, surgeons have been identified using random letters of the 
alphabet. These identifying letters do not correspond with those used in chapters 
reporting on other types of graft, i.e. Surgeon X in this chapter is not the same surgeon 
identified as Surgeon X in the chapter on Descemet’s stripping (automated) endothelial 
keratoplasty.  
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Number at risk (years post-graft) 
 
1 2 4 6 8 10 
<30 DALK registered 246 161 45 17 3 1 
Surgeon M 78 32 7 2 1 NA 
Surgeon N 62 38 16 4 1 NA 
Surgeon B 76 50 19 8 2 NA 
Surgeon V 51 37 15 7 4 2 
Surgeon C 48 30 11 3 NA NA 
Surgeon X 46 35 18 2 NA NA 
Surgeon Z 31 18 5 3 1 1 
Surgeon L 37 21 8 6 NA NA 
Surgeon K 36 27 16 9 1 1 
Surgeon J 32 20 6 NA NA NA 
Surgeon H 26 15 9 4 3 2 
 
Probability of graft survival (years post-graft) 
 
1 2 4 
<30 DALK registered 0.93 0.93 0.82 
Surgeon M 0.90 0.81 NA 
Surgeon N 0.92 0.86 NA 
Surgeon B 0.94 0.91 NA 
Surgeon V 0.98 0.98 NA 
Surgeon C 1.00 0.97 NA 
Surgeon X 0.94 0.90 NA 
Surgeon Z 0.90 NA NA 
Surgeon L 0.98 0.98 NA 
Surgeon K 0.95 0.95 NA 
Surgeon J 0.95 0.95 NA 
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5.5 Operative procedures at the time of graft 
 
Only one DALK had an anterior vitrectomy at the time of graft and four had a peripheral 
iridectomy. Thus, these factors were not further analysed. 
5.6 Post-graft Events 
 
Table 5.8 shows the occurrence of post-graft events, which were found to be significant 
in univariate analyses.  
Table 5.8 Post-graft events, significant in univariate analyses 
 
Deep Anterior Lamellar Corneal Graft 
Post-graft Events 
 
 Registered (%) Followed (%) 
Post-graft neovascularisation   
  No 1470 (96%) 860 (93%) 
  Yes 61 (4%) 61 (7%) 
   
Total 1531 (100 %) 921 (100 %) 
   
 
Table 5.9 shows the number of grafts within each of the variable sub-groups, for the post-
graft events found to be non-significant in univariate analyses. The sum for each 
variable equals the total number of grafts (1,531 registered and 921 with follow-up 
provided) and the percentages, summed vertically, total 100. The result of the Kaplan-
Meier survival analysis is also provided. Only six DALK had post-graft herpetic infection, 
15 had microbial keratitis, one had synechia, and four had uveitis reported. Thus, these 
factors were not further analysed. Please note: post-graft data may be incomplete when 
follow-up is based on a registration for a replacement graft. 
Table 5.9 Post-graft events, not significant in univariate analyses 
 
Deep Anterior Lamellar Corneal Graft 
Post-graft Events 
 
 Registered (%) Followed (%) 
Post-graft rise in IOP   
  No 1469 (96%) 859 (93%) 
  Yes 62 (4%) 62 (7%) 
Chi²=1.71, df=1, p=0.191   
   
At least one rejection episode   
  No 1476 (96%) 866 (94%) 
  Yes 55 (4%) 55 (6%) 
Chi²=0.07, df=1, p=0.792   
   
Time to removal of sutures   
  Within 6-months post-graft 24 (2%) 24 (3%) 
  Between 6 and 12 months post-graft 103 (7%) 103 (11%) 
  Between 1 and 2-years post-graft 194 (13%) 194 (21%) 
  More than 2-years post-graft 44 (3%) 44 (5%) 
  Not yet removed/not advised 1166 (76%) 556 (60%) 
Chi²=0.21, df=3, p=0.976   
   
Total 1531 (100 %) 921 (100 %) 
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Table 5.10 shows post-graft surgical procedures, as reported by follow-up practitioners. 
Please note: post-graft data may be incomplete when follow-up is based on a registration 
for a replacement graft. 
Table 5.10 Post-graft surgical procedures 
91 DALK were reported to have undergone a re-grafting procedure (separate to 
subsequent concurrent graft/s) at the date last seen. Of these 74 had not had additional 
post-graft operative procedures reported, while 17 had. 
 
 
Deep Anterior Lamellar Corneal Graft 
Post-Graft Surgical Procedures 
 
Type of procedure Number 
  
Cataract removal/IOL insertion (87 both, 2 cataract only, 2 IOL only) 91 
IOL exchange/reposition/piggyback lens 7 
Wound repair/resutured 49 
PRK laser 29 
YAG laser 19 
Suture adjustment 17 
Keratectomy 9 
Relaxing incision 9 
Intravitreal injection(s) 9 
LASIK 7 
Tarsorrhaphy 7 
Air bubble 6 
Other* 44 
  
Total number of surgical procedures (number of grafts) 303 (277) 
  
 
* Other included: additional concurrent graft (4), keratotomy (4), compression sutures (4), 
wedge resection (4), vitrectomy (4), retinal detachment surgery (3), corneal cross-linking 
(2), corneal laser regularisation (2), cryotherapy (2), removal of cyst (2), removal of 
folds/wrinkles in membrane (2), trabeculectomy (2), Baerveldt tube inserted (1), chalazion 
removal (1), corneal diathermy (1), creation of flaps for glaucoma (1), drainage of double 
anterior chamber (1), ectropion repair (1), entropion surgery (1), epithelial debridement 
(1), evisceration (1), fine needling (1), graft rotation (1), intraocular contact lens inserted 
(1), iridotomy (1), lash epilation (1), limbal renal lever (1), membrane peel (1), non-
specified glaucoma drainage device inserted (1), paracentesis (1), periotomy (1), 
pterygium repair (1), ptosis surgery (1), removal of interface fluid (1), removal of foreign 
body (1), removal of Kerarings (1), removal of limbal lesion (1), removal of silicone oil (1), 
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5.6.1 DALK survival: influence of post-graft corneal neovascularisation 
 
Figure 5.6.1 shows the survival for grafts where post-graft corneal neovascularisation was 
reported, compared to those that did not have any post-graft corneal neovascularisation. 
A significant difference was found between groups (Log Rank Statistic=21.76; df=1; 
p<0.001). This variable was retained in the final multivariate model, suggesting that this 
is an independent factor significantly affecting graft survival. 
Figure 5.6.1 Post-graft corneal neovascularisation 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
No neovascularisation 722 450 163 63 16 7 
Neovascularisation 47 34 12 2 NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
No neovascularisation 0.95 0.92 0.87 0.79 
Neovascularisation 0.85 0.83 NA NA 
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5.7 Multivariate Analysis 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all other variables in the model. This analysis was 
performed using STATA version 11. 
In the preceding univariate analyses, each registered DALK, together with its archival 
follow-up records, was treated as a separate and independent entity. Some recipients 
had multiple DALK performed during the census period (up to 31/7/2017), with some 
having repeat grafts in a single eye, some grafts in both eyes and some a combination of 
both. To control for potential inter-graft and/or inter-eye dependence in the multivariate 
analyses, the multivariate model was adjusted to allow for clustering by individual patient 
[see references 7 & 8]. 
Variables to be included in the Cox Proportional Hazards regression model were identified 
based on the results of the univariate Kaplan-Meier analyses, with a cut-off significance 
level of p<0.08 used to select variables for inclusion. Some variables that were found to 
be significant in the univariate analyses were omitted due to co-linearity, or because of 
large amounts of missing data (>50%). Where data were missing for 1% to 50% of cases, 
additional groups for each if these categorical variables were created, called “not 
advised”. Each variable was initially analysed individually to determine if it remained 
significant once clustered by individual patient. Where the variable was no longer found 
to be significant (p>0.08), it was excluded from the multivariate analysis. 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in a 
stepwise manner, beginning with the least significant variable. For categorical variables 
with more than two groups, Bonferroni adjustment was applied to determine if significant 
differences were present between groups. The Kaplan-Meier plots, and additional 
appropriate STATA analyses, were used to assess whether each included variable met 
the assumption of proportional hazards. Where variables were found to be time-variant, 
they were treated as such in the multivariate model.  
Table 5.11 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained 
in the final model.  
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Table 5.11 Multivariate model 
 
Deep Anterior Lamellar Corneal Graft 
Multivariate Model 
 
Not significant in univariate analysis 
Donor sex 
Donor age group 
Cause of donor death 
Multi-organ donor 
Storage medium 
Time from death to enucleation 
Time from enucleation to storage 
Storage time in Optisol 
Endothelial cell density 
Australian State where graft was performed 
Interstate transportation 
Recipient sex 
Donor/recipient sex match/mismatch 
Eye grafted 
Graft size 
Previous contralateral graft(s) 
Surgeon experience and level of follow-up 
Raised intraocular pressure post-graft 
Post-graft rejection episode(s) 
Time to removal of sutures 
 
Significant in univariate analysis but excluded from the multivariate model 
due to missing data 
Storage time in organ culture* 
 
Significant in univariate analysis but not retained in the multivariate model 
Indication for graft 
Change in lens status pre- to post-graft 
Type of DALK 
 
Significant in univariate analysis AND retained in the multivariate model 
    Recipient age group 
Pre-graft neovascularisation 
Pre-graft inflammation and/or steroid use 
Graft era 
The Centre effect 
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Table 5.12 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The group of each categorical variable with the highest 
number of cases was taken as the referent. The hazard ratios for a given variable are 
adjusted for all other variables in the model. This model included data from the 1,517 
deep anterior lamellar keratoplasties, performed in 1,382 recipients, for whom there were 
valid responses for each of the included variables (14 cases were excluded as their pre-
graft inflammation and/or steroid use status was unknown). 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, 
a global test was applied to calculate the overall p-value. The overall model was highly 
significant: (Chi²=156.80, p<0.0001).  
Table 5.12 Clustered multivariate model 
 
Deep Anterior Lamellar Corneal Graft 















Recipient age group 
Under 60 years 1343 1.00   0.016  
60 years to 69 years 97 1.16 0.31 0.590  0.68 - 1.95 
70 years or older 77 2.60 0.86 0.004  1.36 - 4.99 
       
Pre-graft inflammation and/or steroid use (tvc) 
No 1384 1.00     
Yes 133 3.24 1.11 0.001  1.65 - 6.35 
 
Pre-graft corneal neovascularisation 
None or one quadrant 1413 1.00     
More than one quadrant 104 2.13 0.60 0.008  1.22 - 3.71 
       
Graft era 
2000-2004 35 0.58 0.39 0.347  0.18 - 1.82 
2005-2009 359 0.85 0.21 0.499  0.53 - 1.37 
2010-2014 796 1.00   0.025  
2015-2017 327 2.37 0.77 0.008  1.25 - 4.48 
 
Individual surgeon 
< 30 DALK registered 461 1.00     
Other surgeons (lowest HR  








<0.001 0.03 - 1.69 
1.78 - 5.34 
       
Post-graft corneal neovascularisation 
No 1457 1.00     
Yes 60 1.79 0.50 0.037  1.04 - 3.08 
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5.7.1 Significant differences in the deep anterior lamellar keratoplasty multivariate 
model for categories with more than two groups following Bonferroni 
correction for multiple comparisons 
 
5.7.1.1 Recipient age group 
 
Grafts performed in recipients aged 70 years or older had significantly poorer survival 
than those performed in recipients aged 60 to 69 (p=0.035) or under 60 years or age 
(p=0.004). 
 
5.7.1.2 Graft era  
 
Grafts survival was significantly poorer for the most recent grafts, performed between 
2015 and 2017, compared to all other eras (p=0.030, p=0.005, and p=0.008, 
respectively). The poor performance of grafts in this category is likely due to the lag time 
effect discussed in section 2.3.1.  
 
5.7.1.3 The Centre effect 
 
Individual results varied widely for surgeons with 30 or more DALK registered with the 
ACGR compared to the balance of the database (DALK performed by surgeons with 
fewer than 30 registered DALK). The hazard ratios ranged from 0.23 to 3.08. 
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5.8 Reasons for Graft Failure 
 
Of the 921 followed grafts, 113 (12%) were known to have failed by the census date. This 
equates to 7% of the 1,531 registered grafts. Surgeons were asked to indicate the reason 
for graft failure. This information was also gathered from repeat registration forms, where 
the reason for failure of the previous graft was provided. Table 5.13 shows the reasons 
for failure specified.  
Table 5.13 Reasons for graft failure 
 
Deep Anterior Lamellar Corneal Graft 
Reasons for Graft Failure 
 
  Scarring  14 (12%) 
  Primary graft failure 14 (12%) 
  Non herpetic infection 13 (12%) 
  Astigmatism 10 (9%) 
  Corneal ulcer 7 (6%) 
  Endothelial cell failure 6 (5%) 
  Trauma 5 (4%) 
  Other specified* 21 (19%) 
  Unspecified 23 (20%) 
  
Total 113 (100%) 
  
 
*Other included: vascularisation (4), herpetic infection (3), lattice dystrophy (3), corneal 
melt (2), rejection (2), Descemet’s detachment (1), exposure keratopathy (1), granular 
dystrophy (1), inflammation (1), lipid keratopathy (1), recurrent Reis Buckler dystophy (1), 
unspecified dystrophy (1). 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. For lamellar procedures, primary graft failure is recorded as reported by 
surgeons. Additional information is collected to ascertain whether this occurred within 28 
days of the graft. Where surgeons indicate that the failure was due to surgical 
complications, this is also recorded. 
Of the 14 grafts reported by surgeons to have been primary graft failures, in nine cases 
no further information was provided. Specific reasons given in the remaining five were: 
Descemet’s detachment (1), Descemet’s rupture (1), fungal keratitis (1), oedema (1) and 
residual opacity (1). 
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5.9 Post-graft Changes in Best Corrected Visual Acuity 
 
5.9.1 All indications for graft 
 
Post-graft best corrected visual acuity (BCVA) is an important outcome for corneal graft 
recipients. A desire for improved visual acuity was specified as a reason for graft in 1,429 
(93%) of registered deep anterior lamellar keratoplasties. In 92% of cases (1,411), this 
was the sole desired outcome indicated. It is likely that this was also at least part of the 
reason for graft in some of the further 70 (5%) grafts where no reason was specified.  
Follow-ups occur at varying times post-graft, depending on when a surgeon sees a 
recipient. Where post-graft best corrected visual acuity (without pinhole) information was 
provided, we categorised this according to the length of time since graft. The first two 
categories were: 
• BCVA provided at between 6 and 12 months post-graft, and 
• BCVA provided at between 12 and 18 months post-graft. 
Subsequent groups were at yearly intervals. For each year point, any measurements 
provided within 6-months of that date, rounded to the nearest day, were included (e.g. for 
2-year follow-up, any BCVA given at between 730 and 913 days post-graft was included). 
We analysed post-graft best corrected visual acuity in several ways. Where more than 20 
grafts had VA measurements provided, we examined: 
1. The percentage of surviving grafts achieving different levels of Snellen visual 
acuity (6/6 or better, 6/7.5 to 6/12, 6/15 to 6/24, 6/36 to 6/60, count fingers (CF) 
or hand movements (HM), and light perception (LP) or no light perception 
(NLP)) at yearly time-points post-graft. Grafts that had been reported to have 
failed at the time of last follow-up, but had prior follow-ups with BCVA 
measurements provided when the graft was surviving, had these prior data 
included in these analyses.  
2. The average Snellen visual acuity achieved at yearly intervals post-graft, again 
by surviving grafts. 
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Table 5.14 and Figure 5.9.1 show the reported post-graft best corrected visual acuity for 
all failed grafts at the time of last follow-up, separated by indication for graft. Visual acuity 
at time of failure was reported for 90 (80%) of 113 failed DALK. As might be expected, 
the majority of failed grafts had accompanying poor visual acuity. 
Table 5.14 Post-graft best corrected visual acuity 
 
Deep Anterior Lamellar Keratoplasty:  











CF or HM LP or NLP 
Failed previous graft 0 (0%) 0 (0%) 2 (15%) 5 (38%) 4 (31%) 2 (15%) 
Keratoconus 0 (0%) 4 (8%) 7 (14%) 13 (25%) 24 (47%) 3 (6%) 
Herpetic eye disease 0 (0%) 0 (0%) 0 (0%) 1 (8%) 11 (92%) 0 (0%) 
Corneal degeneration 0 (0%) 0 (0%) 0 (0%) 2 (40%) 3 (60%) 0 (0%) 
Corneal dystrophy 0 (0%) 0 (0%) 2 (50%) 1 (25%) 1 (25%) 0 (0%) 
Corneal scars & opacity 0 (0%) 0 (0%) 1 (50%) 0 (0%) 1 (50%) 0 (0%) 
Non-herpetic infection 0 (0%) 0 (0%) 3 (33%) 1 (11%) 3 (33%) 2 (22%) 
Other specified 0 (0%) 1 (25%) 0 (0%) 2 (50%) 1 (25%) 0 (0%) 
Total 0 (0%) 5 (5%) 15 (15%) 25 (25%) 48 (48%) 7 (7%) 
       
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
 
Figure 5.9.1 Best corrected visual acuity at time of last follow-up for failed deep 
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Figure 5.9.2 shows the best corrected visual acuity in the grafted eye, as reported to the 
ACGR, and categorised into six levels of vision, for all surviving deep anterior lamellar 
keratoplasties. Prior to graft over half of eyes (52%) had vision of CF or worse, with 
another quarter (27%) having 6/36 to 6/60. By 6-months post-graft, almost three-quarters 
(71%) of eyes with surviving grafts had vision of 6/24 or better, with almost half (47%) 
having functional vision of 6/12 or better by 12-months post-graft. Similar patterns could 
be seen for surviving grafts followed for up to 5-years post-graft.  
 
Figure 5.9.2 Best corrected visual acuity for deep anterior lamellar keratoplasties, 
surviving at time of measurement 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
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5.9.2 Individual indications for graft 
 
The only indication for graft with sufficient data to examine the visual outcomes 
individually was keratoconus. Figure 5.9.3 shows levels of best corrected visual acuity 
reported to the ACGR, at yearly intervals for surviving deep anterior lamellar 
keratoplasties for keratoconus. Approximately three-quarters of grafts had visual acuity 
of 6/24 or better by 6-months post-graft. This percentage remained consistent up to 4-
years post-graft. Post-graft vision of 6/12 or better was reported in the just over half (53%) 
of surviving deep anterior lamellar keratoplasties for keratoconus that had BCVA 
measurements reported between 12 and 18-months post-graft. This percentage was also 
maintained up to 4-years post-graft. 
 
Figure 5.9.3 Keratoconus: level of best corrected visual acuity reported at yearly 
time points for surviving grafts 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
  
Traditional Lamellar Keratoplasty 
232 Australian Corneal Graft Registry Report 2018 
  
 
Traditional Lamellar Keratoplasty 
233 Australian Corneal Graft Registry Report 2018 
6 Traditional Lamellar Keratoplasty 
 
This chapter presents the results of analyses conducted on data relating to the 1,495 
traditional lamellar keratoplasties (TLK) registered with the ACGR. These are all the 
lamellar grafts registered with the ACGR that are not deep anterior lamellar keratoplasties 
or endothelial keratoplasties. Kaplan-Meier survival analyses were conducted using IBM 
SPSS for Windows (Version 22.0), to compare the graft survival across groups for a range 
of variables relating to the corneal donor, graft recipient, surgical procedure, surgeon, and 
follow-up care. 
6.1 Donor and Eye Banking Factors 
 
Table 6.1 shows the number of grafts within each of the variable sub-groups, for the donor 
factors found to be significant in univariate analyses. The sum of these numbers for each 
variable equals the total number of grafts (1,495 registered and 1,114 followed) and the 
percentages, which should be summed vertically for each variable, total 100. 
Table 6.1 Donor and eye banking factors, significant in univariate analyses 
 
Traditional Lamellar Corneal Grafts 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Eye bank   
  Eye bank M 824 (55%) 605 (54%) 
  Eye bank K 200 (13%) 146 (13%) 
  Eye bank V 160 (11%) 121 (11%) 
  Eye bank J 132 (9%) 82 (7%) 
  Eye bank N 129 (9%) 115 (10%) 
  Not advised 50 (3%) 45 (4%) 
   
Storage medium   
  Optisol 378 (25%) 266 (24%) 
  Organ culture 140 (9%) 75 (7%) 
  Moist pot 757 (51%) 588 (53%) 
  Superseded media 200 (13%) 167 (15%) 
  Not advised 20 (1%) 18 (2%) 
   
Total 1495 (100%) 1114 (100%) 
   
 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
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Comparisons between the percentages of grafts registered and followed in each category 
were examined using Chi² analyses. Likelihood of follow-up was significantly less likely 
(p<0.001) for grafts from Eye bank J and grafts stored in organ culture.  
Table 6.2 shows the number of grafts within each of the variable sub-groups, for the donor 
and eye banking factors found to be non-significant in univariate analyses. The sum for 
each variable equals the total number of grafts (1,495 registered and 1,114 with follow-
up provided) and the percentages, summed vertically for each variable, total 100. The 
result of the Kaplan-Meier survival analysis is also provided for each variable.  
Table 6.2 Donor and eye banking factors, not significant in univariate analysis 
 
Traditional Lamellar Corneal Grafts 
Donor and Eye Banking Factors 
 
 Registered (%) Followed (%) 
Death-to-enucleation time   
  ≤ 3 hours 178 (12%) 136 (12%) 
  4 to 6 hours 306 (20%) 236 (21%) 
  7 to 9 hours 338 (23%) 255 (23%) 
  10 to 12 hours 301 (20%) 234 (21%) 
  13 to 15 hours 163 (11%) 114 (10%) 
  16 to 18 hours 82 (5%) 55 (5%) 
  ≥ 18 hours 84 (6%) 46 (4%) 
  Not advised 43 (3%) 38 (3%) 
Chi²=5.74, df=6, p=0.453   
   
Enucleation-to-storage time   
  ≤ 3 hours 766 (51%) 571 (51%) 
  4 to 6 hours 149 (10%) 108 (10%) 
  7 to 12 hours 74 (5%) 60 (5%) 
  ≥ 13 hours 56 (4%) 41 (4%) 
  Not advised 450 (30%) 334 (30%) 
Chi²=1.98, df=3, p=0.578   
   
Storage-to-graft time - hypothermic   
  Within 5 days 214 (14%) 169 (15%) 
  6 to 7 days 64 (4%) 47 (4%) 
  More than a week 157 (11%) 115 (10%) 
  Not advised 937 (63%) 694 (62%) 
  Not applicable 123 (8%) 89 (8%) 
Chi²=1.82, df=2, p=0.403   
   
Storage-to-graft time - organ 
culture 
  
  Within 2 weeks 36 (2%) 22 (2%) 
  2 to 3 weeks 40 (3%) 19 (2%) 
  More than 3 weeks 33 (2%) 17 (2%) 
  Not advised 31 (2%) 17 (2%) 
  Not applicable 1355 (91%) 1039 (93%) 
Chi²=3.97, df=2, p=0.138   
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 Registered (%) Followed (%) 
Death-to-graft time - moist pot   
  Within 48 hours 86 (6%) 71 (6%) 
  2 to 7 days 136 (9%) 109 (10%) 
  8 to 14 days 107 (7%) 90 (8%) 
  More than 2 weeks 203 (14%) 149 (13%) 
  Not advised 225 (15%) 169 (15%) 
  Not applicable 738 (49%) 526 (47%) 
Chi²=3.12, df=3, p=0.373   
   
Sex of donor   
  Female 620 (41%) 459 (41%) 
  Male 828 (55%) 612 (55%) 
  Not Advised 47 (3%) 43 (3%) 
Chi²=0.21, df=1, p=0.650   
   
Age group   
  Under 50 years 159 (11%) 121 (11%) 
  50 to 59 years 181 (12%) 126 (11%) 
  60 to 69 years 381 (25%) 282 (25%) 
  70 to 79 years 478 (32%) 355 (32%) 
  80 years or older 262 (18%) 200 (18%) 
  Not advised 34 (2%) 30 (3%) 
Chi²=6.86, df=4, p=0.144   
   
Cause of death   
  Cardiac event 513 (34%) 384 (34%) 
  Malignancy 351 (23%) 266 (24%) 
  Trauma 86 (6%) 64 (6%) 
  Respiratory event 158 (11%) 121 (11%) 
  Intracranial/cerebral haemorrhage 237 (16%) 170 (15%) 
  Other specified 66 (4%) 49 (4%) 
  Not advised* 84 (6%) 60 (5%) 
Chi²=6.40, df=5, p=0.269   
   
Multi-organ donor status   
  No 1408 (94%) 1056 (95%) 
  Yes 87 (6%) 58 (5%) 
Chi²=0.02, df=1, p=0.876   
   
Central corneal endothelial cell density 
  <2500 cells/mm² 41 (3%) 25 (2%) 
  2500 to 2749 cells/mm² 46 (3%) 25 (2%) 
  2750 to 2999 cells/mm² 39 (3%) 18 (2%) 
  ≥ 3000 cells/mm² 49 (3%) 31 (3%) 
  Not advised 1320 (88%) 1015 (91%) 
Chi²=4.49, df=3, p=0.213   
   
Total 1495 (100%) 1114 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not advised or not applicable. 
 
* ACGR advised that cause of death was not yet determined but there were no medical contraindications and the eye 
had been cleared for release, by the Medical Director, in accordance with EBAANZ guidelines. 
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6.1.1 Traditional lamellar graft survival: influence of Australian eye bank 
 
Donor corneas are retrieved, processed, stored and distributed by five eye banks around 
Australia. Figure 6.1.1 shows the comparison of graft survival for corneas provided by 
each of these eye banks. Data were not available for 1 case.  A significant difference was 
found across eye banks (Log Rank Statistic=30.20; df=4; p<0.001), with grafts performed 
using tissue from Eye Bank M having better survival than those using tissue from Eye 
Bank K or Eye Bank V (both p<0.001), and grafts performed using tissue from Eye Bank 
N having better survival than those using tissue from Eye Bank V (p=0.001). This variable 
was not retained in the multivariate analysis (see section 6.7), suggesting that this is not 
an independent factor significantly affecting graft survival. 
Figure 6.1.1 Australian eye bank 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
Eye bank M 385 268 138 74 48 22 13 
Eye bank K 94 62 35 20 10 5 3 
Eye bank V 58 40 16 6 3 1 NA 
Eye bank J 52 33 22 15 9 7 4 
Eye bank N 72 45 28 15 9 8 4 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 
Eye bank M 0.86 0.82 0.77 0.68 0.66 0.52 
Eye bank K 0.79 0.70 0.60 0.51 NA NA 
Eye bank V 0.68 0.63 0.56 NA NA NA 
Eye bank J 0.80 0.72 0.67 NA NA NA 
Eye bank N 0.89 0.80 0.74 NA NA NA 
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6.1.2 Traditional lamellar graft survival: influence of modern corneal storage 
media 
 
In Australia, two storage media are currently commonly used to preserve donor corneas 
prior to transplantation. Further details of these storage media can be found in Section 
2.1.3 of this report. A third storage technique, in which the donor eye is stored in a moist 
pot, is also still used occasionally, particularly for donor tissue to be used in a traditional 
lamellar graft. Data were not analysed for 20 donor corneas for which the eye bank did 
not specify the medium used.  
Figure 6.1.2 shows the comparison of graft survival for corneas stored in hypothermic 
medium compared to organ culture medium and moist pot. A significant difference was 
found between media (Log Rank Statistic=19.75; df=2; p<0.001), with those stored in 
moist pot having better survival than the other two groups (both p<0.001). This variable 
was not retained in the multivariate analysis (see section 6.7), suggesting that this is not 
an independent factor significantly affecting graft survival. 
Figure 6.1.2 Modern corneal storage media 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
Organ culture 44 30 9 3 1 NA NA 
Hypothermic 256 167 92 53 33 22 13 
Moist pot 366 253 140 75 50 23 14 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 
Organ culture 0.71 0.66 NA NA NA NA 
Hypothermic 0.81 0.73 0.65 0.59 0.55 0.49 
Moist pot 0.86 0.82 0.77 0.67 0.67 0.56 
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6.2 Recipient Factors 
 
Table 6.3 shows the number of grafts within each of the variable sub-groups, for the 
recipient factors examined in this report that were found to be significant predictors of 
graft survival in univariate analyses. The sum of these numbers for each variable equals 
the total number of grafts (1,495 registered and 1,114 followed) and the percentages, 
which should be summed vertically for each variable, total 100. 
Table 6.3 Recipient factors, significant in univariate analysis 
 
Traditional Lamellar Corneal Grafts 
Recipient Factors 
 
 Registered (%) Followed (%) 
Indication for graft   
  Failed previous 221 (15%) 160 (14%) 
  Keratoconus 105 (7%) 71 (6%) 
  Corneal scars and opacities 29 (2%) 20 (2%) 
  Corneal ulcer/perforation 190 (13%) 130 (12%) 
  Herpetic eye disease 63 (4%) 50 (4%) 
  Trauma 70 (5%) 51 (5%) 
  Non herpetic infections 50 (3%) 41 (4%) 
  Corneal degenerations 73 (5%) 57 (5%) 
  Descemetocoele 31 (2%) 22 (2%) 
  Pterygium 234 (16%) 202 (18%) 
  Scleral necrosis 200 (13%) 149 (13%) 
  Limbal dermoid 72 (5%) 56 (5%) 
  Cancer 42 (3%) 30 (3%) 
  Glaucoma 29 (2%) 12 (1%) 
  Other* 86 (6%) 63 (6%) 
   
Australian State where graft was performed   
  State M 828 (55%) 609 (55%) 
  State K 188 (13%) 133 (12%) 
  State V 151 (10%) 115 (10%) 
  State J 155 (10%) 99 (9%) 
  State N 120 (8%) 106 (10%) 
  State C 52 (3%) 51 (5%) 
  Other 1 (<1%) 1 (<1%) 
   
Interstate transportation   
  Yes 84 (6%) 73 (7%) 
  No 1361 (91%) 996 (89%) 
  Not advised 50 (3%) 45 (4%) 
   
Recipient age group   
  Under 20 years 111 (7%) 88 (8%) 
  20 to 29 years 108 (7%) 82 (7%) 
  30 to 39 years 149 (10%) 123 (11%) 
  40 to 49 years 161 (11%) 123 (11%) 
  50 to 59 years 195 (13%) 151 (14%) 
  60 to 69 years 250 (17%) 185 (17%) 
  70 to 79 years 315 (21%) 229 (21%) 
  80 years or older 206 (14%) 133 (12%) 
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 Registered (%) Followed (%) 
Change in lens status pre- to post-graft   
  Phakic/phakic 1150 (77%) 882 (79%) 
  Other 345 (23%) 232 (21%) 
   
Pre-graft neovascularisation   
  None 988 (66%) 712 (64%) 
  One quadrant 130 (9%) 95 (9%) 
  Two quadrants 171 (11%) 139 (12%) 
  Three quadrants 63 (4%) 55 (5%) 
  Four quadrants 143 (10%) 113 (10%) 
   
Pre-graft inflammation and/or steroid use   
  No 831 (56%) 617 (55%) 
  Yes 602 (40%) 452 (41%) 
  Not advised 62 (4%) 45(4%) 
   
History of raised intraocular pressure   
  No 1341 (90%) 1013 (91%) 
  Yes 154 (10%) 101 (9%) 
   
Prior existing contralateral graft/s   
  None 1366 (91%) 1018 (91%) 
  One 94 (6%) 73 (7%) 
  Two or more 35 (2%) 23 (2%) 
   
Total 1495 (100%) 1114 (100%) 
   
 
*Other included: wound dehiscence (19), corneal dystrophy (15), pseudophakic bullous 
keratopathy (8), scleromalacia (7), interstitial keratitis (4), keratoglobus (4), lipid 
keratopathy (4), band keratopathy (3), not advised (3), amyloidosis (2), ectodermal 
dysplasia (2), scleral fistula (2), aniridic keratopathy (1), aphakia (1), atopic 
keratoconjunctivitis (1), autograft repair (1), congenital cataract (1), epithelial defect (1), 
Goldenhar’s syndrome (1), limbal stem cell failure (1), ocular sarcoidosis (1), reticular 
pigmentary disorder (1), rosacea (1), Sjogren’s syndrome (1), Stevens Johnson 
syndrome (1). 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. 
Follow-up was significantly more likely (p<0.05) to have been received for grafts 
performed with tissue transported interstate, in recipients who remained phakic post-graft, 
those with no history of raised intraocular pressure, and those with pre-graft corneal 
neovascularisation. Significant differences in follow-up were also found across groups for 
recipient State, recipient age, and indication for graft. 
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Table 6.4 shows the number of grafts within each of the variable sub-groups, for the 
recipient factor found to be non-significant in univariate analyses. The sum for each 
variable equals the total number of grafts (1,495 registered and 1,114 with follow-up 
provided) and the percentages, summed vertically, total 100. The result of the Kaplan-
Meier survival analysis is also provided. 
Table 6.4 Recipient factors, not significant in univariate analysis 
 
Traditional Lamellar Corneal Grafts 
Recipient Factors 
 
 Registered (%) Followed (%) 
Recipient sex   
  Female 596 (40%) 447 (40%) 
  Male 899 (60%) 667 (60%) 
Chi²=2.69, df=1, p=0.101   
   
Donor/recipient sex match/mismatch   
  Female/female 255 (17%) 190 (17%) 
  Female/male 365 (24%) 269 (24%) 
  Male/female 322 (22%) 241 (22%) 
  Male/male 506 (34%) 371 (33%) 
  Not advised 47 (3%) 43 (4%) 
Chi²=2.43, df=3, p=0.489   
   
Eye in which graft was performed   
  Left 771 (52%) 577 (52%) 
  Right 723 (48%) 536 (48%) 
  Not advised 1 (<1%) 1 (<1%) 
Chi²=0.13, df=1, p=0.715   
   
Total 1495 (100%) 1114 (100%) 
   
Note: Kaplan-Meier analyses did not include grafts where categorisation was not advised. 
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6.2.1 Traditional lamellar graft survival: influence of indication for graft 
 
Figure 6.2.1 shows the comparison of graft survival depending on indication for graft. All 
repeat grafts were analysed together, regardless of original pathology. A significant 
difference was found across groups (Log Rank Statistic=159.57; df=14; p<0.001). Grafts 
performed for herpetic eye disease had significantly poorer survival than those performed 
for keratoconus, trauma, corneal degenerations, pterygium, scleral necrosis, or limbal 
dermoid (all p<0.001). Grafts performed for a failed previous graft, or corneal ulcer, had 
significantly poorer survival than those performed for keratoconus, trauma, pterygium, 
scleral necrosis, or limbal dermoid (all p<0.0005). Grafts performed for non-herpetic 
infections had significantly poorer survival than those performed for pterygium, scleral 
necrosis, or limbal dermoid (all p<0.0005).  
There was no significant difference (p=0.443) in the survival of grafts performed for any 
of the indications for graft for which fewer than 50 grafts had been registered (including 
those already classified as “other”) and so these groups were combined for the 
multivariate analysis. Survival of grafts performed in eyes with one previous graft (of any 
kind) and those performed in eyes with more than one previous graft (of any kind) was 
not significantly different (p=0.330). Indication for graft was retained in multivariate 
analysis (see section 6.7) suggesting that this is an independent factor significantly 
affecting graft survival. 
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Number at risk (years post-graft) 
 
1 2 4 6 8 10 
Failed previous graft 90 58 27 16 8 5 
Keratoconus 56 38 20 15 7 4 
Corneal scar/opacity 11 7 4 2 2 2 
Ulcer/perforation 63 34 17 11 5 1 
Herpetic eye disease 19 14 5 3 3 2 
Trauma 34 30 16 10 7 6 
Non-herpetic infection 26 18 12 4 3 1 
Corneal degeneration 41 25 17 8 5 4 
Descemetocoele 13 8 4 3 2 2 
Pterygium 127 85 47 32 24 12 
Scleral necrosis 92 65 41 21 14 8 
Limbal dermoid 44 29 15 7 3 1 
Cancer 19 13 7 5 NA NA 
Glaucoma 8 6 1 NA NA NA 
Other 44 38 19 7 6 2 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 
Failed previous graft 0.68 0.59 0.49 NA NA 
Keratoconus 0.91 0.80 0.73 NA NA 
Corneal scar/opacity NA NA NA NA NA 
Ulcer/perforation 0.68 0.57 NA NA NA 
Herpetic eye disease NA NA NA NA NA 
Trauma 0.87 0.87 NA NA NA 
Non-herpetic infection 0.77 NA NA NA NA 
Corneal degeneration 0.85 0.80 NA NA NA 
Descemetocoele NA NA NA NA NA 
Pterygium 0.93 0.91 0.91 0.88 0.88 
Scleral necrosis 0.94 0.90 0.88 0.75 NA 
Limbal dermoid 1.00 1.00 NA NA NA 
Cancer NA NA NA NA NA 
Glaucoma NA NA NA NA NA 
Other 0.85 0.83 NA NA NA 
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6.2.2 Traditional lamellar graft survival: influence of Australian State where graft 
was performed 
 
Figure 6.2.2 shows the comparison of graft survival depending on the Australian State in 
which the transplantation occurred. One graft was performed in the Northern Territory, 
and was excluded from the analysis. A significant difference was found across groups 
(Log Rank Statistic=33.08; df=5; p<0.001), with grafts performed in State M and State N 
having better survival than those performed in State V and State C (all p<0.001), and 
grafts performed in State K having better survival than those performed in state C 
(p=0.002). This variable was not retained in the multivariate analysis (see section 6.7), 
suggesting that this is not an independent factor significantly affecting graft survival. 
Figure 6.2.2 Australian State where graft was performed 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
State M 386 268 137 72 47 21 12 
State K 90 66 37 20 11 7 5 
State V 50 33 13 7 5 3 2 
State J 60 38 24 16 9 7 4 
State N 70 44 29 16 10 8 4 
State C 31 19 13 9 8 4 2 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 
State M 0.85 0.81 0.76 0.66 0.64 0.54 
State K 0.84 0.80 0.74 0.66 NA NA 
State V 0.67 0.61 NA NA NA NA 
State J 0.79 0.71 0.62 NA NA NA 
State N 0.90 0.81 0.74 NA NA NA 
State C 0.79 NA NA NA NA NA 
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6.2.3 Traditional lamellar graft survival: influence of interstate transportation 
 
In the majority of transplants, donor corneas are sourced in the same State as the surgery 
occurs, however, in some cases corneas are transported interstate via air freight. Figure 
6.2.3 shows the comparison of graft survival for grafts where the surgery was performed 
in the same State as the donor cornea was sourced, compared to those where the donor 
cornea was from interstate. The graft where donor State was not available was excluded 
from the analysis. A significant difference was found between groups (Log Rank 
Statistic=16.78; df=1; p<0.001). This variable was not retained in the multivariate analysis 
(see section 6.7), suggesting that this is not an independent factor significantly affecting 
graft survival. 
Figure 6.2.3 Interstate transportation 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
Different State 43 27 17 8 6 4 2 
Same State 619 421 222 122 73 39 22 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
Different State 0.74 0.58 NA NA NA NA NA 
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6.2.4 Traditional lamellar graft survival: influence of recipient age (years) 
 
Figure 6.2.4 shows the comparison of graft survival depending on the age of the corneal 
transplant recipient. Data for grafts where the recipient was aged under 20 years, and 
those where they were aged over 80 years, were all analysed together due to the low 
numbers in these groups. A significant difference was found across groups (Log Rank 
Statistic=22.84; df=7; p=0.002), with poorer survival for grafts performed in recipients 
aged 80 years or older compared to those aged under 20 years, 30 to 39 years and 60 to 
69 years (all p<0.001). This variable was not retained in the multivariate analysis (see 
section 6.7), suggesting that this is not an independent factor significantly affecting graft 
survival. 
 




Traditional Lamellar Keratoplasty 





Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
Under 20 years 62 40 23 12 7 4 1 
20 to 29 years 56 33 15 9 7 3 3 
30 to 39 years 88 63 32 23 15 10 8 
40 to 49 years 69 51 35 18 15 8 5 
50 to 59 years 85 61 34 21 13 8 6 
60 to 69 years 128 82 46 29 16 12 5 
70 to 79 years 138 105 53 24 12 4 1 
80 years or older 61 33 14 4 4 1 NA 
 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
Under 20 years 0.90 0.86 0.80 NA 
20 to 29 years 0.88 0.79 NA NA 
30 to 39 years 0.90 0.85 0.77 0.71 
40 to 49 years 0.76 0.69 0.63 NA 
50 to 59 years 0.79 0.73 0.69 0.66 
60 to 69 years 0.86 0.82 0.80 0.69 
70 to 79 years 0.80 0.76 0.69 0.61 
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6.2.5 Traditional lamellar graft survival: influence of change in lens status  
 
Figure 6.2.5 shows the comparison of graft survival stratified by the change of lens status 
from pre- to post-graft. “Phakic/phakic” means the eye was phakic both before and after 
the graft. “Other” means the eye was phakic, pseudophakic or aphakic before the graft, 
and either aphakic or pseudophakic afterwards.  
A significant difference was found across groups (Log Rank Statistic=5.79; df=1; 
p=0.016). This variable was not retained in the multivariate analysis (see section 6.7), 
suggesting that this is not an independent factor significantly affecting graft survival. 
Figure 6.2.5 Change in lens status 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
Phakic/phakic 548 375 212 120 76 43 26 
Other 139 93 40 20 13 7 3 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
Phakic/phakic 0.84 0.78 0.72 0.64 0.64 0.55 0.50 
Other 0.80 0.74 0.64 0.57 NA NA NA 
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6.2.6 Traditional lamellar graft survival: influence of pre-graft corneal 
neovascularisation 
 
Figure 6.2.6 shows the comparison of graft survival between those recipients with corneal 
neovascularisation pre-graft and those without (Log Rank Statistic=56.36; df=4; p<0.001). 
Recipients with avascular corneas pre-graft, or one quadrant of pre-graft 
neovascularisation, had significantly better survival than those with two or four quadrants 
of neovascularisation (all p<0.005). Recipients with avascular corneas pre-graft, or one 
quadrant of pre-graft neovascularisation, did not have significantly different graft survival 
(p=0.440). Recipients with two or three quadrants of pre-graft neovascularisation, did not 
have significantly different graft survival (p=0.972). This variable was recategorised for 
the multivariate analysis, according to this finding. This variable was retained in the 
multivariate analysis (see section 6.7), suggesting that this is an independent factor 
significantly affecting graft survival.  
Figure 6.2.6 Pre-graft corneal neovascularisation 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
None 460 325 168 99 58 34 20 
One quadrant 61 32 24 15 10 7 3 
Two quadrants 78 51 29 11 10 4 3 
Three quadrants 29 15 9 5 4 NA NA 
Four quadrants 59 35 22 10 7 5 3 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
None 0.87 0.82 0.76 0.69 0.66 0.57 0.51 
One quadrant 0.89 0.84 0.76 NA NA NA NA 
Two quadrants 0.77 0.70 0.64 NA NA NA NA 
Three quadrants 0.79 NA NA NA NA NA NA 
Four quadrants 0.62 0.53 0.48 NA NA NA NA 
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6.2.7 Traditional lamellar graft survival: influence of inflammation and/or steroid 
use at time of graft 
 
Figure 6.2.7 shows the comparison of graft survival between grafts performed in an eye 
with current inflammation and/or steroid use within the past two weeks, compared to those 
with neither of these factors (Log Rank Statistic=67.89; df=1; p<0.001). Data on this 
variable were not provided in 4% of cases. A further category was thus created called 
“not advised”. A significant difference was still found across groups when this category 
was included (Log Rank Statistic=68.26; df=2; p<0.001). Inflammation and/or steroid use 
was thus categorised into these three groups for multivariate analysis. This variable was 
retained in the multivariate analysis (see section 6.7), suggesting that this is an 
independent factor significantly affecting graft survival.  
Figure 6.2.7 Inflammation and/or steroid use at time of graft 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
No inflammation/steroid use 424 291 163 99 61 37 22 
Inflammation/steroid use 234 155 78 37 26 12 6 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
No inflammation/steroid use 0.91 0.86 0.81 0.73 0.71 0.61 0.55 
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6.2.8 Traditional lamellar graft survival: influence of history of raised intraocular 
pressure (IOP)  
 
Figure 6.2.8 shows the comparison of graft survival between grafts with a history of raised 
IOP and those without. A history of raised IOP, means IOP had been raised in the eye 
previously, regardless of whether it was raised at the time of the graft. A significant 
difference was found across groups (Log Rank Statistic=10.69; df=1; p=0.001). This 
variable was not retained in the multivariate analysis (see section 6.7), suggesting that 
this is not an independent factor significantly affecting graft survival. 




Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
No raised IOP 628 434 237 134 85 48 28 
Raised IOP 59 34 15 6 4 2 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
No raised IOP 0.84 0.78 0.72 0.64 0.62 0.53 0.46 
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6.2.9 Traditional lamellar graft survival: influence of number of previous grafts in 
the contralateral eye 
 
Figure 6.2.9 shows the comparison of graft survival between grafts where the recipient 
had undergone a single previous contralateral graft, multiple previous contralateral grafts, 
and no previous contralateral grafts. Recipients in each category may have undergone 
any number of previous ipsilateral grafts. A significant difference was found across groups 
(Log Rank Statistic=7.28; df=2; p=0.026), with grafts performed in recipients with two or 
more previous grafts in the contralateral eye having poorer survival (p=0.008). This 
variable was not retained in the multivariate analysis (see section 6.7), suggesting that 
this is not an independent factor significantly affecting graft survival. 
Figure 6.2.9 Number of previous grafts in the contralateral eye 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
None 625 425 229 129 81 45 24 
One 50 35 18 8 6 3 3 
Two or more 12 8 5 3 2 2 2 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
None 0.84 0.78 0.72 0.64 0.62 0.53 0.45 
One 0.82 0.73 NA NA NA NA NA 
Two or more NA NA NA NA NA NA NA 
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6.3 Graft Era 
 
Table 6.5 shows the number of grafts registered and followed, in blocks of five years. The 
percentages, which should be summed vertically, total 100. 
Table 6.5 Graft era 
 
Traditional Lamellar Corneal Graft 
Graft Era 
 
 Registered (%) Followed (%) 
Year of graft   
  1985 to 1989 93 (6%) 76 (7%) 
  1990 to 1994 243 (16%) 209 (19%) 
  1995 to 1999 255 (17%) 205 (18%) 
  2000 to 2004 293 (20%) 217 (19%) 
  2005 to 2009 242 (16%) 186 (17%) 
  2010 to 2014 223 (15%) 166 (15%) 
  2015 to 2017 146 (10%) 55 (5%) 
   
Total 1495 (100%) 1114 (100%) 
   
 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses and 
found to be significant (p<0.001). Follow-up was lower for grafts performed in more recent 
years. 
Consideration was given to the effect of follow-up lag time on this analysis. Up-to-date 
information on failed grafts is more likely to be known than for surviving grafts. This is 
because, while information on surviving grafts must be provided by a surgeon, the fact 
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6.3.1 Traditional lamellar graft survival: influence of era of graft 
 
Figure 6.3.1 shows the comparison of graft survival between year of graft, stratified into 
five-year groups (Log Rank Statistic=34.97; df=6; p<0.001), with all prior eras having 
superior survival to 2015-2017 (all p<0.001). This finding is likely due to the lag time 
discussed on the previous page. This variable was not retained in the multivariate 
analysis (see section 6.7), suggesting that this is not an independent factor significantly 
affecting graft survival. 
Figure 6.3.1 Graft era 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
1985 to 1989 40 33 20 15 11 9 7 
1990 to 1994 138 93 63 32 22 14 10 
1995 to 1999 114 75 44 26 20 14 7 
2000 to 2004 131 87 44 31 21 10 5 
2005 to 2009 125 94 59 34 15 3 NA 
2010 to 2014 120 86 22 2 NA NA NA 
2015 to 2017 19 NA NA NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 
1985 to 1989 0.88 0.85 0.78 NA NA 
1990 to 1994 0.89 0.82 0.79 0.68 0.63 
1995 to 1999 0.79 0.70 0.66 0.62 0.62 
2000 to 2004 0.82 0.78 0.68 0.61 0.59 
2005 to 2009 0.83 0.78 0.71 0.61 NA 
2010 to 2014 0.86 0.81 0.72 NA NA 
2015 to 2017 NA NA NA NA NA 
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6.4 Surgery and Surgeon Factors 
 
Table 6.6 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors examined in this report that were found to be significant in 
univariate analyses.  
Table 6.6 Surgery and surgeon factors, significant in univariate analysis 
 
Traditional Lamellar Corneal Grafts 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Size of graft (diameter)   
  6.0 mm or less 350 (23%) 266 (24%) 
  6.1 to 8.0 mm 427 (29%) 335 (30%) 
  More than 8.0 mm 281 (19%) 216 (19%) 
  Not advised 437 (29%) 297 (27%) 
   
The Centre effect   
  Fewer than 30 registered TLK 903 (60%) 656 (59%) 
  Surgeon A 133 (9%) 128 (11%) 
  Surgeon S 126 (8%) 71 (6%) 
  Surgeon D 93 (6%) 84 (8%) 
  Surgeon F 71 (5%) 65 (6%) 
  Surgeon G 48 (3%) 16 (1%) 
  Surgeon H 45 (3%) 35 (3%) 
  Surgeon J 42 (3%) 41 (4%) 
  Surgeon K   34 (2%) 18 (2%) 
     
Total 1495 (100%) 1114 (100%) 
   
 
Differences in rates of follow-up across sub-groups may affect survival calculations for 
these factors. This is because, while information on surviving grafts must be provided by 
a surgeon, the fact that a graft has failed may also be known when a registration is 
received for a replacement graft. Differences in survival across sub-groups for variables 
where a significant difference was found in rates of follow-up should thus be interpreted 
with this in mind. 
Comparisons between the percentages of grafts registered and followed in each category 
showed some differences. These differences were examined using Chi² analyses. Due 
to the nature of the variable, follow-up was, logically, significantly higher (p<0.001) for 
grafts performed by surgeons with 30+ registered grafts and ≥75% follow-up. 
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Table 6.7 shows the number of grafts within each of the variable sub-groups, for the 
surgery and surgeon factors found to be non-significant in univariate analyses. The sum 
of these numbers for each variable equals the total number of grafts (1,495 registered 
and 1,114 followed) and the percentages, which should be summed vertically for each 
variable, total 100.  
Table 6.7 Surgery and surgeon factors, not significant in univariate analysis 
 
Traditional Lamellar Corneal Grafts 
Surgery and Surgeon Factors 
 
 Registered (%) Followed (%) 
Surgeon volume   
  Fewer than 30 registered TLK 903 (60%) 656 (59%) 
  30+ registered TLK, <75% follow-up 208 (14%) 105 (9%) 
  30+ registered TLK, ≥75% follow-up 384 (26%) 353 (32%) 
Chi²=0.50, df=2, p=0.780   
     
Total 1495 (100%) 1114 (100%) 
   
 
75% was selected as the cut-off point for the follow-up categories as this (74.5%) was the 
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6.4.1 Traditional lamellar graft survival: influence of graft size 
 
Figure 6.4.1 shows a comparison of graft survival depending on the size of the graft, 
based on the donor button diameter, as reported by surgeons. A significant difference 
was found across groups (Log Rank Statistic=28.36; df=2; p<0.001), with survival of 
grafts sized 6.1mm to 8.0mm significantly better than both those smaller and larger (both 
p<0.001). Data on this variable were not provided in 29% of cases. A further category 
was thus created called “not advised”. A significant difference was still found across 
groups when this category was included (Log Rank Statistic=29.07; df=3; p<0.001). Graft 
size was thus categorised into these four groups for multivariate analysis. This variable 
was retained in the final model (see section 6.7), suggesting that this is an independent 
factor significantly affecting graft survival. 
Figure 6.4.1 Graft size 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
6.0 mm or less 146 98 42 22 13 6 2 
6.1 mm to 8.0 mm 231 161 100 66 42 25 17 
More than 8.0 mm 134 88 48 23 11 7 4 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
6.0 mm or less 0.78 0.73 0.64 0.55 NA NA NA 
6.1 mm to 8.0 mm 0.91 0.87 0.80 0.77 0.73 0.60 NA 
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6.4.2 Traditional lamellar graft survival: influence of the Centre effect  
 
Figure 6.4.2 shows the comparison of graft survival for individual surgeons (shown in 
random order) for which 30 or more traditional lamellar keratoplasties had been registered 
with the ACGR, and all other TLK (performed by 177 surgeons) combined (Log Rank 
Statistic=55.55; df=8; p<0.001). This variable was retained in the multivariate analysis 
(see section 6.7), suggesting that this is an independent factor significantly affecting graft 
survival. 
 
Figure 6.4.2 The centre effect 
 
 
Note: To preserve anonymity, surgeons have been identified using random letters of the 
alphabet. These identifying letters do not correspond with those used in chapters 
reporting on other types of graft, i.e. Surgeon A in this chapter is not the same surgeon 
identified as Surgeon A in the chapter on penetrating keratoplasty. 
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Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
<30 TLK registered 405 269 143 77 45 28 15 
Surgeon A 87 63 35 24 17 11 7 
Surgeon S 49 39 25 12 7 2 1 
Surgeon D 63 48 29 14 10 4 2 
Surgeon F 20 12 7 5 4 3 2 
Surgeon G 10 7 3 1 NA NA NA 
Surgeon H 18 11 1 1 1 NA NA 
Surgeon J 23 13 8 6 5 3 2 
Surgeon K 12 6 1 NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 
<30 TLK registered 0.85 0.77 0.71 0.63 0.61 0.53 
Surgeon A 0.92 0.87 0.84 0.81 NA NA 
Surgeon S 0.83 0.83 0.83 NA NA NA 
Surgeon D 0.92 0.92 0.80 NA NA NA 
Surgeon F 0.53 NA NA NA NA NA 
Surgeon G NA NA NA NA NA NA 
Surgeon H NA NA NA NA NA NA 
Surgeon J 0.73 NA NA NA NA NA 
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6.5 Operative procedures at the time of graft 
 
Only seventeen TLKs had an anterior vitrectomy at the time of graft and ten had a 
peripheral iridectomy. Thus, these factors were not further analysed. 
 
6.6 Post-graft Events 
 
Table 6.8 shows the occurrence of post-graft events, which were found to be significant 
in univariate analyses.  
Table 6.8 Post-graft events, significant in univariate analysis 
 
Traditional Lamellar Corneal Graft 
Post-graft Events 
 
 Registered (%) Followed (%) 
Post-graft microbial keratitis   
  No 1460 (98%) 1079 (97%) 
  Yes 35 (2%) 35 (3%) 
   
Post-graft rise in intraocular pressure*   
  No 1424 (95%) 1043 (94%) 
  Yes 71 (5%) 71 (6%) 
   
At least one rejection episode   
  No 1462 (98%) 1081 (97%) 
  Yes 33 (2%) 33 (3%) 
   
Total 1495 (100 %) 1114 (100 %) 
   
* Note: significant at p<0.08 for inclusion in multivariate analyses but not at p<0.05. 
Table 6.9 shows the number of grafts within each of the variable sub-groups, for the post-
graft events found to be non-significant in univariate analyses. The sum for each 
variable equals the total number of grafts (1,495 registered and 1,114 with follow-up 
provided) and the percentages, summed vertically, total 100. The result of the Kaplan-
Meier survival analysis is also provided. Only 18 TLK had post-graft herpetic infection, 
four had post-graft synechia, and eight had post-graft uveitis reported. Thus, the impact 
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Table 6.9 Post-graft events, not significant in univariate analysis 
 
Traditional Lamellar Corneal Graft 
Post-graft Events 
 
 Registered (%) Followed (%) 
Post-graft neovascularisation   
  No 1389 (93%) 1009 (91%) 
  Yes 105 (7%) 105 (9%) 
Chi²=1.22, df=1, p=0.269   
   
Time to removal of sutures   
  Within 3 months post-graft 114 (8%) 114 (10%) 
  Between 3 and 6 months post-graft 113 (8%) 113 (10%) 
  Between 6 and 12 months post-graft 85 (6%) 85 (8%) 
  More than 12 months post-graft 117 (8%) 117 (11%) 
  Not yet removed/not advised 1056 (71%) 675 (61%) 
Chi²=2.63, df=3, p=0.453   
   
Total 1495 (100 %) 1114 (100 %) 
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Table 6.10 shows post-graft surgical procedures, as reported by follow-up practitioners. 
Please note: post-graft data may be incomplete when follow-up is based on a registration 
for a replacement graft. 
Table 6.10 Post-graft surgical procedures 
206 TLK were reported to have undergone a re-grafting procedure (separate to 
subsequent concurrent graft/s) at the date last seen. Of these 177 had not had additional 
post-graft operative procedures reported, while 29 had. 
 
 
Traditional Lamellar Corneal Grafts 
Post-graft Surgical Procedures 
 
Type of procedure Number 
  
Cataract removal/IOL insertion (90 both, 2 cataract only, 7 IOL only) 99 
Additional concurrent graft (5, TLK, 4 PK, 4 conjunctival, 1 DSEK) 14 
YAG laser 13 
Tarsorrhaphy 12 
Gunderson flap 11 
Enucleation 9 
Wound repair/resutured 9 
Relaxing incision 7 
Suture adjustment 7 
Pterygium removal 5 
PRK laser 5 
LASIK 4 
Glaucoma tube insertion: 2 Baerveldt, 1 Molteno 3 
Evisceration 3 
Intravitreal injection 3 
Vitrectomy 3 
Wedge resection 3 
Other* 40 
  
Total number of surgical procedures (number of grafts) 250 (203) 
  
 
* Other included: amniotic membrane transplant (2), cryotherapy (2), IOL exchange (2), 
lash epilation (2), removal of calcified plaque (2), trabeculectomy (2), argon laser 
trabeculoplasty (1), collagen cross-linking (1), conjunctival resection (1), corneal gluing 
(1), corneal scraping (1), cyclodiode (1), debridement of corneal ulcer (1), de-bulking (1), 
entropion repair (1), epithelial debridement (1), evacuation of haematoma under lamellar 
graft (1), exenteration (1), iridectomy (1), iridoplasty (1), keratectomy (1), keratotomy (1), 
ptosis repair (1),  punctal cautery (1), punctal occlusion surgery (1), removal of Gunderson 
flap (1), removal of limbal lesion (1), removal of bank keratopathy (1), removal of gold 
weight from eyelid (1), removal of conjunctival tumour (1), removal of cysts (1), removal 
of giant cell granuloma (1), removal of small cell carcinoma (1), scleral buckle (1).   
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6.6.1 Traditional lamellar graft survival: influence of post-graft microbial keratitis 
 
Figure 6.6.1 shows the survival for grafts where the eye had microbial keratitis post-graft, 
compared to those where there was no such infection. A significant difference was found 
between groups (Log Rank Statistic=28.80; df=1; p<0.001). This variable was not 
retained in the multivariate analysis (see section 6.7), suggesting that this is not an 
independent factor significantly affecting graft survival. 
Figure 6.6.1 Post-graft microbial keratitis 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
No microbial keratitis 673 460 247 137 88 49 28 
Microbial keratitis 15 8 5 3 1 1 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
No microbial keratitis 0.84 0.78 0.72 0.64 0.62 0.53 0.46 
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6.6.2 Traditional lamellar graft survival: influence of raised IOP post-graft 
 
Figure 6.6.2 shows the comparison of graft survival for grafts where the eye was reported 
to have had raised intraocular pressure post-graft to those where the IOP remained in the 
normal range. No significant difference was found between groups (Log Rank 
Statistic=3.79; df=1; p=0.052), however this variable met the p<0.08 criteria for inclusion 
in the multivariate analyses. It was not retained in the final model (see section 6.7), 
suggesting that this is not an independent factor significantly affecting graft survival.  
  
Figure 6.6.2 Post-graft raised intraocular pressure 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
No raised IOP 636 431 227 124 79 43 24 
Raised IOP 51 37 25 16 10 7 5 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
No raised IOP 0.82 0.76 0.70 0.62 0.60 0.52 0.45 




Traditional Lamellar Keratoplasty 
265 Australian Corneal Graft Registry Report 2018 
6.6.3 Traditional lamellar graft survival: influence of any rejection episode/s 
 
Figure 6.6.3 shows the comparison of graft survival depending on whether the graft 
underwent at least one rejection episode. A significant difference was found between 
groups (Log Rank Statistic=7.91; df=1; p=0.005). This variable was not retained in the 
final model (see section 6.7), suggesting that this is not an independent factor 
significantly affecting graft survival. 
Figure 6.6.3 Any rejection 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 
No rejection 663 451 242 136 85 48 27 
Any rejection 25 17 10 4 4 2 2 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 
No rejection 0.83 0.78 0.72 0.64 0.62 0.53 0.46 
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6.7 Multivariate Analysis 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all other variables in the model. This analysis was 
performed using STATA version 11. 
In the preceding univariate analyses, each registered TLK, together with its archival 
follow-up records, was treated as a separate and independent entity. Some recipients 
had multiple TLK performed during the census period (up to 31/7/2017), with some having 
repeat grafts in a single eye, some grafts in both eyes and some a combination of both. 
To control for potential inter-graft and/or inter-eye dependence in the multivariate 
analyses, the multivariate model was adjusted to allow for clustering by individual patient 
[see references 7 & 8]. 
Variables to be included in the Cox Proportional Hazards regression model were identified 
based on the results of the univariate Kaplan-Meier analyses, with a cut-off significance 
level of p<0.08 used to select variables for inclusion. No variables were excluded due to 
collinearity or missing data. Each variable was initially analysed individually to determine 
if it remained significant once clustered by individual patient. Where the variable was no 
longer found to be significant (p>0.08), it was excluded from the multivariate analysis. 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The model excluded variables with a p-value 
of p ≥ 0.05 (or global p-value of p ≥ 0.05 for variables with more than two categories) in a 
stepwise manner, beginning with the least significant variable. For categorical variable 
with more than two groups, Bonferroni adjustment was applied to determine if significant 
differences were present between groups. The Kaplan-Meier plots, and additional 
appropriate STATA analyses, were used to assess whether each included variable met 
the assumption of proportional hazards. Where variables were found to be time-variant, 
they were treated as such in the multivariate model.  
Table 6.11 shows each of the variables analysed in the univariate analyses, stratified by 
whether they were included in the initial multivariate model and whether they remained in 
the final model.  
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Table 6.11 Multivariate model 
 
Traditional Lamellar Corneal Graft 
Multivariate Model 
 
Not significant in univariate analysis 
Donor sex 
Donor age group 
Cause of donor death 
Multi-organ donor 
Time from death to enucleation 
Time from enucleation to storage 
Storage time in Optisol 
Storage time in organ culture 
Time from death to graft - moist pot storage 
Endothelial cell density 
Recipient sex 
Donor/recipient sex match/mismatch 
Eye grafted 
Surgeon experience and level of follow-up 
Post-graft corneal neovascularisation 
Time to removal of sutures 
 





Recipient age group 
Change in lens status pre- to post-graft 
History of raised intraocular pressure 
Previous contralateral graft(s) 
Graft era 
Post-graft microbial keratitis 
Raised intraocular pressure post-graft* 
Post-graft rejection episode(s) 
 
Significant in univariate analysis AND retained in multivariate model 
Indication for graft 
Pre-graft inflammation and/or steroid use 
Pre-graft corneal neovascularisation 
Graft size 
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Table 6.12 tabulates the parameter estimates resulting from the fit of the best clustered 
Cox model. The table shows the variable, the hazard ratio, the standard error of the 
regression coefficient, the corresponding probability value and the 95% confidence 
interval for the hazard ratio. The group of each categorical variable with the highest 
number of cases (excluding not advised) was taken as the referent. The hazard ratios for 
a given variable are adjusted for all other variables in the model. This model included data 
from 1,495 traditional lamellar keratoplasties, performed in 1,349 recipients.  
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, 
a global test was applied to calculate the overall p-value. The overall model was highly 
significant: (Chi²=200.05, p<0.0001).  
Table 6.12 Clustered multivariate model 
 
Traditional Lamellar Corneal Graft 














Pre-graft inflammation and/or steroid use 
No 831 1.00   0.023  
Yes 602 1.50 0.22 0.006  1.12 - 2.00 
Not advised 62 1.12 0.36 0.722  0.59 - 2.12 
 
Indication for graft  
Failed previous graft 221 4.21 1.14 <0.001  2.47 - 7.16 
Keratoconus 105 2.64 0.88 0.004  1.38 - 5.08 
Corneal ulcer/perforation 190 4.27 1.24 <0.001  2.42 - 7.53 
Herpetic eye disease 63 5.49 1.80 <0.001  2.88 - 10.44 
Trauma 70 1.28 0.52 0.545  0.58 - 2.83 
Non-herpetic infections 50 4.38 1.53 <0.001  2.20 - 8.70 
Corneal degeneration 73 1.72 0.73 0.200  0.75 - 3.94 
Pterygium 234 1.00   <0.001  
Scleral necrosis 200 1.83 0.59 0.058  0.98 - 3.43 
Limbal dermoid 72 0.25 0.25 0.171  0.04 - 1.80 
Other 217 2.45 0.74 0.003  1.35 - 4.44 
 
Graft size 
Up to 6.0 mm 350 1.77 0.32 0.001  1.25 - 2.52 
6.1 mm to 8.0 mm 427 1.00   <0.001  
8.1 mm or larger 281 2.19 0.39 <0.001  1.55 - 3.10 
Not advised 437 1.55 0.29 0.21  1.07 - 2.23 
       
Pre-graft corneal neovascularisation 
None/one quadrant 1118 1.00   <0.001  
Two/three quadrants 234 1.68 0.28 0.002  1.21 - 2.33 
Four quadrants 143 2.41 0.44 <0.001  1.69 - 3.43 
       
The Centre effect       
< 30 TLK registered 903 1.00   <0.001  
Other surgeons (lowest HR  







 0.31 - 0.92 
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6.7.1 Significant differences in the traditional lamellar keratoplasty multivariate 
model for categories with more than two groups following Bonferroni 
correction for multiple comparisons 
 
6.7.1.1 Indication for graft  
 
Grafts performed for pterygium had significantly better survival than those performed for 
herpetic eye disease, failed previous grafts, corneal ulcers, and non-herpetic infections 
(all p<0.001), and those performed for “other” specified indications (p=0.003).  
Grafts performed for trauma had significantly better survival than those performed for 
herpetic eye disease (p<0.001), failed previous graft (p=0.001), corneal ulcer (p=0.001), 
and non-herpetic infections (p=0.003).  
Grafts performed for scleral necrosis had significantly better survival than those 
performed for herpetic eye disease (p<0.001), failed previous graft (p<0.001), and corneal 
ulcers (p=0.001). 
Grafts performed for limbal dermoid had significantly better survivial than those performed 
for herpetic eye disease (p=0.002). 
 
6.7.1.2 Pre-graft corneal neovascularisation  
 
Grafts performed in eyes with no, or one quadrant of, pre-graft corneal neovascularisation 
had significantly better survival than those with two or three quadrants (p=0.002), or four 
quadrants (p<0.001).  
 
6.7.1.3 Graft size  
 
Grafts that were 6.1 mm up to 8.0 mm had significantly better survival than grafts that 
were 6.0 mm or smaller (p=0.001) and those that were 8.1 mm or larger (p<0.001).  
 
6.7.1.4 Individual surgeon  
 
Individual results varied widely for surgeons with 30 or more TLK registered with the 
ACGR compared to the balance of the database (TLK performed by surgeons with fewer 
than 30 registered TLK). The hazard ratios ranged from 0.53 to 2.40. 
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6.8 Reasons for Graft Failure 
 
Of the 1,114 followed grafts, 296 (27%) were known to have failed by the census date. 
This equates to 20% of the 1,495 registered grafts. Surgeons were asked to indicate the 
reason for graft failure. This information was also gathered from repeat registration forms, 
where the reason for failure of the previous graft was given. Table 6.13 shows the reasons 
for failure given.  
Table 6.13 Reasons for graft failure 
 
Traditional Lamellar Corneal Grafts 
Reasons for Graft Failure 
 
  Corneal melt 37 (13%) 
  Corneal ulcer/perforation 37 (13%) 
  Non herpetic infection 31 (11%) 
  Primary graft failure 15 (5%) 
  Scarring  15 (5%) 
  Endothelial cell failure 13 (4%) 
  Herpetic infection 12 (4%) 
  Rejection 11 (4%) 
  Scleral necrosis 11 (4%) 
  Recurrent pterygium 10 (3%) 
  Astigmatism 10 (3%) 
  Other specified* 40 (14%) 
  Unspecified 54 (18%) 
  
Total 296 (100%) 
  
 
*Other included: cancer recurrence (9), wound leak (7), vascularisation (5), epithelial 
defect (3), keratoconus (2), Stevens-Johnson syndrome (2), trauma (2), atopic 
keratoconjunctivitis (1), band keratopathy (1), cataract (1), corneal thinning (1), 
descemetocoele (1), glaucoma (1), keratoglobus (1), ocular pemphigoid (1), 
symblepharon (1), Wegener’s granulomatosis (1). 
 
Of the 15 grafts reported by surgeons to have been primary graft failures, eight had no 
further information provided. Specific reasons given were: corneal melt (3), persistent 
wound leakage (2), perforation (1) and surgical trauma (1). 
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6.9 Post-graft Changes in Best Corrected Visual Acuity 
 
6.9.1 All indications for graft 
 
Post-graft best corrected visual acuity (BCVA) is an important outcome for many corneal 
graft recipients. A desire for improved visual acuity was specified as a reason for graft in 
322 (22%) of registered traditional lamellar keratoplasties. In 20% of cases (303), this 
was the sole desired outcome indicated. These percentages were much lower than for 
any other type of grafts, with traditional lamellar keratoplasties most often performed for 
structural repair (see section 1.1.3).  
Follow-ups occur at varying times post-graft, depending on when a surgeon sees a 
recipient. Where post-graft best corrected visual acuity (without pinhole) information was 
provided, we categorised this according to the length of time since graft. The first two 
categories were: 
• BCVA provided at between 6 and 12 months post-graft, and 
• BCVA provided at between 12 and 18 months post-graft. 
Subsequent groups were at yearly intervals. For each year point, any measurements 
provided within 6-months of that date, rounded to the nearest day, were included (e.g. for 
two year follow-up, any BCVA given at between 730 and 913 days post-graft was 
included). 
We analysed post-graft best corrected visual acuity in several ways. Where more than 20 
grafts had BCVA measurements provided, we examined: 
1. The percentage of surviving grafts achieving different levels of Snellen visual 
acuity (6/6 or better, 6/7.5 to 6/12, 6/15 to 6/24, 6/36 to 6/60, count fingers (CF) 
or hand movements (HM), and light perception (LP) or no light perception 
(NLP)) at yearly time-points post-graft. Grafts that had been reported to have 
failed at the time of last follow-up, but had prior follow-ups with BCVA 
measurements provided when the graft was surviving, had these prior data 
included in these analyses.  
2. The average Snellen visual acuity achieved at yearly intervals post-graft, again 
by surviving grafts. 
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Table 6.14 and Figure 6.9.1 show the reported post-graft best corrected visual acuity for 
all failed grafts at the time of last follow-up, separated by indication for graft. Visual acuity 
at time of failure was reported for 191 (65%) of 296 failed TLK. Where fewer than 10 
grafts had visual acuity reported at time of failure for a particular indication, these data 
were included in the “other specified” group. As might be expected, the majority of failed 
grafts had accompanying poor visual acuity, though large proportions of the TLK 
performed for pterygium or scleral necrosis had good visual acuity despite having failed. 
Table 6.14 Post-graft best corrected visual acuity 
 
Traditional Lamellar Corneal Graft:  











CF or HM LP or NLP 
Failed previous graft 0 (0%) 4 (8%) 2 (4%) 6 (12%) 24 (48%) 14 (28%) 
Keratoconus 0 (0%) 0 (0%) 2 (17%) 1 (8%) 9 (75%) 0 (0%) 
Corneal ulcers 1 (3%) 6 (18%) 0 (0%) 3 (9%) 13 (39%) 10 (30%) 
Herpetic eye disease 0 (0%) 0 (0%) 1 (5%) 3 (16%) 12 (63%) 3 (16%) 
Non-herpetic infection 0 (0%) 0 (0%) 2 (15%) 3 (23%) 5 (38%) 3 (23%) 
Pterygium 4 (33%) 4 (33%) 0 (0%) 2 (17%) 2 (17%) 0 (0%) 
Scleral necrosis 1 (9%) 3 (27%) 2 (18%) 1 (9%) 4 (36%) 0 (0%) 
Other specified 1 (2%) 6 (15%) 1 (2%) 6 (15%) 23 (56%) 4 (10%) 
Total 7 (4%) 23 (12%) 10 (5%) 25 (13%) 92 (48%) 34 (18%) 
       
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
Figure 6.9.1 Best corrected visual acuity at time of last follow-up for failed 
traditional lamellar keratoplasties 
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Figure 6.9.2 shows the best corrected visual acuity in the grafted eye, as reported to the 
ACGR, and categorised into six levels of vision, for all surviving traditional lamellar 
keratoplasties. Prior to graft over a third of eyes (35%) had vision of CF or worse. By 6-
months post-graft, almost three-quarters (74%) of eyes with surviving grafts had 
functional vision of 6/12 or better. Only 10% of eyes had vision of CF or worse by 6-
months post-graft. Similar patterns could be seen for surviving grafts followed for up to 
7-years post-graft.  
 
Figure 6.9.2 Best corrected visual acuity for traditional lamellar keratoplasties, 
surviving at time of measurement 
 
CF=count fingers at 1 metre, HM=hand movements, LP=light perception, NLP=no light perception 
  
  
Traditional Lamellar Keratoplasty 
274 Australian Corneal Graft Registry Report 2018 
6.9.2 Individual indications for graft 
 
There were insufficient data to examine changes in best corrected visual acuity for the 
majority of indications for graft. Levels of visual acuity reported to the ACGR, pre-graft 
and at 1-year post-graft for surviving grafts performed for pterygium, scleral necrosis or 
corneal ulcers are shown in Figure 6.9.3.  
There were very minimal changes in the visual acuity for grafts performed for pterygium 
or scleral necrosis, both of which had approximately 80% of grafts with visual acuity of 
6/12 or better pre-graft, and rarely listed improvement in visual acuity as a reason for graft 
(14%). Just under half (48%) of the surviving grafts performed for corneal ulcers and/or 
perforations had achieved 6/12 vision by 1-year post-graft, an increase from just 13% pre-
graft. Interestingly, less than 10% of TLK performed for this reason had indicated a 
desired improvement in visual acuity as a reason for graft. 
 
Figure 6.9.3 Level of best corrected visual acuity reported at 1-year post-graft for 
surviving grafts 
 




Post-graft Factors Affecting Visual Acuity 
275 Australian Corneal Graft Registry Report 2018 
7 Post-graft factors affecting visual acuity 
 
Surgeons reported additional factors affecting visual acuity in the grafted eye. These are 
shown in Table 7.1. Percentages given are of the number of followed grafts. 
Table 7.1 Factors affecting visual acuity in the grafted eye at last follow-up 
 
PK DS(A)EK DMEK DALK TLK 
Glaucoma* 2359 (12%) 481 (15%) 42 (7%) 29 (3%) 49 (4%) 
Macular degeneration 1805 (9%) 197 (6%) 16 (3%) 4 (<1%) 37 (3%) 
Opacity/scar 1168 (6%) 183 (6%) 31 (5%) 61 (7%) 77 (7%) 
Anisometropia 1284 (6%) 6 (<1%) 0 (0%)  5 (<1%)  14 (1%)  
Cystoid macular oedema 1085 (5%) 71 (2%) 16 (3%) 6 (<1%) 11 (1%) 
Cataract 829 (4%)  6 (<1%) 1 (<1%) 49 (5%)  62 (6%) 
Myopia 640 (3%) 8 (<1%) 0 (0%) 18 (2%) 17 (2%) 
Amblyopia 546 (3%)  27 (<1%) 6 (1%)  21 (2%) 39 (4%) 
Retinal detachment 354 (2%) 41 (1%) 3 (<1%) 5 (<1%) 7 (<1%) 
Diabetic retinopathy 113 (<1%) 26 (<1%) 0 (0%) 3 (<1%) 4 (<1%) 
      
 
* Surgeons were asked to indicate if patients had glaucoma. While often related, this was 
a separate question to whether they had experienced raised intraocular pressure post-
graft, which could occur for other reasons.  
In addition, major astigmatism (defined as 5 dioptres of more) was reported in 3,469 
(17%) penetrating keratoplasties, 56 (2%) Descemet’s stripping (automated) endothelial 
keratoplasties, 5 (<1%) Descemet’s membrane endothelial keratoplasties, 111 (12%) 
deep anterior lamellar keratoplasties, and 54 (5%) traditional lamellar keratoplasties. 
In grafts performed for keratoconus, 1,371 penetrating keratoplasties (22%) were 
reported to have major astigmatism at last follow-up, compared to 97 deep anterior 
lamellar keratoplasties (14%). This difference was statistically significant, Chi²=22.14 
p<0.001. 
The specific amount of astigmatism, in dioptres, was provided for 2,323 penetrating 
keratoplasties (968 in grafts performed for keratoconus) and 89 deep anterior lamellar 
keratoplasties (78 in grafts performed for keratoconus). The severity of major astigmatism 
in eyes grafted for keratoconus did not differ between penetrating keratoplasties and deep 
anterior lamellar keratoplasties (p=0.574). 
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Surgeons reported whether graft recipients used visual aids (glasses and/or contact lens) 
to attain the best corrected visual acuity at the time of last follow-up.  
Table 7.2 shows the proportion of followed grafts for each graft type for which the recipient 
wore glasses and a contact lens. It also shows the proportions of followed recipients for 
each graft type who had an IOL in place. Note: this group does not include those known 
to have an IOL inserted at time of graft but for which no follow-up information has been 
received. Percentages given are of the number of followed grafts. 
Table 7.2 Post-graft visual correction 
 
PK DS(A)EK  DMEK DALK TLK 
      
IOL 10622 (52%) 3146 (96%) 566 (94%) 148 (16%) 299 (27%) 
Glasses 8429 (41%) 1407 (43%) 238 (40%) 297 (32%) 317 (29%) 
Contact lens 1223 (6%) 18 (<1%) 8 (1%) 60 (7%) 22 (2%) 
      
 
In some cases, recipients were reported to use both glasses and contact lenses, or to 
use these in conjunction with an existing IOL. Table 7.3 shows the combinations of visual 
aids used following the different types of graft.  
Table 7.3 Post-graft visual correction combinations 
 
PK DS(A)EK  DMEK DALK TLK 
None 5088 (25%) 85 (3%) 24 (4%) 477 (52%) 579 (52%) 
      
IOL only 5883 (29%) 1758 (54%) 332 (55%) 97 (11%) 201 (18%) 
Glasses & IOL 4505 (22%) 1372 (42%) 226 (38%) 45 (5%) 96 (9%) 
Glasses only 3637 (18%) 30 (<1%) 10 (2%) 242 (26%) 216 (19%) 
Contact lens only 764 (4%) 1 (<1%) 0 (0%) 47 (5%) 16 (1%) 
Glasses & contact lens 225 (1%) 1 (<1%) 0 (0%) 7 (<1%) 4 (<1%) 
Contact lens & IOL 172 (<1%) 12 (<1%) 6 (<1%) 3 (<1%) 1 (<1%) 
      
All three 62 (<1%) 4 (<1%) 2 (<1%) 3 (<1%) 1 (<1%) 
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8 Comparisons Across Graft Types 
 
This chapter presents the results of analyses which compare the outcomes of different 
types of grafts, performed for the same indications, across the same time period. Kaplan-
Meier survival analyses were conducted using IBM SPSS for Windows (Version 22.0), to 
compare the graft survival across groups. 
8.1 Keratoconus 
 
Two types of graft are primarily performed for keratoconus: penetrating keratoplasty and 
deep anterior lamellar keratoplasty. The latter technique has increased in use for the 
treatment of keratoconus over recent years, as shown in Figure 8.1.1. 
Figure 8.1.1 Number of grafts performed each year, by type of graft performed, for 
keratoconus, 2000 to 2016 
 
Note: the majority of grafts performed in 2017 had not been entered into the registry at 
the censor date and so these data are not shown. At 31st January 2018, 249 grafts for 
keratoconus, which had been performed in 2017, were registered with the ACGR. A 
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8.1.1 Survival of grafts for keratoconus: influence of graft type 
 
Figure 8.1.2 shows the comparison of survival between penetrating keratoplasties and 
deep anterior lamellar keratoplasties performed for keratoconus since the year 2000, up 
to the censor date. 
Figure 8.1.2 Type of graft for keratoconus, 2000 onwards 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 12 14 
PK 2815 2016 1126 691 405 349 141 49 
DALK 586 360 123 46 11 5 2 1 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 10 12 14 
PK 0.98 0.97 0.94 0.92 0.88 0.85 0.77 0.69 
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Figure 8.1.3 shows the mean visual acuity reported for grafts performed for keratoconus, 
since 2000, pre-graft and at various time-points post-graft. Pre-graft visual acuity is based 
on all registered grafts with this condition for which this information was provided. Post-
graft visual acuity is for grafts that were surviving at these time points. 
Figure 8.1.3 Change in visual acuity in surviving grafts performed for keratoconus, 
since 2000, stratified by graft type, over time post-graft  
 
Number of surviving grafts with visual acuity provided 
 
Pre-graft 6-months 1 year 2 years 3 years 4 years 
PK 3963 95 773 628 315 222 
DALK 1112 31 203 122 50 26 
 
There was no significant difference (p=0.376) in the pre-graft visual acuity reported for 
eyes undergoing penetrating keratoplasty for keratoconus compared to those undergoing 
deep anterior lamellar keratoplasty since the year 2000.  
Visual acuity in surviving grafts was significantly improved (p<0.001) at 1-year post-graft, 
and this difference remained significant up to 4-years post-graft (p<0.001), for both 
penetrating keratoplasty and deep anterior lamellar keratoplasty. At 1-year post-graft the 
mean visual acuity reported for surviving penetrating keratoplasties had reached the 
6/12 level. It increased to 6/9 by 2-years post-graft and remained above it up to 10-years 
post-graft. The average post-graft visual acuity also reached 6/12 level for surviving 
DALK at 1-year post-graft. It remained at this level until 4-years post-graft. 
The difference in post-graft visual acuity in surviving PK versus DALK grafts was not 
significantly different at 6-months post-graft (p=0.305), however it became significant at 
12-months post-graft and remained so at 2 and 3-years post-graft (all p<0.001). At 4-
years post-graft, the difference was again non-significant (p=0.060).   
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8.2 Pseudophakic Bullous Keratopathy 
 
Two types of graft are primarily performed for pseudophakic bullous keratopathy, these 
being penetrating keratoplasty and Descemet’s stripping (automated) endothelial 
keratoplasty. Descemet’s membrane endothelial keratoplasties have also been 
performed for this indication, in smaller numbers.  The DS(A)EK technique was 
introduced in Australia in 2006 and its use in treating pseudophakic bullous keratopathy 
has continuously increased since then, so that it is now the more common technique used 
to treat this condition. This has accompanied an increase in recent years, in the total 
number of transplants being performed for pseudophakic bullous keratopathy, as shown 
in Figure 8.2.1.  
Figure 8.2.1 Number of grafts performed each year, by type of graft performed, for 
pseudophakic bullous keratopathy, 2005 to 2016 
 
Note: the majority of grafts performed in 2017 had not been entered into the registry at 
the censor date and so these data are not shown. At 31st January 2018, 238 grafts for 
pseudophakic bullous keratopathy, which had been performed in 2017, were registered 
with the ACGR. A further seven grafts that had been performed for this indication in 2016 
had also been registered, as had a further two grafts from 2006 and one from each of 
2007 and 2009. 
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8.2.1 Survival of grafts for pseudophakic bullous keratopathy: influence of graft 
type 
 
Figure 8.2.2 shows the comparison of survival between penetrating keratoplasties, 
Descemet’s membrane endothelial keratoplasties, and Descemet’s stripping (automated) 
endothelial keratoplasties, performed for pseudophakic bullous keratopathy since the 
introduction of the latter technique in 2006 up to the censor date. A significant difference 
was found between the three groups (Log Rank Statistic=54.83; df=2; p<0.001). PKs had 
significantly better survival than DS(A)EK (p=0.032) and DMEK (p<0.001), and DS(A)EK 
also had superior survival to DMEK (p<0.001). 
Figure 8.2.2 Type of graft for pseudophakic bullous keratopathy, 2006 onwards 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
PK 402 301 154 68 19 4 
DS(A)EK 584 371 118 29 2 NA 
DMEK 41 12 NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
PK 0.92 0.84 0.67 0.52 
DS(A)EK 0.88 0.79 0.62 0.45 
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Figure 8.2.3 shows the mean visual acuity reported for grafts performed for pseudophakic 
bullous keratopathy, since 2006, pre-graft and at various time-points post-graft. Pre-graft 
visual acuity is based on all registered grafts with this condition for which this information 
was provided. Post-graft visual acuity is for grafts that were surviving at these time 
points. 
Figure 8.2.3 Change in visual acuity in surviving grafts performed for pseudophakic 
bullous keratopathy since 2006, stratified by graft type, over time post-graft  
 
Number of surviving grafts with visual acuity provided 
 
Pre-graft 1 year 2 years 3 years 4 years 5 years 
PK 620 86 89 44 33 24 
DS(A)EK 1208 167 115 57 27 24 
DMEK 200 20 4 1 0 0 
 
The pre-graft visual acuity reported for eyes undergoing penetrating keratoplasty for 
pseudophakic bullous keratopathy since the year 2006 was significantly worse than for 
those undergoing Descemet’s stripping (automated) endothelial keratoplasty or 
Descemet’s membrane endothelial keratoplasty (both p<0.001).  
Visual acuity in surviving grafts was significantly improved (p<0.001) at 1-year post-graft, 
for all three types of graft, reaching 6/24 for PK, 6/18 for DS(A)EK and 6/12 for DMEK. 
This difference remained significant up to 4-years post-graft (p<0.001), for both PK and 
DS(A)EK. There were insufficient numbers of grafts with both pre- and post-graft vision 
after these points to make comparisons. The average post-graft visual acuity remained 
under 6/15 for surviving PK and reached it at 4-years post-graft for surviving DS(A)EK, 
before dropping back under at 5-years post-graft.  
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8.2.1.1 Survival of grafts for pseudophakic bullous keratopathy: influence of graft 
type and early failures 
 
A greater proportion of Descemet’s stripping (automated) endothelial keratoplasties, and 
Descemet’s membrane endothelial keratoplasties performed for pseudophakic bullous 
keratopathy than penetrating keratoplasties for the same indication, failed within three 
months (90 days) of graft (60/1282=4.7% and 23/214=10.7% vs. 10/648=1.5%). 
Figure 8.2.4 shows the comparison of survival between penetrating keratoplasties, 
Descemet’s membrane endothelial keratoplasties, and Descemet’s stripping (automated) 
endothelial keratoplasties performed for pseudophakic bullous keratopathy since the 
introduction of the latter technique in 2006, excluding these early failures. A significant 
difference was still found between the three groups (Log Rank Statistic=10.63; df=2; 
p=0.005), however the difference between PK and DS(A)EK was no longer significant 
(Log Rank Statistic=0.33; df=1; p=0.565). 
Figure 8.2.4 Type of graft for pseudophakic bullous keratopathy, 2006 onwards, 
excluding early failures 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
PK 402 301 154 68 19 4 
DS(A)EK 584 371 118 29 2 NA 
DMEK 41 12 NA NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 
PK 0.94 0.86 0.68 0.53 
DS(A)EK 0.94 0.85 0.67 0.49 
DMEK 0.90 NA NA NA 
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8.3 Fuchs’ Endothelial Dystrophy 
 
Two types of graft are primarily performed for Fuchs’ endothelial dystrophy, these being 
Descemet’s stripping (automated) endothelial keratoplasty and Descemet’s membrane 
endothelial keratoplasties. Penetrating keratoplasty is now rarely performed for this 
indication. The DS(A)EK technique was introduced in Australia in 2006 and its use in 
treating Fuchs’ endothelial dystrophy has increased since then, so that it is now the more 
common technique used to treat this condition. The use of DMEK has also continually 
increased over the past five years. This has accompanied a corresponding large increase 
in recent years (of approximately three times the overall numbers reported when the new 
techniques were first introduced), in the total number of transplants being performed for 
Fuchs’ endothelial dystrophy. This continues on an upward trajectory to 2016, as shown 
in Figure 8.3.1. 
Figure 8.3.1 Number of grafts performed each year, by type of graft performed, for 
Fuchs' endothelial dystrophy, 2005 to 2016 
 
 
Note: the majority of grafts performed in 2017 had not been entered into the registry at 
the censor date and so these data are not shown. At 31st January 2018, 525 grafts for 
Fuchs’ endothelial dystrophy, which had been performed in 2017, were registered with 
the ACGR. A single further graft that had been performed for this indication, had also 
been registered in each of 2006, 2008, 2009, 2010, and 2013. 
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8.3.1 Survival of grafts for Fuchs’ endothelial dystrophy: influence of graft type 
 
Figure 8.3.2 shows the comparison of survival between penetrating keratoplasties, 
Descemet’s stripping (automated) endothelial keratoplasties, and Descemet’s membrane 
endothelial keratoplasties performed for Fuchs’ endothelial dystrophy since 2006 up to 
the censor date. A significant difference was found between the three groups (Log Rank 
Statistic=219.18; df=2; p<0.001). PKs had significantly better survival than DS(A)EK and 
DMEK (both p<0.001), and DS(A)EK also had superior survival to DMEK (p<0.001). 
Figure 8.3.2 Type of graft for Fuchs' endothelial dystrophy, 2006 onwards 
 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
PK 403 338 231 148 65 8 
DS(A)EK 1179 839 314 93 12 NA 
DMEK 144 65 4 NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 
PK 0.98 0.95 0.89 0.80 0.72 
DS(A)EK 0.89 0.85 0.79 0.69 NA 
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Figure 8.3.3 shows the mean visual acuity reported for grafts performed for Fuchs’ 
endothelial dystrophy, since 2006, pre-graft and at various time-points post-graft. Pre-
graft visual acuity is based on all registered grafts with this condition for which this 
information was provided. Post-graft visual acuity is for grafts that were surviving at 
these time points. 
Figure 8.3.3 Change in visual acuity in surviving grafts performed for Fuchs' 
endothelial dystrophy, since 2006, stratified by graft type, over time post-graft  
 
Number of surviving grafts with visual acuity provided 
 
Pre-graft 1 year 2 years 3 years 4 years 5 years 
PK 530 78 89 49 47 38 
DS(A)EK 2193 355 242 160 78 66 
DMEK 658 69 28 6 1 0 
 
The pre-graft visual acuity reported for eyes undergoing penetrating keratoplasty for 
Fuchs’ endothelial dystrophy since the year 2006 was significantly worse than for those 
undergoing Descemet’s stripping (automated) endothelial keratoplasty or Descemet’s 
membrane endothelial keratoplasty (both p<0.001). The pre-graft visual acuity reported 
for eyes undergoing DMEK was also significantly better than those undergoing DS(A)EK 
(p<0.001). 
Visual acuity in surviving grafts was significantly improved (p<0.001) at 1-year post-graft, 
for all three types of graft. This difference remained significant up to 2-years post-graft for 
DMEK and up to 4-years post-graft for both PK and DS(A)EK (all p<0.001). There were 
insufficient numbers of grafts with both pre- and post-graft vision after these points to 
make comparisons. The average post-graft visual acuity in surviving grafts reached 6/12 
for all three groups - by 1-year post-graft for DMEK and DS(A)EK, and 2-years post-graft 
for PK.   
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8.3.1.1 Survival of grafts for Fuchs’ endothelial dystrophy: influence of graft type 
and early failures 
 
A greater proportion of Descemet’s stripping (automated) endothelial keratoplasties, and 
Descemet’s membrane endothelial keratoplasties performed for Fuchs' endothelial 
dystrophy than penetrating keratoplasties for the same indication, failed within three 
months (90 days) of graft (110/2282=4.8% and 102/680=15.0% vs. 5/550=0.9%). 
Figure 8.3.3 shows the comparison of survival between penetrating keratoplasties, 
Descemet’s membrane endothelial keratoplasties, and Descemet’s stripping (automated) 
endothelial keratoplasties performed for Fuchs' endothelial dystrophy since the 
introduction of the latter technique in 2006, excluding these early failures. A significant 
difference was still found between the three groups (Log Rank Statistic=23.65; df=2; 
p<0.001). PKs still had significantly better survival than DS(A)EK and DMEK (both 
p<0.001), while the difference in survival between DS(A)EK and DMEK was no longer 
significant (p=0.039), once Bonferroni correction was applied. 
Figure 8.3.4 Type of graft for Fuchs' endothelial dystrophy, 2006 onwards, 
excluding early failures 
 
Number at risk (years post-graft) 
 
1 2 4 6 8 10 
PK 403 338 231 148 65 8 
DS(A)EK 1179 839 314 93 12 NA 
DMEK 144 65 4 NA NA NA 
 
Probability of graft survival (years post-graft) 
 
1 2 4 6 8 
PK 0.99 0.96 0.89 0.81 0.73 
DS(A)EK 0.95 0.91 0.84 0.73 NA 
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9 Summary 
 
Up to 31st July 2017, 33,920 grafts were registered with the Australian Corneal Graft 
Registry. 26,297 (78%) of these had follow-up received by the census date. The 
introduction of partial-thickness lamellar keratoplasty techniques have resulted in a shift 
away from full-thickness penetrating keratoplasties.  
 
9.1 Donor and Eye Banking Factors 
 
No donor or eye banking factors were found to be significant independent risk factors for 
failure of deep anterior lamellar keratoplasty (DALK) or traditional lamellar keratoplasty 
(TLK).  
Donor age group was retained in multivariate analysis relating to penetrating keratoplasty, 
Descemet’s stripping (automated) endothelial keratoplasty (DS(A)EK) and Descemet’s 
membrane endothelial keratoplasty (DMEK), with grafts performed using tissue from 
younger donors exhibiting better survival for PK and DS(A)EK, but poorer survival for 
DMEK.  
For DS(A)EK, pre-graft central endothelial cell density was a significant independent risk 
factor with grafts performed using donor tissue with <2500 cells/mm² exhibiting poorer 
survival. Endothelial cell density was excluded from the multivariate model for PK due to 
a high proportion of missing data, but grafts with <2500 cells/mm² also exhibited poorer 
survival in the univariate analysis. 
 
9.2 Recipient Factors 
 
Indication for graft was found to be a significant independent risk factor for failure of PK, 
DS(A)EK, and TLK. There was a large amount of variation in survival across indications 
for PK. Superior survival was observed for grafts performed for keratoconus, while the 
poorest survival was observed for grafts performed for corneal ulcer. Grafts performed 
for Fuchs’ endothelial dystrophy had the best survival for DS(A)EK. For TLK, grafts for 
pterygium, trauma and scleral necrosis had superior survival, while those for herpetic eye 
disease faired most poorly. Recipient age group was found to be a significant independent 
factor for DMEK and DALK survival. Grafts performed in recipients under 50 years of age 
had poor survival for DMEK. For DALK, grafts performed in recipients aged under 60 had 
superior survivial to those performed in recipients aged 60 and over. 
Interstate transportation of corneas for PK was shown to result in a higher risk of failure, 
while for DS(A)EK and DMEK the Australian State where the graft had been registered 
was a significant independent risk factor. For DS(A)EK, male recipients had poorer 
survival than female recipients, while for PK the donor and recipient sexes in combination 
were a significant risk factor, with female to female grafts exhibiting superior survival to 
donor lenticules from either sex grafted into male recipients. The presence of a single 
prior corneal graft in the contralateral eye was an independent significant factor 
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The change in lens status from pre- to post-graft was a significant independent risk factor 
for both PK and DS(A)EK. In both cohorts, poorest survival occurred in eyes that were 
aphakic before and/or after the graft, or eyes that were pseudophakic both before and 
after graft. Pre-graft inflammation or steroid use was a significant independent risk factor 
for failure of PK, DALK and TLK. A history of raised intraocular pressure prior to, or at the 
time of, graft was a significant independent risk factor for failure of PK and DS(A)EK. Pre-
graft corneal neovascularisation was a significant independent risk factor for failure of PK, 
DALK, and TLK, with grafts performed in eyes with greater than one quadrant of 
neovascularisation having poorer survival. For DMEK, a pre-cut donor lenticule was an 
independent significant factor associated with superior survival. 
 
9.3 Graft Era 
 
Graft era, stratified into 5-year groups, was a significant independent risk factor for 
survival of PK and DALK, with improved outcomes in more recent eras for PK. PK and 
DALK performed from 2015 to 2017 had poorer survival than those performed in any 
other era from 2000 onwards. Graft era, stratified into 2-year groups, was a significant 
independent risk factor for survival of DS(A)EK and DMEK. For both cohorts, grafts 
performed in 2016/2017 had poorer survival than earlier eras. The single exception for 
this was DS(A)EK performed prior to 2008, which also had poorer survival than all grafts 
performed in subsequent eras. 
The effect of lag time on these analyses is acknowledged, the effect being most 
pronounced in the early years following graft registration. This is most likely to affect the 
data relating to grafts from the most recent cohorts, which have not yet had follow-up 
requested. 
 
9.4 Surgery and Surgeon Factors 
 
Graft size was a significant independent risk factor for PK, with grafts outside of the range 
of 7.75 mm to 8.75 mm, exhibiting significantly poorer survival. An optimal graft size 
window was also found for TLK with those between 6.1 mm and 8.0 mm having better 
survival than those that were either smaller or larger. For DS(A)EK, both graft size and 
incision size were found to be significant independent factors in graft survival, with grafts 
8.25 mm or larger faring better, but those with an incision size of 5.0 mm or greater 
exhibiting poorer survival.  
Surgeon experience and level of follow-up was shown to be a significant independent risk 
factor in the survival of PK and DS(A)EK. For both types of graft, surgeons with lower 
volumes of registered grafts, and those with high volumes of registered grafts but below 
average levels of follow-up, exhibited poorer survival. The Centre effect was a significant 
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9.5 Post-graft Events 
 
Significantly poorer graft survival was found in multivariate analyses for PK and DS(A)EK 
that had undergone at least one episode of post-graft rejection. Post-graft rejection 
occurred most frequently following penetrating keratoplasty and very few lamellar grafts 
underwent more than one post-graft rejection episode (see Table 9.1). 
Table 9.1 Number of post-graft rejection episodes stratified by graft type 
 
None One Two Three or more 
PK 20717 (83%) 2991 (12%) 692 (3%) 427 (2%) 
DS(A)EK 4473 (94%) 236 (5%) 20 (<1%) 7 (<1%) 
DMEK 1228 (98%) 21 (2%) 1 (<1%) 0 (0%) 
DALK 1476 (96%) 45 (3%) 8 (<1%) 2 (<1%) 
TLK 1462 (98%) 29 (2%) 3 (<1%) 1 (<1%) 
     
 
Higher risk of graft failure was also found for PK, DS(A)EK and DALK that had post-graft 
corneal neovascularisation. Lower risk was associated with raised intraocular pressure 
post-graft for both PK and DS(A)EK. Presence of post-graft microbial keratitis, and post-
graft herpetic infection, were both significant independent factors affecting graft survival 
for PK. 
 
9.6 Comparisons Across Graft Types 
 
Primary graft failure was reported most often following DMEK and DS(A)EK (13% and 
5% of registered grafts, respectively), and least often following PK, DALK and TLK (all 
<1% of registered grafts). 
PK performed for keratoconus since 2000, exhibited significantly better survival than 
DALK performed for the same reason over the same period. There were no significant 
differences in the pre-graft best corrected visual acuity (BCVA) recorded for PK and 
DALK, however there were significant differences in post-graft BCVA over time. Average 
post-graft BCVA was greatly improved and reached 6/12 for both groups.  
PK performed for pseudophakic bullous keratopathy (PBK) since 2006, exhibited 
significantly better survival than both DS(A)EK and DMEK performed for the same reason 
over the same period, and DS(A)EK exhibited significantly better survival than DMEK. 
Poorer survival was still observed for DMEK following removal of early failures from the 
analysis. Eyes undergoing PK for PBK had significantly worse pre-graft BCVA than those 
undergoing DS(A)EK or DMEK. Post-graft BCVA in surviving grafts improved for all graft 
types.  
PK performed for Fuchs’ endothelial dystrophy (FED) since 2006, exhibited significantly 
better survival than both DS(A)EK and DMEK performed for the same reason over the 
same period, and DS(A)EK exhibited significantly better survival than DMEK. Superior 
survival of PK was still observed following removal of early failures from the analysis. 
Eyes undergoing PK for FED had significantly worse pre-graft BCVA than those 
undergoing DS(A)EK, which had significantly worse BCVA than those undergoing DMEK. 
Post-graft BCVA improved and reached 6/12 for surviving grafts of all types. 
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10 Methods and Definitions 
 
10.1 Registration and Follow-up 
 
Grafts are registered by contributing surgeons as soon as possible after the graft. Follow-
up information is requested by the ACGR at intervals of about 12 months. Follow-up is 
initially sought from the operating surgeon. Thereafter, it may be sought from either the 
operating surgeon or an alternative follow-up practioner (ophthalmologist or optometrist), 
as advised by the operating surgeon. Information is provided by mail, with missing data 
routinely sought via follow-up letter or via phone.  
Each graft is followed until graft failure or until the death or loss to follow-up of the patient. 
Data-linkage with the National Death Index is performed on a five-yearly basis, the most 
recent linkage being completed in 2014. The study period for the analyses in this report 
was May 1985 to July 2017 (32 years), except where otherwise stated. 
 
10.2 Definition of Variables 
 
All information regarding diagnoses, ocular history and treatment are provided to the 
Registry by the operating surgeons. Information on donor factors is provided by eye 
banks. Multiple processes are in place to cross-check data consistency. 
A history of past inflammation is recorded if the individual is specifically reported to have 
had such an episode or if there is a history of the use of topical corticosteroids in that eye 
in the weeks immediately preceding the graft.  
Vessel ingrowth into the cornea at the time of graft is scored on a scale of 0-4, with 0 
representing no growth in any quadrant, 1 representing growth in 1 quadrant, 2 
representing growth in 2 quadrants, 3 being vessel ingrowth in 3 quadrants and 4 being 
vessel ingrowth in 4 quadrants. No distinction is made between superficial or deep 
vessels, patent or ghost vessels, or single or multiple vessel leashes. After corneal 
transplantation, the presence of even one vessel leash extending into the graft is 
considered enough to classify that graft as vascularized.  
The intraocular pressure (IOP) is generally considered to be raised if a reading of 25 mm 
of mercury or greater is made by applanation tonometry, but the decision is at the 
discretion of the ophthalmologist.  
Original pathology, current indications for graft, post-operative complications and reasons 
for graft failure are provided by individual surgeons and are coded by Registry staff using 
the ICD.9.CM system (US Department of Health and Human Services). Original 
pathologies for repeat grafts are cross-checked with previous information provided to the 
Registry. 
Information is collected on recipient bed size, incision size and donor button size, as 
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10.3 Graft Failure, Rejection and Complications 
 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. For penetrating grafts, the time from graft to failure is as reported by the 
surgeon. It is usually 1-2 days but no more than 7 days. For lamellar procedures, primary 
graft failure can occur after a longer period of time and is analysed as reported by 
surgeons. Additional information is collected to ascertain whether this occurred within 28 
days of the graft. Where surgeons indicate that the failure was due to surgical 
complications, this is also recorded. 
Any existing graft that is replaced by another in the same eye, irrespective of graft clarity 
and for whatever reason, is classified as a failed graft. An example in this category would 
be a clear graft with an unacceptably high degree of irregular astigmatism, not improved 
by refractive surgery, which is then replaced. In all other cases, graft failure is defined as 
oedema and irremediable loss of clarity in a previously thin, clear graft. The day of failure 
is the first day the patient is seen with an oedematous, opaque graft that subsequently 
fails to thin and clear. 
In some cases, partial-thickness grafts are performed in eyes that have undergone 
previous full-thickness grafts. The original penetrating grafts are still considered to have 
failed in these cases and are recorded as such. In a very small number of cases, 
recipients have multiple concurrent grafts in the same eye (e.g. a deep anterior lamellar 
graft and a Descemet’s stripping (automated) endothelial keratoplasty). In these cases, 
both grafts are considered to be surviving, regardless of the order they were performed. 
Rejection is defined as the development of a rejection line (epithelial or endothelial) or a 
unilateral anterior chamber reaction with corneal infiltrates and spreading corneal 
oedema in a previously thin, clear graft. 
Any development with the potential to compromise graft outcome is considered to be a 
complication.  Post-operative complications are collected in two ways.  First, a number of 
specified complications (stitch abscess, microbial keratitis, neovascularization of the 
graft, synechiae, uveitis, rise in IOP, cataract, rejection episode, herpetic recurrence, 
early changes of bullous keratopathy), refractive and related errors (anisometropia, 5 
dioptres astigmatism) and factors potentially affecting visual outcome but unrelated to the 
graft (cataract, amblyopia, retinal detachment, age related macular degeneration and 
diabetic retinopathy) are listed, requiring a yes/no answer.  Second, contributors are 
asked to specify any other relevant complications, information or departures from their 
preferred treatment. 
For surviving grafts, trial time was calculated as the time between the date of graft and 
the date on which the patient was last seen. For failed grafts, trial time was calculated as 
the time between the date of graft and the date of failure, specified on a daily basis. 
Although data were collected centrally within the Registry at least once yearly, individual 
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10.4 Statistical Analyses 
 
The Australian Corneal Graft Registry database is constructed in Microsoft Access and 
was designed by Ms Sandra Bobleter. This has subsequently been modified by Mrs 
Helene Holland, Ms Ngaere Hornsby, Ms Carmel McCarthy, Mrs Chris Bartlett, Mrs Marie 
Lowe, Dr Rachel Galettis, Ms Louise Smith and Dr Miriam Keane.  
For this report, data were extracted from the Access database, via an automated import 
process, into SPPS version 22 (SPSS Inc.). Individual databases were also created for 
each type of graft analysed. Univariate Kaplan–Meier survival analyses [see reference 3] 
were performed in IBM SPSS for Windows (Version 22.0) with significance set at p<0.05 
[Mantel–Cox log-rank² statistic – see references 4 & 5]. Bonferroni correction was applied 
for multiple comparisons [see reference 6]. Corresponding survival curves were 
generated in SPSS, for use in the report. The SPSS database was also saved as a 
STATA data file and multivariate Cox-proportional hazards regression analyses were 
performed using STATA version 11 [see references 7 & 8]. The report was prepared using 
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